
<!DOCTYPE html>
<html>
<head>
<!-- Required meta tags -->
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<!-- Check Browser, as well as Hostname and set JS, CSS, Favicon path based on that-->

<!-- Favicon --><!-- cpcommit -->
<!-- <link rel="shortcut icon" type="image/x-icon" href="https://www.sec.gov/favicon.ico"> -->

<script>
	(function() {
		var hostName = window.location.hostname;

		var browserAccepted = function() {

			var ua = window.navigator.userAgent;
			var trident = ua.indexOf('Trident/'); //IE 11;
			var msie = ua.indexOf('MSIE '); // IE 10 or older
			if (msie > 0) {
				return false;
			}
			return true;
		}();

		var pathToLibs = 'https://www.sec.gov/js';
		var pathToError = '/';
		if (hostName === 'www-test.sec.gov' || hostName === 'www.sec.gov') {
			pathToLibs = 'https://www.sec.gov/ixviewer/js';
			pathToError = '/ixviewer/';
		}
		if (browserAccepted) {

			// css
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/custom-bootstrap.css>');
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/lib/fontawesome/css/all.min.css>');
			document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/app.css>');

			// js
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/jquery-3.3.1.slim.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/popper.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/bootstrap.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/moment.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/vanilla-picker.min.js"><\/script>');
			document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/he.js"><\/script>');

			var date = new Date();
			var todaysDate = date.getDate() + '-' + (date.getMonth() + 1) + '-'
					+ date.getFullYear();
			document.write('<script type = "text/javascript" defer=true src="'
					+ pathToLibs + '/production.min.js?d=' + todaysDate
					+ '"><\/script>');
		} else {
			// user us on a browser that we do not support
			var currentUrl = window.location.href.split('?')[0];
			var browserError = currentUrl.substring(0, currentUrl
					.lastIndexOf('/'));
			browserError += pathToError + 'browser-error.html?url='
					+ encodeURIComponent(window.location.href);
			window.location.href = browserError;
		}
	})();
</script><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/css/custom-bootstrap.css"><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/lib/fontawesome/css/all.min.css"><link rel="stylesheet" href="https://www.sec.gov/ixviewer/js/css/app.css"><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/jquery-3.3.1.slim.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/popper.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/bootstrap.min.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/moment.js"></script><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/vanilla-picker.min.js"></script><style>.picker_wrapper.no_alpha .picker_alpha{display:none}.picker_wrapper.no_editor .picker_editor{position:absolute;z-index:-1;opacity:0}.picker_wrapper.no_cancel .picker_cancel{display:none}.layout_default.picker_wrapper{display:-webkit-box;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;flex-flow:row wrap;-webkit-box-pack:justify;justify-content:space-between;-webkit-box-align:stretch;align-items:stretch;font-size:10px;width:25em;padding:.5em}.layout_default.picker_wrapper input,.layout_default.picker_wrapper button{font-size:1rem}.layout_default.picker_wrapper>*{margin:.5em}.layout_default.picker_wrapper::before{content:'';display:block;width:100%;height:0;-webkit-box-ordinal-group:2;order:1}.layout_default .picker_slider,.layout_default .picker_selector{padding:1em}.layout_default .picker_hue{width:100%}.layout_default .picker_sl{-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_sl::before{content:'';display:block;padding-bottom:100%}.layout_default .picker_editor{-webkit-box-ordinal-group:2;order:1;width:6.5rem}.layout_default .picker_editor input{width:100%;height:100%}.layout_default .picker_sample{-webkit-box-ordinal-group:2;order:1;-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_done,.layout_default .picker_cancel{-webkit-box-ordinal-group:2;order:1}.picker_wrapper{box-sizing:border-box;background:#f2f2f2;box-shadow:0 0 0 1px silver;cursor:default;font-family:sans-serif;color:#444;pointer-events:auto}.picker_wrapper:focus{outline:none}.picker_wrapper button,.picker_wrapper input{box-sizing:border-box;border:none;box-shadow:0 0 0 1px silver;outline:none}.picker_wrapper button:focus,.picker_wrapper button:active,.picker_wrapper input:focus,.picker_wrapper input:active{box-shadow:0 0 2px 1px dodgerblue}.picker_wrapper button{padding:.4em .6em;cursor:pointer;background-color:whitesmoke;background-image:-webkit-gradient(linear, left bottom, left top, from(gainsboro), to(transparent));background-image:-webkit-linear-gradient(bottom, gainsboro, transparent);background-image:linear-gradient(0deg, gainsboro, transparent)}.picker_wrapper button:active{background-image:-webkit-gradient(linear, left bottom, left top, from(transparent), to(gainsboro));background-image:-webkit-linear-gradient(bottom, transparent, gainsboro);background-image:linear-gradient(0deg, transparent, gainsboro)}.picker_wrapper button:hover{background-color:white}.picker_selector{position:absolute;z-index:1;display:block;-webkit-transform:translate(-50%, -50%);transform:translate(-50%, -50%);border:2px solid white;border-radius:100%;box-shadow:0 0 3px 1px #67b9ff;background:currentColor;cursor:pointer}.picker_slider .picker_selector{border-radius:2px}.picker_hue{position:relative;background-image:-webkit-gradient(linear, left top, right top, from(red), color-stop(yellow), color-stop(lime), color-stop(cyan), color-stop(blue), color-stop(magenta), to(red));background-image:-webkit-linear-gradient(left, red, yellow, lime, cyan, blue, magenta, red);background-image:linear-gradient(90deg, red, yellow, lime, cyan, blue, magenta, red);box-shadow:0 0 0 1px silver}.picker_sl{position:relative;box-shadow:0 0 0 1px silver;background-image:-webkit-gradient(linear, left top, left bottom, from(white), color-stop(50%, rgba(255,255,255,0))),-webkit-gradient(linear, left bottom, left top, from(black), color-stop(50%, rgba(0,0,0,0))),-webkit-gradient(linear, left top, right top, from(gray), to(rgba(128,128,128,0)));background-image:-webkit-linear-gradient(top, white, rgba(255,255,255,0) 50%),-webkit-linear-gradient(bottom, black, rgba(0,0,0,0) 50%),-webkit-linear-gradient(left, gray, rgba(128,128,128,0));background-image:linear-gradient(180deg, white, rgba(255,255,255,0) 50%),linear-gradient(0deg, black, rgba(0,0,0,0) 50%),linear-gradient(90deg, gray, rgba(128,128,128,0))}.picker_alpha,.picker_sample{position:relative;background:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E") left top/contain white;box-shadow:0 0 0 1px silver}.picker_alpha .picker_selector,.picker_sample .picker_selector{background:none}.picker_editor input{font-family:monospace;padding:.2em .4em}.picker_sample::before{content:'';position:absolute;display:block;width:100%;height:100%;background:currentColor}.picker_arrow{position:absolute;z-index:-1}.picker_wrapper.popup{position:absolute;z-index:2;margin:1.5em}.picker_wrapper.popup,.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{background:#f2f2f2;box-shadow:0 0 10px 1px rgba(0,0,0,0.4)}.picker_wrapper.popup .picker_arrow{width:3em;height:3em;margin:0}.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{content:"";display:block;position:absolute;top:0;left:0;z-index:-99}.picker_wrapper.popup .picker_arrow::before{width:100%;height:100%;-webkit-transform:skew(45deg);transform:skew(45deg);-webkit-transform-origin:0 100%;transform-origin:0 100%}.picker_wrapper.popup .picker_arrow::after{width:150%;height:150%;box-shadow:none}.popup.popup_top{bottom:100%;left:0}.popup.popup_top .picker_arrow{bottom:0;left:0;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.popup.popup_bottom{top:100%;left:0}.popup.popup_bottom .picker_arrow{top:0;left:0;-webkit-transform:rotate(90deg) scale(1, -1);transform:rotate(90deg) scale(1, -1)}.popup.popup_left{top:0;right:100%}.popup.popup_left .picker_arrow{top:0;right:0;-webkit-transform:scale(-1, 1);transform:scale(-1, 1)}.popup.popup_right{top:0;left:100%}.popup.popup_right .picker_arrow{top:0;left:0}</style><script type="text/javascript" src="https://www.sec.gov/ixviewer/js/lib/he.js"></script><script type="text/javascript" defer="true" src="https://www.sec.gov/ixviewer/js/production.min.js?d=20-4-2022"></script>
<title>Inline XBRL Viewer</title>
<style type="text/css" id="customized-styles"> #dynamic-xbrl-form [enabled-taxonomy="true"][continued-taxonomy="false"]{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;display:inline;} #dynamic-xbrl-form [enabled-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;} #dynamic-xbrl-form [enabled-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;border-top:none;border-bottom:none;} #dynamic-xbrl-form [highlight-taxonomy="true"]{background-color:#FFD700 !important;} #dynamic-xbrl-form [highlight-taxonomy="true"] > *{background-color:#FFD700 !important;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-taxonomy="false"]{border:3px solid #003768 !important;display:inline;} #dynamic-xbrl-form [hover-taxonomy="true"]{background-color:rgba(255,0,0,0.3);} .tagged-data-example-1{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;} .search-results-example-1{background-color:#FFD700;} .tag-shading-exmple-1:hover{background-color:rgba(255,0,0,0.3);} .selected-fact-example-1{border:3px solid #003768 !important;}</style></head>
<body style="overflow:auto">
<!--?xml version="1.0" encoding="utf-8"?-->


     <title></title>
<meta http-equiv="Content-Type" content="text/html">

<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_MOBQ_mobiquity.com_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001084267 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->

<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0001084267</ix:nonnumeric>
  <ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonnumeric>
  <ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonnumeric>
  <ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonnumeric>
  <ix:nonnumeric contextref="From2021-01-01to2021-12-31" id="xdx2ixbrl0045" name="dei:AuditorFirmId">5041</ix:nonnumeric>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0315" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0316" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0317" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0323" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0324" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0325" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0331" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0332" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0333" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0334" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0337" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0338" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0339" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0345" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0346" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0347" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0353" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0354" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0355" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0361" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0362" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0372" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0373" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0381" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0382" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0383" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0384" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0385" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0389" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0397" unitref="Shares" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0415" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0416" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0417" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0423" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0424" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0425" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0426" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0431" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0432" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0433" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0441" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0451" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0452" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0453" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0459" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0460" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0461" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0462" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0465" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0466" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0467" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0468" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" id="xdx2ixbrl0471" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" id="xdx2ixbrl0472" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember" id="xdx2ixbrl0473" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0474" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0475" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0496" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0497" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0500" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0501" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0504" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0505" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0508" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0509" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0512" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0513" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0516" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0517" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0520" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0521" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-01to2021-12-31" id="xdx2ixbrl0522" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0524" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0525" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-01to2021-12-31" id="xdx2ixbrl0526" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0528" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0542" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0543" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0546" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0547" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0550" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0551" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0554" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0555" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31" id="xdx2ixbrl0556" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0558" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0559" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0562" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0563" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0566" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0567" unitref="USD" xs:nil="true"></ix:nonfraction>
  <ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_us-gaap_TreasuryStockMember" id="xdx2ixbrl0570" unitref="USD" xs:nil="true"></ix:nonfraction>
  </ix:hidden>
 <ix:references>
  <link:schemaref xlink:href="mobq-20211231.xsd" xlink:type="simple">
  </link:schemaref></ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CommonStock0.001ParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:CommonStock0.001ParValuePerShareMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PurchaseWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:PurchaseWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AaaPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:AaaPreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AaaPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:AaaPreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PreferredStockSeriesCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:PreferredStockSeriesCMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PreferredStockSeriesCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:PreferredStockSeriesCMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PreferredSeriesEMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:PreferredSeriesEMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PreferredSeriesEMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:PreferredSeriesEMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MezzaninePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:MezzaninePreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesEPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesEPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SeriesCPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesCPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_MezzaninePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:MezzaninePreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesEPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesEPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesCPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesCPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:MezzaninePreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SeriesEPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesEPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesCPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:MezzaninePreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesEPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SeriesCPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesCPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MezzaninePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:MezzaninePreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SeriesEPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesEPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SeriesCPreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">MOBQ:SeriesCPreferredStocksMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AdvangelistsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">MOBQ:AdvangelistsLLCMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-082020-09-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-09-08</xbrli:startdate>
        <xbrli:enddate>2020-09-09</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_SixCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">MOBQ:SixCustomersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_SixCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">MOBQ:SixCustomersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">MOBQ:FourCustomersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FiveCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">MOBQ:FiveCustomersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FiveCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">MOBQ:FiveCustomersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AtosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">MOBQ:AtosMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AtosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">MOBQ:AtosMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AtosPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">MOBQ:AtosPlatformMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AtosPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">MOBQ:AtosPlatformMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AtosPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">MOBQ:AtosPlatformMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MobFoxUSLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:MobFoxUSLLCMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MobFoxUSLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:MobFoxUSLLCMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_DrSalkindMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:DrSalkindMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DrSalkindMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:DrSalkindMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:SmallBusinessAdministrationMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:SmallBusinessAdministrationMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SubscriptionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:SubscriptionAgreementsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubscriptionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:SubscriptionAgreementsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BlueLakePartnersTalosVictoryFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BlueLakePartnersTalosVictoryFundMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_BlueLakePartnersTalosVictoryFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BlueLakePartnersTalosVictoryFundMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BusinessCapitalProvidersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_BusinessCapitalProvidersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_SmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:SmallBusinessAdministrationMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-07-01</xbrli:startdate>
        <xbrli:enddate>2021-09-30</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ThreeLenderInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:ThreeLenderInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_BusinessCapitalProvidersMember_custom_ElevenLenderInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:ElevenLenderInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ElevenLenderInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:ElevenLenderInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_BusinessCapitalProvidersMember_custom_FourLenderInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:FourLenderInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_FourLenderInvestorsMember_custom_OneOutOfFourLenderInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:FourLenderInvestorsMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:SecuritiesFinancingTransactionAxis">MOBQ:OneOutOfFourLenderInvestorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:TwentyNineSubscriptionsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember_custom_TwelveNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:TwentyNineSubscriptionsMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:SecuritiesFinancingTransactionAxis">MOBQ:TwelveNotesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember_custom_SixteenNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:TwentyNineSubscriptionsMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:SixteenNotesMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember_custom_OneNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:TwentyNineSubscriptionsMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:SecuritiesFinancingTransactionAxis">MOBQ:OneNoteMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_custom_BlueLakePartnersTalosVictoryFund1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BlueLakePartnersTalosVictoryFund1Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_custom_BlueLakePartnersTalosVictoryFundMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BlueLakePartnersTalosVictoryFundMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BlueLakePartnersTalosVictoryFundMember_custom_WarrantsConvertedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BlueLakePartnersTalosVictoryFundMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:WarrantsConvertedMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TalosVictoryFundMember_custom_WarrantsConvertedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:TalosVictoryFundMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:WarrantsConvertedMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_BlueLakePartnersMember_custom_WarrantsConvertedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BlueLakePartnersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DebtConversionByUniqueDescriptionAxis">MOBQ:WarrantsConvertedMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-12-31_custom_BusinessCapitalProvidersMember_custom_NonAffiliatedThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:BusinessCapitalProvidersMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:SecuritiesFinancingTransactionAxis">MOBQ:NonAffiliatedThirdPartyMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-10-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NonAffiliatedPersonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">MOBQ:NonAffiliatedPersonMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember198564156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember198564171">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PreferredSeriesEMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:PreferredSeriesEMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PreferredSeriesEMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:PreferredSeriesEMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PreferredSeriesEMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:PreferredSeriesEMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_WarrantsMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:WarrantsMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NoteHolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NoteHolderMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-04-08_custom_OneInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-04-08</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-08_custom_OneInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-04-14_custom_OneInvestor2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor2Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-04-14</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-04-16_custom_OneInvestor3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor3Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-04-16</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-16_custom_OneInvestor3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor3Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-04-21_custom_OneInvestor2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor2Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-04-21</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-04-21_custom_SaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:SaleOfStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-04-21</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-21_custom_SaleOfStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:SaleOfStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-04-30_custom_OneInvestor4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor4Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-04-30</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OneInvestor4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor4Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-05-10_custom_OneInvestor5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor5Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-05-10</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-10_custom_OneInvestor5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor5Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-05-17_custom_OneInvestor6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor6Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-05-17</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-17_custom_OneInvestor6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor6Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-05-18_custom_OneInvestor7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor7Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-05-18</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-18_custom_OneInvestor7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor7Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-05-19_custom_OneInvestor8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor8Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-05-19</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-19_custom_OneInvestor8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor8Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-05-24_custom_OneInvestor9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor9Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-05-24</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-24_custom_OneInvestor9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor9Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-09_custom_ThreeInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:ThreeInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-09_custom_ThreeInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:ThreeInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-06-09</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-18_custom_TwoInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-18_custom_TwoInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-06-18</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-08_custom_TwoInvestors1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestors1Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-07-08_custom_TwoInvestors1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestors1Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-07-08</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-14_custom_TwoInvestors2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestors2Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-07-14_custom_TwoInvestors2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestors2Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-07-14</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-14_custom_TwoInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-15_custom_TwoInvestors3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestors3Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-07-15_custom_TwoInvestors3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestors3Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-07-15</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-11_custom_OneInvestor10Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor10Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-08-11_custom_OneInvestor9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor9Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-08-11</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-12_custom_TwoInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-012021-08-12_custom_TwoInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-08-01</xbrli:startdate>
        <xbrli:enddate>2021-08-12</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-08-16_custom_OneInvestor11Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor11Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-08-16</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-25_custom_TwoInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-08-25_custom_TwoInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:TwoInvestorMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-08-25</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-02_custom_OneInvestor12Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor12Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-07_custom_OneInvestor13Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor13Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-07_custom_OneInvestor13Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor13Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-09-07</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-10_custom_OneInvestor14Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor14Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-15_custom_OneInvestor15Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor15Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-15_custom_OneInvestor15Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor15Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-09-15</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-16_custom_OneInvestor16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor16Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-16_custom_OneInvestor16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:OneInvestor16Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-09-16</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DrSalkindMember_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:DrSalkindMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DrSalkindMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:DrSalkindMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DrSalkindMember_custom_WarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">MOBQ:DrSalkindMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementClassOfStockAxis">MOBQ:WarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-132021-12-31_custom_ConsultingAgreementMember_custom_Capital622Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:ConsultingAgreementMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:Capital622Member</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-12-13</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-132021-12-31_custom_ConsultingAgreementMember_custom_AlchemyAdvisoryLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:TransactionTypeAxis">MOBQ:ConsultingAgreementMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:AlchemyAdvisoryLlcMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-12-13</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OptionsAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">MOBQ:OptionsAndWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_OptionsAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">MOBQ:OptionsAndWarrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EmployeesMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:EmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmployeesMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:EmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EmployeesMember_custom_StockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:EmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">MOBQ:StockGrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmployeesMember_custom_StockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:EmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">MOBQ:StockGrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_NonEmployeesMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NonEmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NonEmployeesMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NonEmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_NonEmployeesMember_custom_StockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NonEmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">MOBQ:StockGrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NonEmployeesMember_custom_StockGrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NonEmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">MOBQ:StockGrantsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_NonEmployeesMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NonEmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_NonEmployeesMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">MOBQ:NonEmployeesMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2020-01-01</xbrli:startdate>
        <xbrli:enddate>2020-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_FyberMonetizationMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">MOBQ:FyberMonetizationMember</xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2022-01-01</xbrli:startdate>
        <xbrli:enddate>2022-03-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AdvangelistsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001084267</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">MOBQ:AdvangelistsMember</xbrldi:explicitmember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startdate>2021-01-01</xbrli:startdate>
        <xbrli:enddate>2021-12-31</xbrli:enddate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitnumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitnumerator>
        <xbrli:unitdenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitdenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 7pt"><a href="#a_001">Table of Contents</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOBIQUITY TECHNOLOGIES, INC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FORM <span id="xdx_909_edei--DocumentType_c20210101__20211231_zVM6HT5ywYSj"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K</ix:nonnumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_907_edei--DocumentAnnualReport_c20210101__20211231_zI8CEXrREoVY"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">☒</ix:nonnumeric></span> ANNUAL REPORT PURSUANT TO SECTION 13 OR
15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FOR THE FISCAL YEAR ENDED <span id="xdx_907_edei--DocumentPeriodEndDate_c20210101__20211231_zh5YrxiG1gDo"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_905_edei--CurrentFiscalYearEndDate_c20210101__20211231_zQCNi7B5AV2f"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">DECEMBER 31</ix:nonnumeric></span>, 2021</ix:nonnumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="text-align: center; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_904_edei--DocumentTransitionReport_c20210101__20211231_zKlQ9xCQrdfE"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">☐</ix:nonnumeric></span> TRANSITION REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="text-align: center; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt">For the transition period from _____ to _____</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">COMMISSION FILE NUMBER: <span style="font: normal 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityFileNumber_c20210101__20211231_zFZMUljEciih"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">001-41117</ix:nonnumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_908_edei--EntityRegistrantName_c20210101__20211231_z4E8sy94lQTV" style="font-size: 12pt"><b><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">MOBIQUITY
TECHNOLOGIES, INC.</ix:nonnumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of Registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 50%; text-align: justify"><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20210101__20211231_zfk5nOmKtOLo"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">New York</ix:nonnumeric></span></td>
    <td style="border-bottom: black 1pt solid; width: 50%; text-align: right"><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20210101__20211231_znWreDmPFBTw"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">11-3427886</ix:nonnumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(State of jurisdiction of</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">incorporation or organization)</p></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">(I.R.S. Employee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Identification Number)</p></td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: justify"><span id="xdx_908_edei--EntityAddressAddressLine1_c20210101__20211231_zax7G2nqfqkD"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">35 Torrington Lane</ix:nonnumeric></span> <span id="xdx_90A_edei--EntityAddressCityOrTown_c20210101__20211231_zp0y0RF2FYTo"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">Shoreham</ix:nonnumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20210101__20211231_zYlN91PQpDbF"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityAddressStateOrProvince">NY</ix:nonnumeric></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_905_edei--EntityAddressPostalZipCode_c20210101__20211231_zoDaGubnOg2U"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">11786</ix:nonnumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td>(Address of principal executive offices)</td>
    <td style="text-align: right">(Zip Code)</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid">Registrant's telephone number, including area code:</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span id="xdx_90F_edei--CityAreaCode_c20210101__20211231_zcym49LZXxJr"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:CityAreaCode">(516)</ix:nonnumeric></span> <span id="xdx_902_edei--LocalPhoneNumber_c20210101__20211231_zJretcoLac1y"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">246-9422</ix:nonnumeric></span></td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(b)
of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 40%; font-size: 10pt; text-align: center"><span style="text-decoration: underline">Title of each class</span></td>
    <td style="text-align: center; width: 20%"><span style="text-decoration: underline">Trading Symbol</span></td>
    <td style="width: 40%; font-size: 10pt; text-align: center"><span style="text-decoration: underline">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_907_edei--Security12bTitle_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValuePerShareMember_zf9cCqpEFgfe"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_CommonStock0.001ParValuePerShareMember" name="dei:Security12bTitle">Common
Stock, $.001 par value</ix:nonnumeric></span></p></td>
    <td style="text-align: center"><span id="xdx_90F_edei--TradingSymbol_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValuePerShareMember_zjzC3EQhmuaa"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_CommonStock0.001ParValuePerShareMember" name="dei:TradingSymbol">MOBQ</ix:nonnumeric></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The <span id="xdx_90A_edei--SecurityExchangeName_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStock0.001ParValuePerShareMember_zPbXUTSfrFRf"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_CommonStock0.001ParValuePerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonnumeric>
</span></b><b>Stock Market LLC</b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span id="xdx_900_edei--Security12bTitle_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--PurchaseWarrantsMember_zWItU4lnDOG3"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_PurchaseWarrantsMember" name="dei:Security12bTitle">Common Stock Purchase Warrants</ix:nonnumeric></span></td>
    <td style="text-align: center"><span id="xdx_90C_edei--TradingSymbol_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--PurchaseWarrantsMember_zFYsDc9xttj6"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_PurchaseWarrantsMember" name="dei:TradingSymbol">MOBQW</ix:nonnumeric></span></td>
    <td style="text-align: center; font-size: 10pt"><b>The <span id="xdx_90D_edei--SecurityExchangeName_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--PurchaseWarrantsMember_zYOtI0ScZI7f"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_PurchaseWarrantsMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonnumeric></span> Stock Market LLC</b></td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section 12(g)
of the Act: </b>None</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐&nbsp;<span id="xdx_908_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_zVFoZNQVaG5P"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonnumeric></span> ☒</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check whether the Registrant is not required
to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes ☐&nbsp;&nbsp;<span id="xdx_904_edei--EntityVoluntaryFilers_c20210101__20211231_zrK5MrUrkV7b"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonnumeric></span> ☒</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the Registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements
for the past 90 days. <span id="xdx_908_edei--EntityCurrentReportingStatus_c20210101__20211231_ztCXAI2966mc"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonnumeric></span> ☒&nbsp;No ☐</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the Registrant
has submitted electronically, every Interactive data file required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_90A_edei--EntityInteractiveDataCurrent_c20210101__20211231_zzAFLG76GrE1"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonnumeric></span>
☒&nbsp;No ☐</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”,
and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 25%">Large accelerated filer</td>
    <td style="width: 40%">☐</td>
    <td style="width: 30%">Accelerated filer</td>
    <td style="width: 5%">☐</td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_90B_edei--EntityFilerCategory_c20210101__20211231_zxFjONIzdgfU"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonnumeric></span></td>
    <td>☒</td>
    <td>Smaller reporting company</td>
    <td><span id="xdx_90A_edei--EntitySmallBusiness_c20210101__20211231_znszT2PDQr9a"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">☒</ix:nonnumeric></span></td></tr>
  <tr style="vertical-align: top">
    <td>Emerging growth company</td>
    <td><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20210101__20211231_zU5MeiOi6cPn"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">☐</ix:nonnumeric></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">☐</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. ☐</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the Registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;<span id="xdx_905_edei--EntityShellCompany_c20210101__20211231_zh3atDi5uekB"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonnumeric></span> ☒</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2021, the number of shares of Common
Stock held by non-affiliates was approximately 2,382,100 shares based upon 3,100,782 post-split shares of Common Stock outstanding. The
approximate market value based on the last sale (i.e. $9.50 per share as of June 30, 2021) of the Company’s Common Stock held by
non-affiliates was approximately $<span id="xdx_90E_edei--EntityPublicFloat_iI_c20210630_zFU4q5LiaGYJ"><ix:nonfraction name="dei:EntityPublicFloat" contextref="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitref="USD">22,629,950</ix:nonfraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of shares outstanding of the Registrant’s Common Stock
as of March 25, 2022, was <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20220325_zaXkYybamlVl"><ix:nonfraction name="dei:EntityCommonStockSharesOutstanding" contextref="AsOf2022-03-25" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,560,751</ix:nonfraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 9, 2020, the Company effected a one-for-400 reverse stock
split. All share and per share amounts set forth herein give retroactive effect to such stock split unless the context indicates otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORWARD-LOOKING STATEMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
believe this annual report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform
Act of 1995. These statements are subject to risks and uncertainties and are based on the beliefs and assumptions of our management, based
on information currently available to our management. When we use words such as "believes," "expects," "anticipates,"
"intends," "plans," "estimates," "should," "likely" or similar expressions, we are making
forward-looking statements. Forward-looking statements include information concerning our possible or assumed future results of operations
set forth under "Business" and/or "Management's Discussion and Analysis of Financial Condition and Results of Operations."
Forward-looking statements are not guarantees of performance. They involve risks, uncertainties and assumptions. Our future results and
stockholder values may differ materially from those expressed in the forward-looking statements. Many of the factors that will determine
these results and values are beyond our ability to control or predict. Stockholders are cautioned not to put undue reliance on any forward-looking
statements. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities
Litigation Reform Act of 1995. For a discussion of some of the factors that may cause actual results to differ materially from those suggested
by the forward-looking statements, please read carefully the information under "Risk Factors." In addition to the Risk Factors
and other important factors discussed elsewhere in this annual report, you should understand that other risks and uncertainties and our
public announcements and filings under the Securities Exchange Act of 1934, as amended could affect our future results and could cause
results to differ materially from those suggested by the forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>As used in this Form 10-K, the terms “we,”
“our,” “us,” “Mobiquity Technologies” or “the Company” refer to Mobiquity Technologies,
Inc. and its subsidiaries, taken as a whole, unless the context otherwise requires it.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our financial statements are stated in United
States dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. All references to “common
stock” refer to the common shares in our capital stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_001"></span>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 95%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; width: 5%; text-align: center">PAGE</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_002">PART I</a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_003">Item 1 Business</a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_005">Item 1A Risk Factors</a></td>
    <td style="text-align: center">13</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_006">Item 1B Unresolved Staff Comments</a></td>
    <td style="text-align: center">30</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_007">Item 2 Properties</a></td>
    <td style="text-align: center">30</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_008">Item 3 Legal Proceedings</a></td>
    <td style="text-align: center">31</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_009">Item 4 Mine Safety Disclosures</a></td>
    <td style="text-align: center">31</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_010">PART II</a></td>
    <td style="text-align: center">32</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_011">Item 5 Market for Common Equity, related Stockholders Matters, and Issuer</a></td>
    <td style="text-align: center">32</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_012">Item 6 Selected Financial Data</a></td>
    <td style="text-align: center">34</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_013">Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations</a></td>
    <td style="text-align: center">34</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_014">Item 7A Qualitative and Qualitative Disclosures about Market Risk</a></td>
    <td style="text-align: center">39</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_015">Item 8 Financial Statements</a></td>
    <td style="text-align: center">39</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_016">Item 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></td>
    <td style="text-align: center">74</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_017">Item 9A Controls and Procedures</a></td>
    <td style="text-align: center">74</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_018">Item 9B Other Information</a></td>
    <td style="text-align: center">74</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_019">PART III</a></td>
    <td style="text-align: center">75</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_020">Item 10 Directors, Executive Officers and Corporate Governance</a></td>
    <td style="text-align: center">75</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_021">Item 11 Executive Compensation</a></td>
    <td style="text-align: center">84</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_022">Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></td>
    <td style="text-align: center">94</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_023">Item 13 Certain Relationships and Related Transactions and Director Independence</a></td>
    <td style="text-align: center">95</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_024">Item 14 Principal Accountant Fees and Services</a></td>
    <td style="text-align: center">97</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><a href="#a_025">PART IV</a></td>
    <td style="text-align: center">98</td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td><a href="#a_026">Item 15 Exhibits and Financial Statement Schedules</a></td>
    <td style="text-align: center">98</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_002"></span>PART I</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_003"></span>Item 1. Business</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Company Background</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mobiquity Technologies,
Inc. is a next-generation marketing and advertising technology and data intelligence company which operates through our proprietary
software platforms in the programmatic advertising space. Our product solutions are comprised of two proprietary software
platforms:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td><p style="text-align: justify; margin-top: 0; margin-bottom: 0">Our advertising technology operating system (or ATOS) platform; and</p>
        <p style="margin-top: 0; margin-bottom: 0"></p></td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Our data intelligence platform.</td></tr>
  </tbody></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Products</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The ATOS Platform</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&nbsp;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
ATOS platform blends artificial intelligence (or AI) and machine learning (ML) based optimization technology for automatic ad serving
that manages digital advertising inventory and campaigns. The ATOS platform:</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">creates an automated marketplace of advertisers and publishers on digital media outlets to host online auctions to facilitate the sale of digital advertising (known as&nbsp;digital real estate) targeted at users while engaged on their internet-connected TV, laptop, tablet, desktop computer, mobile, and over-the-top (or OTT) streaming media devices; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>gives advertisers the capability to understand and interact with their audiences and engage them in a meaningful way by using ads in both image and video formats (known as rich media) to increase their awareness, customer&nbsp;base and foot traffic to their e-commerce site, voting site or physical locations.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ATOS platform engages with approximately 10
billion advertisement opportunities per day, based on our daily logs. Our sales and marketing strategy for our ATOS platform is focused
on providing a de-fragmented operating system that facilitates a considerably more efficient and effective way for advertisers and publishers
to transact with each other. Our goal is to become the programmatic display advertising industry standard for small and medium sized advertisers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ATOS technology is proprietary
and primarily consists of know-how and trade secrets developed internally, as well as certain open-source software.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Users of the ATOS platform get access to
benefits including&nbsp;among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">ease of set up;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">targeting features based on audience profiles and location through an in-house data management platform (or DMP);</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Inventory management and yield optimization;</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">support for all rich media creators’ ad tags;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">machine learning and AI powered optimization which aids in delivering a higher click through rate on ad links;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">support for third-party trackers and custom scripts for make-the-most-of-your media (or MOAT) analytics, Integral Ad Science (or IAS), and forensics to enable independent verification by advertisers for transparency;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">detailed campaign wrap-up reporting that gives a breakdown on publishers, categories, demonstrations, and devices to better understand advertisement campaign performance;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">access to business&nbsp;intelligence via&nbsp;an analytics dashboard;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">advanced ad targeting;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td><p style="text-align: justify; margin-top: 0; margin-bottom: 0">easy campaign uploading;</p>
        <p style="margin-top: 0; margin-bottom: 0"></p></td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">automated performance optimization;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">real time reporting;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">fraud prevention tools; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">24x7 support, along with guided managed services to enable users to rapidly harness and operate all the features of the ATOS platform.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our
ATOS platform includes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Adserver;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Demand Side Platform;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Advertisement quality tools;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Analytics dashboard;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Avails Engine;</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Advertisement prediction and delivery tools;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Supply quality tools;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Private marketplace tools;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Audience and location targeting;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Wrap up reports;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">An Advertisement software development kit (or SDK);</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Prebid adaptor;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">contextual targeting;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">identity graph capabilities;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">cookie syncing; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the updated version of our quality and security tools, among other things for our ATOS platform.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>The Data Intelligence Platform</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
data intelligence platform provides precise data and insights on consumer’s real-world behavior and trends for use in marketing
and research. We believe, based on our experience in our industry, that we provide one of the most accurate and scaled solutions for data
collection and analysis, utilizing multiple proprietary technologies. Our data intelligence platform technology allows for the ingestion
and normalization of various data sources, such as location data, transactional data, contextual data, and search data to reach the right
target audience with the right message. Utilizing massively parallel cluster computing and machine learning algorithms and technology,
our data intelligence solutions make available actionable data for marketers, researchers and application publishers through an automated
platform. We are seeking to generate several revenue streams from our data collection and analysis, including, among other things; advertising,
data licensing, attribution reporting, and custom research.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also offer a self-service alternative through
our MobiExchange product, which is a SaaS fee model. MobiExchange is a data focused technology solution that enables individuals and companies
to rapidly build actionable data and insights for their own use or for resale. MobiExchange’s easy-to-use, self-service tools allow
users to reduce the complex technical and financial barriers typically associated with turning offline data, and other business data,
into actionable digital products and services. MobiExchange provides out-of-the-box private labeling, flexible branding, content management,
user management, user communications, subscriptions, payment, invoices, reporting, gateways to third party platforms, and help desk among
other things.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe, based on our
experience in our industry, that we provide one of the most accurate and scaled solutions for data collection and analysis, utilizing
multiple proprietary technologies. MobiExchange is a data focused technology solution that enables individuals and companies
to rapidly build actionable data and insights for its own use or for resale. MobiExchange’s easy-to-use, self-service tools
allow anyone to reduce the complex technical and financial barriers typically associated with turning offline data, and other
business data, into actionable digital products and services. MobiExchange provides out-of-the box private labeling, flexible
branding, content management, user management, user communications, subscriptions, payment, invoices, reporting, gateways to third
party platforms, and help desk, among other things.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our data intelligence
platform is hosted and managed on Amazon Web Service (AWS) and takes full advantage of open standards for processing, storage,
security and big data technology. Specifically, our data intelligence platform uses the following AWS services: EC2, Lambda, Kafka,
Kinesis, S3, Storm, Spark, Machine Learning, RDS, Redshift, Elastic Map Reduction, CloudWatch, DataBricks, and Elastic Search
Service with built-in Kibana integration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Strategy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our strategy in the programmatic advertising space
is to provide small- to medium-sized enterprises with an efficient and effective end-to-end, fully integrated ATOS platform. We believe
that our ATOS platform gives users in these markets the capability of running marketing and branding campaigns without the need for an
extensive marketing team, which enables them to better compete with their larger competitors who have greater marketing financial and
human capital resources. Our sales and marketing approach is focused on providing a de-fragmented operating system that facilitates a
considerably more efficient and effective way for advertisers and publishers to transact with each other. Our goal is to become the programmatic
display advertising industry standard for small- and medium-sized advertisers. Mobiquity plans to hire several new sales and sales support
individuals to help generate additional revenue through the use of our ATOS platform.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our strategy is based on a problem we perceived
in the advertising technology industry as it has rapidly grown over the last 10 years. We viewed the technology in the industry to be
highly fragmented and thus inefficient. Many advertisers have had to mix multiple vendors’ different technologies, or bolt-on third-party
technology to legacy technology, in an effort to create an integrated solution. Often this has resulted in the absence of a central source
to address problems with an integrated system that arise. The flaws that this type of stacked technology ecosystem has includes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Increased cost -- this results from integration costs, technology management costs and revenue sharing arrangements among vendors providing different components of the system.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Decreased speed -- the automated buying and selling of digital advertising space happens in micro-seconds and when the technology stack comprising the system has to work through several distinct vendor components, the system is inherently slower than a single vendor all-inclusive platform.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Lack of transparency – a digital programmatic advertising campaign is comprised of a multitude of metrics each of which can be optimized by the advertiser according to its needs. Lack of transparency occurs when the digital programmatic advertising campaign jumps from its primary platform to the add-on vendors’ platform and the advertiser is unable to see or access certain of the metrics covered by a particular vendor’s component. The user thus loses the ability to optimize that part of the campaign. This is exacerbated as more add-on technologies are added to the system.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
believe our products address and solve the flaws of a stacked system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A typical digital advertising campaign requires
the following components:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>Data Management Platform (or DMP)</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Demand-Side Platform (or DSP)</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Supply-Side Platform (or DSP)</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Bidder</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Ad Server</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Ad Network</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Supply Quality Tools</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Fraud Detection</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Analytical Tools</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Reporting Dashboard</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many
of the companies we target have between 50-70% of the above components and outsource the rest to vendors who bolt-on technology to those
companies’ legacy technology which often results in the flaws discussed above. We provide a single-vendor end-to-end solution integrating
the required components from a single source that work together because they are built together, in an effective and cost-efficient way.
Our ATOS platform decreases the effective cost-basis for users by integrating all the necessary capabilities at no additional cost: DSP
and bidding technologies, AdCop™ Fraud Protection, rich media and ad serving, attribution, reporting dashboard and DMP are all included.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Revenue Streams</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
target brands, advertising agencies and other advertising technology companies as our audience for our ATOS platform products. The ATOS
platform creates three revenue streams.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The first is licensing the ATOS platform as a white-label product for use by advertising agencies, demand-side platforms (or DSP’s), brands and publishers. Under the white-label scenario, the user licenses the ATOS platform from us and is responsible for running its own business operations and is billed a percentage of amounts spent on advertising run through the platform.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The second revenue stream is a managed services model, in which, the user is billed a higher percentage of revenue run through the platform, but all services are managed by us.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The third revenue model is a seat model in which our customer uses our platform and we provide customer service but the customer does everything else, where the user is billed a percentage of revenue run through the platform and business operations are shared between the user and us.</td></tr>
  </tbody></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our data intelligence revenue is driven by
managed services for advertising agencies; brands; market researchers; university research departments; healthcare; and
financial, sports, pet, civil planning, transportation, and other data and technology companies. Often-times
sales to users of our data intelligence platform will lead to them to our ATOS platform as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Intellectual Property</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
portfolio of technology consists of various intellectual property including proprietary source code, trade secrets and know-how that we
have developed internally. We own our technology, although we use open source software for certain aspects, and we protect it though trade
secrets and confidentiality requirements set out in our employee handbook which each employee acknowledges, and assigning any technology
creations and improvements to us. We also have two patents that relate to our location-based mobile advertising technology business which
we are not operating. These patents and patents pending are not material to, or used in, our ATOS or data intelligence related technology
that we use in our current operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Governmental Regulations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="a_004"></span>Federal,
state and international laws and regulations govern the collection, use, retention, sharing and security of data that we collect. We strive
to comply with all applicable laws, regulations, self-regulatory requirements and legal obligations relating to privacy, data protection
and consumer protection, including those relating to the use of data for marketing purposes. As we develop and provide solutions that
address new market segments, we may become subject to additional laws and regulations, which could create unexpected liabilities for us,
cause us to incur additional costs or restrict our operations. From time to time, we may be notified of or otherwise become aware of additional
laws and regulations that governmental organizations or others may claim should be applicable to our business. Our failure to anticipate
the application of these laws and regulations accurately, or other failure to comply, could create liability for us, result in adverse
publicity or cause us to alter our business practices, which could cause our net revenues to decrease, our costs to increase or our business
otherwise to be harmed. See “Item 1A.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to general business regulations
and laws as well as regulations and laws specifically governing the internet, e-commerce and m-commerce in a number of jurisdictions around
the world. Existing and future regulations and laws could impede the growth of the Internet, e-commerce, m-commerce or other online services.
These regulations and laws may involve taxation, tariffs, privacy and data security, anti-spam, data protection, content, copyrights,
distribution, electronic contracts, electronic communications and consumer protection. It is not clear how existing laws and regulations
governing issues such as property ownership, sales and other taxes, libel and personal privacy apply to the Internet as the vast majority
of these laws and regulations were adopted prior to the advent of the Internet and do not contemplate or address the unique issues raised
by the Internet, e-commerce or m-commerce. It is possible that general business regulations and laws, or those specifically governing
the Internet, e-commerce or m-commerce may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another
and may conflict with other rules or our practices. See “Item 1A.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Competition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We compete in the data, marketing and research
business and in all other facets of our business against small, medium and large companies throughout the United States. Some examples
include companies such as Liveramp, Groundtruth and Nielsen. Although we can give no assurance that our business will be able to compete
against other companies with greater experience and resources, we believe we have a competitive advantage with our proprietary software
and technology platform based on our view that our competitor’s products do not provide the end-to-end solutions that our product
solutions do, and their minimum fees are substantially higher than ours for a comparative suite of solutions. See “Item 1A.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employees and Contractors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2021, we have 13 employees,
including executive management, technical personnel, salespeople, and support staff employees. We also utilize several additional firms/persons
who provide services to us on a non-exclusive basis as independent consultants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Customers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During
2020, sales of our products to four customers generated approximately 36% of our revenues. During 2021, sales of our products to four
customers generated approximately 31% of our revenues. Our contracts with our customers generally do not obligate them to a specified
term and they can generally terminate their relationship with us at any time with a minimal amount of notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Debt and Receivables Purchase Financing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
have the following debt financing in place:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gene Salkind, who is our Chairman of
the Board and one of our directors, and his affiliate provided us an aggregate of $2,700,000 in convertible debt financing for convertible
promissory notes and common stock purchase warrants. Dr. Salkind’s principal debt was reduced to $2,562,500 in December 2021. See
“Item 13.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Business Capital Providers, Inc. purchased certain
future receivables from the Company at a 26% discount under the following agreements on the following terms:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Pursuant to a Merchant Agreement dated July 28, 2021, Business Capital Providers purchased $405,000 of future receivables for a purchase price of $300,000. Under the agreement, the Company agrees to have all receivables collected be deposited into a bank account from which the purchased receivables are remitted to Business Capital Providers daily, at the daily percentage of 9% of the daily banking deposits, or daily amounts of $2,531.25, for the term of 160 days. The Company is responsible for ensuring there are sufficient funds in the account to cover the daily payments. Under the agreement, the Company paid an origination fee of 5% of the purchase price. In the event of a default under the agreement, Business Capital Providers may institute an action to enforce its rights, including recovery of its costs of enforcement. Events of default under the agreement include, among others: the Company’s breach of any provision or representation under the agreement; failure to give 24 hours’ notice there will be insufficient funds to cover a daily remittance; the Company offers for sale or sells a substantial portion of its assets or its business; the Company uses other depository accounts, or closes or changes its depository account from which daily remittances are made; a material change in the Company’s operations; loss of a key employee, customer or supplier of the Company; any change in stock float, voting rights or issuance of voting shares; the Company’s failure to renew a real property lease; any Company default under another agreement with Business Capital Providers; or any form of bankruptcy filing or declaration by or for the Company. The Agreement further provides that in the event of a default, lieu of personal guarantees by any Company principals, or if otherwise mutually agreed, Business Capital Providers may convert any portion of amounts payable to it into shares of common stock of the Company at a price equal to 85% of the lowest volume weighted average price for each of the five trading days preceding the conversion date; provided that Business Capital Providers will not convert into shares that will result in it owning more than 4.99% of the Company’s then outstanding shares of common stock.</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Pursuant to a Merchant Agreement dated April 29, 2021, purchased $405,000 of future receivables for a purchase price of $300,000 on terms which are substantially the same as the July 28, 2021, Merchant Agreement, except that the daily percentage is 13% and the daily payment is $2,700 per day for a term of 150 business days.</td></tr>

<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">In the fourth quarter of 2021, Business Capital Providers assigned its Merchant Agreement and related debt described in this paragraph to non-affiliated third parties, which subsequently converted $89,100 in outstanding indebtedness into 13,103 common shares pursuant to its terms.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The Company previously entered into separate Merchant Agreements with Business Capital Providers on eight occasions prior to the April 29, 2021, Merchant Agreement, starting in June 2019, for an aggregate of $1,060,000 in financing, at varying purchase amounts, daily percentages and daily payments, all of which were satisfied in full.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19 private lender-investors,
who were unaffiliated shareholders of the Company and accredited investors as provided under Regulation D Rule 501 promulgated under the
Securities Act of 1933, provided us convertible debt financing during the period May 2021 through September 2021 pursuant to subscription
agreements as described below. (Certain of these investors provided us multiple investments in one or more of these convertible debt structures.):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Nine of the lender-investors provided us an aggregate of $668,000 in convertible debt financing on the following terms:</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The lender-investors were issued shares of Company common stock valued at $6 per share equal to 5% of their investments as original issue discount.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The debt maturity date is October 31, 2021. If the Company receives debt or equity financing of $200,000 or more, the debt is payable within two business days after the Company receives those funds. The maturity dates of six of these investors’ convertible debt was extended to December 31, 2021.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The debt is convertible into shares of Company common stock at a conversion price of $6 per share at any time at the investor’s option until the maturity date.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Three of the lender-investors provided us an aggregate of $200,000 in convertible debt financing on the following terms:</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The lender-investors were issued shares of Company common stock valued at $6 per share equal to 6,000 per $100,000 of principal loan, or on a pro-rata basis if less than $100,000 is loaned (effectively 6% of the amount loaned) as original issue discount.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The debt is convertible into shares of Company common stock at a conversion price of $6 per share at any time at the investor’s option until the maturity date.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">These investors converted all of this convertible debt into a total of 40,000 shares of common stock.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Eleven of the lender-investors provided us an aggregate of $819,500 in convertible debt financing on the following terms:</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The investment amounts included a 10% original issue discount. Accordingly, the total net principal proceeds of this debt that we received was $745,000.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The debt maturity date is June 30, 2022.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The investors may convert the debt at any time through the maturity date
at a 30% discount to the volume weighted average price per share over the 60-day period prior to conversion, with a floor conversion price
of $4 per share. The debt will automatically convert on July 1, 2022, at $4 per share if it not repaid, or converted by the investor,
prior to then.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">All of these investors converted a total of $819,500 of this convertible debt into a total of 156,761 shares of common stock.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Four of the lender-investors provided us $130,000 in convertible debt financing on the following terms: </td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">Interest at the annual rate of 10%.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The debt maturity date is June 30, 2022.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">The investor may convert the debt at any time through the maturity date at a 30% discount to the volume weighted average price per share over the 60-day period prior to conversion, with a floor conversion price of $4 per share. The debt will automatically convert on July 1, 2022, at $4 per share if it not repaid, or converted by the investor, prior to then.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px">o</td>
    <td style="text-align: justify">One of these investors converted a total of $30,000 of this convertible debt into a total of 5,904 shares of common stock.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May of 2020, the Company received Small Business
Administration Cares Act loan of $265,842 due to the COVID-19 pandemic. This loan carried a five-year term, with interests at the annual
rate of 1%. During second fiscal quarter of 2021 the Cares Act loan was forgiven in full under the SBA Cares Act loan rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In June 2020, the Company received a $150,000 Economic
Injury Disaster Loan from the SBA which carries a 30-year term, payable in monthly installments of principal plus interest at the annual
rate of 3.75%. This loan is secured by all the assets of the Company. The loan proceeds were used for working capital to alleviate economic
injury cause by disaster in January 2020 and after that as required by the loan agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 20, 2021, the Company entered into
securities purchase agreements, with two accredited investors, Talos Victory Fund, LLC and Blue Lake Partners LLC, pursuant to which the
Company issued 10% promissory notes with a maturity date of September 20, 2022, in the aggregate principal amount of $1,125,000. In addition,
the Company issued warrants to purchase an aggregate of 56,250 shares of its common stock to these holders. Spartan Capital Securities
LLC and Revere Securities LLC acted as placement agents on this transaction. The promissory notes include the following terms:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">·</span></td>
    <td colspan="2" style="text-align: justify; vertical-align: top">Interest at the annual rate of 10%.</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2" style="vertical-align: top">&nbsp;</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">·</span></td>
    <td colspan="2" style="text-align: justify; vertical-align: top">The notes carry original issue discount of $112,500 in the aggregate. Accordingly, the total net principal of this debt was $1,012,500.</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2" style="vertical-align: top">&nbsp;</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">·</span></td>
    <td colspan="2" style="text-align: justify; vertical-align: top">The Company is required to make interim payments to the holders in the aggregate amount of $225,000, on or before March 18, 2022, towards the repayment of the balance of the notes. The Company may prepay the principal sum under the notes then outstanding plus accrued and unpaid interest in full at any time without any prepayment premium; however, the Company is required to pay a minimum amount of the first 12 months of interest under the notes</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2" style="vertical-align: top">&nbsp;</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">·</span></td>
    <td colspan="2" style="text-align: justify; vertical-align: top">The holders may convert the notes and exercise the warrants into the Company’s common stock (subject to contractual beneficial ownership limitations of 4.99%). The holders have the right to convert the notes at any time into shares of common stock at a conversion price of $5.00 per share; provided, however, if the Company consummates a so-called uplisting offering to a national exchange within 180 days after the closing date, then the Note conversion price shall adjust to equal 70% of the price per share of common stock in that offering. The warrants may also be exercised at any time from date of issuance over a period of five years at the exercise price then in effect. The initial warrant exercise price shall equal $10.00 per share; provided however, if the Company consummates the uplisting offering within the 180-day period noted above, then the exercise price shall adjust to equal 130% of the price per share in that offering. The warrants contain cashless exercise provisions. Both the notes and the warrants contain customary anti-dilution provisions which could cause an adjustment to the conversion price of the notes and the exercise price of the warrants.</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td colspan="2" style="vertical-align: top">&nbsp;</td>
    </tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">·</span></td>
    <td colspan="2" style="text-align: justify; vertical-align: top">The Company is required to make interim payments to the holders in the aggregate amount of $225,000, on or before March 18, 2022, towards the repayment of the balance of the notes. The Company may prepay the principal sum under the notes then outstanding plus accrued and unpaid interest in full at any time without any prepayment premium; however, the Company is required to pay a minimum amount of the first 12 months of interest under the notes.</td>
    </tr>
  <tr>
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px">&nbsp;</td>
    <td>&nbsp;</td>
    </tr>

<tr><td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">·</span></td>
    <td colspan="2" style="text-align: justify; vertical-align: top">The holders may convert the notes and exercise the warrants into the Company’s common stock (subject to contractual beneficial ownership limitations of 4.99%). The holders have the right to convert the notes at any time into shares of common stock at a conversion price of $5.00 per share; provided, however, if the Company consummates a so-called uplisting offering to a national exchange within 180 days after the closing date, then the Note conversion price shall adjust to equal 70% of the price per share of common stock in that offering. The warrants may also be exercised at any time from date of issuance over a period of five years at the exercise price then in effect. The initial warrant exercise price shall equal $10.00 per share; provided however, if the Company consummates the uplisting offering within the 180-day period noted above, then the exercise price shall adjust to equal 130% of the price per share in that offering. The warrants contain cashless exercise provisions. Both the notes and the warrants contain customary anti-dilution provisions which could cause an adjustment to the conversion price of the notes and the exercise price of the warrants.</td>
    </tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>The notes provide that so long as the Company has any obligations under the Notes, the Company will not, among other things:</td></tr></tbody></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>Incur or guarantee any indebtedness which is senior or equal to the notes.</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>Redeem or repurchase any shares of stock, warrants, rights or options without the holders’ consent.</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">o</span></td><td>Sell, lease or otherwise dispose of a significant portion of its assets without the holders’ consent.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The notes contain customary events of default relating to, among other things, payment defaults, breach of representations and warranties, and breach of provisions of the notes or security purchase agreements.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">In an event of default under the notes, which has not been cured within any applicable cure period, if any, the notes shall become immediately due and payable and the Company shall pay to the holders an amount equal to the principal sum then outstanding plus accrued interest, multiplied by 125%. Additionally, upon the occurrence of an event of default, additional interest will accrue from the date of the event of default at the rate equal to the lower of 16% per annum or the highest rate permitted by law.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On
the closing date of this financing, the holders delivered the net amount of $910,000 of the purchase price to the Company in exchange
for the notes (which was net of the original issue discount and other fees and expenses relate to this financing).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 19, 2021, the Company
filed a Form S-1 Registration Statement (File no. 333-260364) with the Securities and Exchange Commission to raise over $10 million dollars
in an underwritten public offering. The next day the Company filed an application to list our common stock on the NASDAQ Capital
Market under the symbol “MOBQ.” This offering was completed on December 13, 2021, and the Company retired the loans of, Talos
Victory Fund, LLC and Blue Lake Partners LLC out of the gross proceeds it received of approximately $10.3 million. Also, Talos Victory
Fund, LLC and Blue Lake Partners, LLC converted all of their warrants on a cashless basis into 24,692 common shares and 24,692 common
shares, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Corporate Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate our business through
two wholly owned subsidiaries, Advangelists, LLC and Mobiquity Networks, Inc. Our corporate structure is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="Diagram

Description automatically generated" style="height: 302px; width: 553px" data-src="https://www.sec.gov/Archives/edgar/data/1084267/000168316822002082/image_001.jpg" src="https://www.sec.gov/Archives/edgar/data/1084267/000168316822002082/image_001.jpg"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Subsidiaries</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Advangelists, LLC</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Advangelists
LLC operates our ATOS platform business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We originally acquired a 48% membership interest
and Glen Eagles Acquisition LP acquired a 52% membership interest in Advangelists in a merger transaction in December 2018 for consideration
valued at $20 Million. At the time Glen Eagles was a shareholder of the Company, owning 412,500 shares of our common stock. The Company
became, and remains, the sole manager of Advangelists following the merger with sole management power. In consideration for the merger:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Mobiquity issued warrants for 269,384 shares of common stock at an exercise price of $56 per share to the pre-merger Advangelsts’ members, and, in February 2019, upon the attainment of the vesting threshold of Advangelists’ combined revenues for the months of December 2018 and January 2019 being at least $250,000, the Company transferred 9,209,722 shares of Gopher Protocol, Inc. common stock to the pre-merger Advangelists members. The Mobiquity warrants were valued at a total of $3,844,444, and the Gopher shares of common stock were valued at a total of $6,155,556.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Glen Eagles paid the pre-merger Advangelists members $10 million. $500,000 was paid at closing in cash (which the Company advanced on behalf of Glen Eagles without any agreement regarding repayment of the advance), and $9,500,000 was paid by Glen Eagles’ promissory note to Deepanker Katyal, as representative of pre-merger Advangelists members, payable in 19 monthly installments of $500,000 each.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The
Company acquired 3% of the Advangelists’ membership interests from Glen Eagles in April 2019 in satisfaction of the Company’s
$500,000 closing payment advance to Glen Eagles, resulting in Mobiquity owning 51% and Glen Eagles owning 49% of Advangelists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2019 the Company acquired the remaining
49% of Advangelists’ membership interests from Glen Eagles, becoming the 100% owner of Advangelists, in a transaction involving
the Company, Glen Eagles, and Gopher Protocol, Inc. In that transaction, Gopher acquired the 49% Advangelists membership interest from
Glen Eagles and assumed Glen Eagles’ promissory note to Deepanker Katyal, as representative of the pre-merger Advangelists owners,
which had a remaining balance of $7,512,500, in satisfaction of indebtedness owed by Glen Eagles to Gopher. Concurrently with that transaction,
the Company acquired the 49% of Advangelists membership interest from Gopher and assumed the promissory note in consideration. Additionally,
warrants for 300,000 shares of Company common stock which are issuable upon the conversion of Mobiquity Class AAA preferred stock owned
by Gopher were amended to provide for a cashless exercise. In September 2019, the assumed note, which then had a principal balance of
$6,780,000, was amended and restated to provide that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">$5,250,000 of the principal was payable in 65,625 shares of the Company’s Class E Preferred Stock, which is convertible into 164,062.50 shares the Company’s common stock, plus warrants to purchase 82,031.25 Company shares of common stock, at an exercise price of $48 per share; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">$1,530,000 of the principal balance, plus all accrued and unpaid interest under the promissory note was payable in three monthly installments of $510,000 each.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The promissory note was paid in full in November 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Mobiquity Networks, Inc.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have established Mobiquity Networks, Inc and
have operated it since January 2011. Mobiquity Networks started and developed as a mobile advertising technology company focused on driving
foot-traffic throughout its indoor network and has evolved and grown into a next generation data intelligence company. Mobiquity Networks
operates our data intelligence platform business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reports to Securities Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
provide an annual report that includes audited financial information to our shareholders. We make our financial information equally available
to any interested parties or investors through compliance with the disclosure rules for a small business issuer under the Exchange Act.
We are subject to disclosure filing requirements including filing Annual Reports on Form 10-K annually and Quarterly Reports on Form 10-Q
quarterly. In addition, we will file Current Reports on Form 8-K and other proxy and information statements from time to time as required.
We do not intend to voluntarily file the above reports in the event that our obligation to file such reports is suspended under the Exchange
Act. The public may read and copy any materials that we file with the Securities and Exchange Commission, including our Forms 10-K, 10-Q
and 8-K and registration statements and proxy and information statements, at the SEC’s Public Reference Room at 100 F Street NE,
Washington, DC 20549, or you can read our SEC filings over the Internet at the SEC’s website at http://www.sec.gov.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The public may obtain information on the
operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_005"></span>Item 1A. Risk Factors</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>An investment in our securities is highly speculative,
involves a high degree of risk and should be made only by investors who can afford a complete loss. You should carefully consider the
following risk factors, together with the other information in this Form 10-K, including our financial statements and the related notes,
before you decide to buy our securities. If any of the following risks actually occurs, then our business, financial condition or results
of operations could be materially adversely affected, the trading of our common stock and warrants could decline, and you may lose all
or part of your investment therein. In addition to the risks outlined below, risks and uncertainties not presently known to us or that
we currently consider immaterial may also impair our business operations. Potential risks and uncertainties that could affect our operating
results and financial condition include, without limitation, the following:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Relating to our Business Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We  have a history of operating losses and our m<span style="background-color: white">anagement
has concluded that factors raise substantial doubt about our ability to continue as a going concern and our auditor has included an explanatory
paragraph relating to our ability to continue as a going concern in&nbsp;</span>its audit report for the fiscal years ended December
31, 2021, and 2020.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To date, we have not been
profitable and have incurred significant losses and cash flow deficits. For the fiscal years ended December 31, 2021, and 2020, we reported
net losses of $35,213,541 and $15,029,395, respectively, and cash flow from operating activities of $(5,870,635) and $(4,750,443). As
of December 31, 2021, we had an aggregate accumulated deficit of $221,116,625. Our operating losses for the past several years are primarily
attributable to the transformation of our company into an advertising technology corporation. We can provide no assurances that our operations
will generate consistent or predictable revenue or be profitable in the foreseeable future. Our m<span style="background-color: white">anagement
has concluded that&nbsp;</span>our historical recurring losses from operations and negative cash flows from operations as well as our
dependence on private equity and other financings&nbsp;<span style="background-color: white">raise substantial doubt about our ability
to continue as a going concern, and our auditor has included an explanatory paragraph relating to our ability to continue as a going concern
in&nbsp;</span>its audit report for the fiscal year ended December 31, 2021, and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our consolidated financial statements do
not include any adjustments that might result from the outcome of this uncertainty. These adjustments would likely include substantial
impairment of the carrying amount of our assets and potential contingent liabilities that may arise if we are unable to fulfill various
operational commitments. In addition, the value of our securities, including common stock issued in this offering, would be greatly impaired.
Our ability to continue as a going concern is dependent upon generating sufficient cash flow from operations and obtaining additional
capital and financing, including funds to be raised in this offering. If our ability to generate cash flow from operations is delayed
or reduced and we are unable to raise additional funding from other sources, we may be unable to continue in business even if this offering
is successful. For further discussion about our ability to continue as a going concern and our plan for future liquidity, see “Item
7.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We cannot predict our future capital needs
and we may not be able to secure additional financing.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From January 2013 through December 2021,
we raised a total of over $60 million in private equity and debt financing to support our transformation from an integrated marketing
company to a technology company. Since we might be unable to generate recurring or predictable revenue or cash flow to fund our operations,
we will likely need to seek additional (perhaps substantial) equity or debt financing even following this offering to provide the capital
required to maintain or expand our operations. We expect that we will also need additional funding for developing products and services,
increasing our sales and marketing capabilities, and acquiring complementary companies, technologies and assets (there being no such acquisitions
which we have identified or are pursuing as of the date of this Form 10-K), as well as for working capital requirements and other operating
and general corporate purposes. We cannot predict our future capital needs with precision, and we may not be able to secure additional
financing on terms satisfactory to us, if at all, which could lead to termination of our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we elect to raise additional
funds or additional funds are required, we may seek to raise funds from time to time through public or private equity offerings, debt
financings or other financing alternatives. Additional equity or debt financing may not be available on acceptable terms, if at all. If
we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we will be prevented from pursuing operational
development and commercialization efforts and our ability to generate revenues and achieve or sustain profitability will be substantially
harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we raise additional funds by issuing equity
securities, our shareholders will experience dilution. Debt financing, if available, would result in increased fixed payment obligations
and may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional
debt, making capital expenditures or declaring dividends. Any debt financing or additional equity that we raise may contain terms, such
as liquidation and other preferences, which are not favorable to us or our stockholders. If we raise additional funds through collaboration
and licensing arrangements with third parties, it may be necessary to relinquish valuable rights to our technologies, future revenue streams
or product candidates or to grant licenses on terms that may not be favorable to us. Should the financing we require to sustain our working
capital needs be unavailable or prohibitively expensive when we require it, our business, operating results, financial condition and prospects
could be materially and adversely affected, and we may be unable to continue our operations. Failure to secure additional financing on
favorable terms could have severe adverse consequences to us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>The Company’s financial condition and
results of operations have been and may continue to be adversely affected by the COVID-19 pandemic.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since March 2020, COVID -19 has caused a
material and substantial adverse impact on our general economy and our business operations. It has caused there to be a substantial decrease
in our sales, cancellations of purchase orders and has resulted in accounts receivables not being timely paid as anticipated. Further,
it has caused us to have concerns about our ability to meet our obligations as they become due and payable. In this respect, our business
is directly dependent upon and correlates closely to the marketing levels and ongoing business activities of our existing clients. If
material adverse developments in domestic and global economic and market conditions adversely affect our clients’ businesses, such
as COVID-19, our business and results of operations could (and in the case of COVID-19) equally suffer. Our results of operations are
affected directly by the level of business activity of our clients, which in turn is affected by the level of economic activity in the
industries and markets that they serve. COVID-19 future widespread economic slowdowns in any of these markets, particularly in the United
States, may negatively affect the businesses, purchasing decisions and spending of our clients and prospective clients, and payment of
accounts receivable due us, which could result in reductions in our existing business as well as our new business development and difficulties
in meeting our cash obligations as they become due. In the event of continued widespread economic downturn caused by COVID-19, we will
likely continue to experience a reduction in projects, longer sales and collection cycles, deferral or delay of purchase commitments for
our data products, processing functionality, software systems and services, and increased price competition, all of which could substantially
adversely affect revenue and our ability to remain a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event we remain a
going concern, the impacts of the global emergence of Coronavirus disease (COVID-19) on our business, sources of revenues and the
general economy, are currently not fully known. We are conducting business as usual with some modifications to employee work
locations, and cancellation of certain marketing events, among other modifications. We lost a purchase order in excess of one
million dollars with a major US sports organization. We have observed other companies taking precautionary and preemptive actions to
address COVID-19 and companies may take further actions that alter their normal business operations. We will continue to actively
monitor the situation and may take further actions that alter our business operations as may be required by federal, state or local
authorities or that we determine are in the best interests of our employees, customers, partners, suppliers and stockholders. It is
not clear what the potential effects any such alterations or modifications may have on our business, including the effects on our
customers and prospects, although we do anticipate it to continue to negatively impact our financial results during fiscal years
2022 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>Forecasts of our revenue are difficult</i></b><i>.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When purchasing our products and services,
our clients and prospects are often faced with a significant commitment of capital, the need to integrate new software and/or hardware
platforms and other changes in company-wide operational procedures, all of which result in cautious deliberation and evaluation by prospective
clients, longer sales cycles and delays in completing transactions. Additional delays result from the significant up-front expenses and
substantial time, effort and other resources necessary for our clients to implement our solutions. For example, depending on the size
of a prospective client’s business and its needs, a sales cycle can range from two weeks to 12 months. Because of these longer sales
cycles, revenues and operating results may vary significantly from period to period. As a result, it is often difficult to accurately
forecast our revenues for any fiscal period as it is not always possible for us to predict the fiscal period in which sales will actually
be completed. This difficulty in predicting revenue, combined with the revenue fluctuations we may experience from period to period, can
adversely affect and cause substantial fluctuations in our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>The reliability of
our product solutions is dependent on data from third parties and the integrity and quality of that data</i></b><i>.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Much of the data that we use is licensed
from third-party data suppliers, and we are dependent upon our ability to obtain necessary data licenses on commercially reasonable terms.
We could suffer material adverse consequences if our data suppliers were to withhold their data from us. For example, data suppliers could
withhold their data from us if there is a competitive reason to do so; if we breach our contract with a supplier; if they are acquired
by one of our competitors; if legislation is passed restricting the use or dissemination of the data they provide; or if judicial interpretations
are issued restricting use of such data. Additionally, we could terminate relationships with our data suppliers if they fail to adhere
to our data quality standards. If a substantial number of data suppliers were to withdraw or withhold their data from us, or if we sever
ties with our data suppliers based on their inability to meet our data standards, our ability to provide products and services to our
clients could be materially adversely impacted, which could result in decreased revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The reliability of our solutions depends
upon the integrity and quality of the data in our database. A failure in the integrity or a reduction in the quality of our data could
cause a loss of customer confidence in our solutions, resulting in harm to our brand, loss of revenue and exposure to legal claims. We
may experience an increase in risks to the integrity of our database and quality of our data as we move toward real-time, non-identifiable,
consumer-powered data through our products. We must continue to invest in our database to improve and maintain the quality, timeliness
and coverage of the data if we are to maintain our competitive position. Failure to do so could result in a material adverse effect on
our business, growth and revenue prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our business practices with respect
to data and consumer protection could give rise to liabilities or reputational harm as a result of governmental regulation, legal requirements
or industry standards relating to consumer privacy, data protection and consumer protection. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Federal, state and international laws and
regulations govern the collection, use, retention, sharing and security of data that we collect. We strive to comply with all applicable
laws, regulations, self-regulatory requirements and legal obligations relating to privacy, data protection and consumer protection, including
those relating to the use of data for marketing purposes. It is possible, however, that these requirements may be interpreted and applied
in a manner that is inconsistent from one jurisdiction to another and may conflict with other rules or our practices. We cannot assure
you that our practices have complied, comply, or will comply fully with all such laws, regulations, requirements and obligations. Any
failure, or perceived failure, by us to comply with federal, state or international laws or regulations, including laws and regulations
regulating privacy, data security, marketing communications or consumer protection, or other policies, self-regulatory requirements or
legal obligations could result in harm to our reputation, a loss in business, and proceedings or actions against us by governmental entities,
consumers, retailers or others. We may also be contractually liable to indemnify and hold harmless performance marketing networks or other
third parties from the costs or consequences of noncompliance with any laws, regulations, self-regulatory requirements or other legal
obligations relating to privacy, data protection and consumer protection or any inadvertent or unauthorized use or disclosure of data
that we store or handle as part of operating our business. Any such proceeding or action, and any related indemnification obligation,
could hurt our reputation, force us to incur significant expenses in defense of these proceedings, distract our management, increase our
costs of doing business and cause consumers and retailers to decrease their use of our marketplace, and may result in the imposition of
monetary liability. Furthermore, the costs of compliance with, and other burdens imposed by, the data and privacy laws, regulations, standards
and policies that are applicable to the businesses of our clients may limit the use and adoption of, and reduce the overall demand for,
our products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A significant breach of the confidentiality of
the information we hold or of the security of our or our customers’, suppliers’, or other partners’ computer systems
could be detrimental to our business, reputation and results of operations. Our business requires the storage, transmission and utilization
of data. Although we have security and associated procedures, our databases may be subject to unauthorized access by third parties. Such
third parties could attempt to gain entry to our systems for the purpose of stealing data or disrupting the systems. We believe we have
taken appropriate measures to protect our systems from intrusion, but we cannot be certain that advances in criminal capabilities, discovery
of new vulnerabilities in our systems and attempts to exploit those vulnerabilities, physical system or facility break-ins and data thefts
or other developments will not compromise or breach the technology protecting our systems and the information we possess. Furthermore,
we face increasing cyber security risks as we receive and collect data from new sources, and as we and our customers continue to develop
and operate in cloud-based information technology environments. In the event that our protection efforts are unsuccessful, and we experience
an unauthorized disclosure of confidential information or the security of such information or our systems are compromised, we could suffer
substantial harm. Any breach could result in one or more third parties obtaining unauthorized access to our customers’ data or our
data, including personally identifiable information, intellectual property and other confidential business information. Such a security
breach could result in operational disruptions that impair our ability to meet our clients’ requirements, which could result in
decreased revenues. Also, whether there is an actual or a perceived breach of our security, our reputation could suffer irreparable harm,
causing our current and prospective clients to reject our products and services in the future and deterring data suppliers from supplying
us data. Further, we could be forced to expend significant resources in response to a security breach, including repairing system damage,
increasing cyber security protection costs by deploying additional personnel and protection technologies, and litigating and resolving
legal claims, all of which could divert the attention of our management and key personnel away from our business operations. In any event,
a significant security breach could materially harm our business, financial condition and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Significant system disruptions, loss of data
center capacity or interruption of telecommunication links could adversely affect our business and results of operations. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our product platforms are hosted and
managed on Amazon Web Service (AWS) and takes full advantage of open standards for processing, storage, security and big data technology.
Significant system disruptions, loss of data center capacity or interruption of telecommunication links could adversely affect our business,
results of operations and financial condition. Our business is heavily dependent upon highly complex data processing capability. The ability
of our platform hosts and managers to protect these data centers against damage or interruption from fire, flood, tornadoes, power loss,
telecommunications or equipment failure or other disasters is beyond our control and is critical to our ability to succeed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>We rely on information technology to operate
our business and maintain competitiveness, and any failure to adapt to technological developments or industry trends could harm our business.
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend on the use of information technologies
and systems. As our operations grow in size and scope, we will be required to continuously improve and upgrade our systems and infrastructure
while maintaining or improving the reliability and integrity of our infrastructure. Our future success also depends on our ability to
adapt our systems and infrastructure to meet rapidly evolving consumer trends and demands while continuing to improve the performance,
features and reliability of our solutions in response to competitive services and product offerings. The emergence of alternative platforms
will require new investment in technology. New developments in other areas, such as cloud computing, could also make it easier for competition
to enter our markets due to lower up-front technology costs. In addition, we may not be able to maintain our existing systems or replace
or introduce new technologies and systems as quickly as we would like or in a cost-effective manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our technology and associated business processes
may contain undetected errors, which could limit our ability to provide our services and diminish the attractiveness of our offerings.
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our technology may contain undetected errors,
defects or bugs. As a result, our customers or end users may discover errors or defects in our technology or the systems incorporating
our technology may not operate as expected. We may discover significant errors or defects in the future that we may not be able to fix.
Our inability to fix any of those errors could limit our ability to provide our solution, impair the reputation of our brand and diminish
the attractiveness of our product offerings to our customers.&nbsp; In addition, we may utilize third party technology or components in
our products, and we rely on those third parties to provide support services to us. Failure of those third parties to provide necessary
support services could materially adversely impact our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>We need to protect our intellectual property,
or our operating results may suffer</i></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Third parties may infringe our intellectual
property and we may suffer competitive injury or expend significant resources enforcing our rights. As our business is focused on data-driven
results and analytics, we rely heavily on proprietary information technology. Our proprietary portfolio consists of various intellectual
property including source code, trade secrets, and know-how. The extent to which such rights can be protected is substantially based on
federal, state and common law rights as well as contractual restrictions. The steps we have taken to protect our&nbsp;intellectual property
may not prevent the misappropriation of our proprietary information or deter independent development of similar technologies by others.
If we do not enforce our intellectual property rights vigorously and successfully, our competitive position may suffer which could harm
our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We could incur substantial costs and
disruption to our business as a result of any claim of infringement of another party’s&nbsp;intellectual property rights, which
could harm our business and operating results.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, third parties may claim
that one or more of our products or services infringe their intellectual property rights. We analyze and take action in response to such
claims on a case-by-case basis. Any dispute or litigation regarding patents or other intellectual property could be costly and time-consuming
due to the complexity of our technology and the uncertainty of intellectual property litigation, which could divert the attention of our
management and key personnel away from our business operations. A claim of intellectual property infringement could force us to enter
into a costly or restrictive license agreement, which might not be available under acceptable terms or at all, or could subject us to
significant damages or to an injunction against development and sale of certain of our products or services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We face intense and growing
competition, which could result in reduced sales and reduced operating margins, and limit our market share.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We compete in the data, marketing and research
business and in all other facets of our business against small, medium and large companies throughout the United States. Some examples
include companies such as LiveRamp, Beeswax and TradeDesk. If we are unable to successfully compete for new business our revenue growth
and operating margins may decline. The market for our advertising and marketing technology operating system platform is competitive. We
believe that our competitors’ product offerings do not provide the end-to-end solutions
our product solutions do, and their minimum fees are substantially higher than ours for a comparative suite of solutions. However, barriers
to entry in our markets are relatively low. With the introduction of new technologies and market entrants, we expect competition to intensify
in the future. Some of these competitors may be in a better position to develop new products and strategies that more quickly and effectively
respond to changes in customer requirements in our markets. The introduction of competent, competitive products, pricing strategies or
other technologies by our competitors that are superior to or that achieve greater market acceptance than our products and services could
adversely affect our business. Our failure to meet a client’s expectations in any type of contract may result in an unprofitable
engagement, which could adversely affect our operating results and result in future rejection of our products and services by current
and prospective clients. Some of our principal competitors offer their products at a lower price, which may result in pricing pressures.
These pricing pressures and increased competition generally could result in reduced sales, reduced margins or the failure of our product
and service offerings to achieve or maintain more widespread market acceptance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our competitors are substantially
larger than we are and have significantly greater financial, technical and marketing resources, and established direct and indirect channels
of distribution. As a result, they are able to devote greater resources to the development, promotion and sale of their products than
we can.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We can provide no assurance that our
business will be able to maintain a competitive technology advantage in the future.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to generate revenues is substantially
based upon our proprietary intellectual property that we own and protect through trade secrets and agreements with our employees to maintain
ownership of any improvements to our intellectual property. Our ability to generate revenues now and in the future is based upon maintaining
a competitive technology advantage over our competition. We can provide no assurances that we will be able to maintain a competitive technology
advantage in the future over our competitors, many of whom have significantly more experience, more extensive infrastructure and are better
capitalized than us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>No assurances can be given that we
will be able to keep up with a rapidly changing business information market.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consumer needs and the business information
industry as a whole are in a constant state of change. Our ability to continually improve our current processes and products in response
to these changes and to develop new products and services to meet those needs are essential in maintaining our competitive position and
meeting the increasingly sophisticated requirements of our customers. If we fail to enhance our current products and services or fail
to develop new products in light of emerging industry standards and information requirements, we could lose customers to current or future
competitors, which could result in impairment of our growth prospects and revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>The market for programmatic
advertising campaigns is relatively new and evolving. If this market develops slower or differently than we expect, our business, growth
prospects and financial condition would be adversely affected.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A substantial portion of
our revenue has been derived from customers that programmatically purchase and sell advertising inventory through our platform. We
expect that spending on programmatic ad buying and selling will continue to be a significant source of revenue for the foreseeable
future, and that our revenue growth will largely depend on increasing spend through our platform. The market for programmatic ad
buying is an emerging market, and our current and potential customers may not shift quickly enough to programmatic ad buying from
other buying methods, reducing our growth potential. Because our industry is relatively new, we will encounter risks and
difficulties frequently encountered by early-stage companies in similarly rapidly evolving industries, including the need to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Maintain our reputation and build trust with advertisers and digital media property owners;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Offer competitive pricing to publishers, advertisers, and digital media agencies;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Maintain quality and expand quantity of our advertising inventory;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Continue to develop, launch and upgrade the technologies that enable us to provide our solutions;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Respond to evolving government regulations relating to the internet, telecommunications, mobile, privacy, marketing and advertising aspects of our business;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Identify, attract, retain and motivate qualified personnel; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Cost-effectively manage our operations, including our international operations.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If
the market for programmatic ad buying deteriorates or develops more slowly than we expect, it could reduce demand for our platform, and
our business, growth prospects and financial condition would be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our failure to maintain and grow the
customer base on our platform may negatively impact our revenue and business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To sustain or increase our revenue, we must
regularly add both new advertiser customers and publishers, while simultaneously keeping existing customers to maintain or increase the
amount of advertising inventory purchased through our platform and adopt new features and functionalities that we add to our platform.
If our competitors introduce lower cost or differentiated offerings that compete with or are perceived to compete with ours, our ability
to sell access to our platform to new or existing customers could be impaired. Our agreements with our customers allow them to change
the amount of spending on our platform or terminate our services with limited notice. Our customers typically have relationships with
different providers and there is limited cost to moving budgets to our competitors. As a result, we may have limited visibility as to
our future advertising revenue streams. We cannot assure you that our customers will continue to use our platform or that we will be able
to replace, in a timely or effective manner, departing customers with new customers that generate comparable revenue. If a major customer
representing a significant portion of our business decides to materially reduce its use of our platform or to cease using our platform
altogether, it is possible that our revenue could be significantly reduced.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We rely substantially
on a limited number of customers for a significant percentage of our sales.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December 31, 2021,
sales of our products to four customers generated 31% of our revenues. Our contracts with our customers generally do not obligate them
to a specified term and they can generally terminate their relationship with us at any time with a minimal amount of notice. If we lose
any of our customers, or any of them decide to scale back on purchases of our products, it will have a material adverse effect on our
financial condition and prospects. Therefore, we must engage in continual sales efforts to maintain revenue, sustain our customer relationships
and expand our client base or our operating results will suffer. If a significant client fails to renew a contract or renews the contract
on terms less favorable to us than before, our business could be negatively impacted if additional business is not obtained to replace
or supplement that which was lost. We may require additional financial resources to expand our internal and external sales capabilities,
although we plan to use a portion of the net proceeds from our December 2021 public offering for this purpose. We cannot assure that we
will be able to sustain our customer relationships and expand our client base. The loss of any of our current customers or our inability
to expand our customer base will have a material adverse effect on our business plans and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>If we fail to innovate and make
the right investment decisions in our offerings and platform, we may not attract and retain advertisers and publishers and our revenue
and results of operations may decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our industry is subject to rapid and frequent
changes in technology, evolving customer needs and the frequent introduction by our competitors of new and enhanced offerings. We must
constantly make investment decisions regarding our offerings and technology to meet customer demand and evolving industry standards. We
may make wrong decisions regarding these investments. If new or existing competitors have more attractive offerings or functionalities,
we may lose customers or customers may decrease their use of our platform. New customer demands, superior competitive offerings or new
industry standards could require us to make unanticipated and costly changes to our platform or business model. If we fail to adapt to
our rapidly changing industry or to evolving customer needs, demand for our platform could decrease and our business, financial condition
and operating results may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We may not be able to integrate, maintain
and enhance our advertising solutions to keep pace with technological and market developments.</i></b>&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for digital video advertising
solutions is characterized by rapid technological change, evolving industry standards and frequent introductions of new products and services.
To keep pace with technological developments, satisfy increasing publisher and advertiser requirements, maintain the attractiveness and
competitiveness of our advertising solutions and ensure compatibility with evolving industry standards and protocols, we will need to
anticipate and respond to varying product lifecycles, regularly enhance our current advertising solutions and develop and introduce new
solutions and functionality on a timely basis. This requires significant investment of financial and other resources. For example, we
will need to invest significant resources into expanding and developing our platforms in order to maintain a comprehensive solution. Ad
exchanges and other technological developments may displace us or introduce an additional intermediate layer between us and our customers
and digital media properties that could impair our relationships with those customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>If we fail to detect advertising fraud,
we could harm our reputation and hurt our ability to execute our business plan.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we are in the
business of providing services to publishers, advertisers and agencies, we must deliver effective digital advertising campaigns.
Despite our efforts to implement fraud protection techniques in our platforms, some of our advertising and agency campaigns may
experience fraudulent and other invalid impressions, clicks or conversions that advertisers may perceive as undesirable, such as
non-human traffic generated by computers designed to simulate human users and artificially inflate user traffic on websites. These
activities could overstate the performance of any given digital advertising campaign and could harm our reputation. It may be
difficult for us to detect fraudulent or malicious activity because we do not own content and rely in part on our digital media
properties<b><i>&nbsp;</i></b>to control such activity. Industry self-regulatory bodies, the U.S. Federal Trade Commission and
certain influential members of Congress have increased their scrutiny and awareness of, and have taken recent actions to address,
advertising fraud and other malicious activity. If we fail to detect or prevent fraudulent or other malicious activity, the affected
advertisers may experience or perceive a reduced return on their investment and our reputation may be harmed. High levels of
fraudulent or malicious activity could lead to dissatisfaction with our solutions, refusals to pay, refund or future credit demands
or withdrawal of future business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>The loss of advertisers and publishers
as customers could significantly harm our business, operating results and financial condition.&nbsp;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customer base consists primarily of advertisers
and publishers. We do not have exclusive relationships with advertising agencies, companies that are advertisers, or publishers, such
that we largely depend on agencies to work with us as they embark on advertising campaigns for advertisers. The loss of agencies as customers
and referral sources could significantly harm our business, operating results and financial condition. If we fail to maintain satisfactory
relationships with an advertising agency, we risk losing business from the advertisers represented by that agency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, advertisers and publishers may
change advertising agencies. If an advertiser switches from an agency that utilizes our platform to one that does not, we will lose revenue
from that advertiser. In addition, some advertising agencies have their own relationships with publishers that are different than our
relationships, such that they might directly connect advertisers with such publishers. Our business may suffer to the extent that advertising
agencies and inventory suppliers purchase and sell advertising inventory directly from one another or through intermediaries other than
us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our sales efforts with advertisers
and publishers require significant time and expense.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attracting new advertisers and publishers
requires substantial time and expense, and we may not be successful in establishing new relationships or in maintaining or advancing our
current relationships.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our solutions, including our programmatic
solutions, and our business model often requires us to spend substantial time and effort educating our own sales force and potential advertisers,
advertising agencies, supply side platforms and digital media properties about our offerings, including providing demonstrations and comparisons
against other available solutions. This process is costly and time-consuming. If we are not successful in targeting, supporting and streamlining
our sales processes, our ability to grow our business may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Changes in consumer sentiment or laws, rules
or regulations regarding tracking technologies and other privacy matters could have a material adverse effect on our ability to generate
net revenues and could adversely affect our ability to collect data on consumer shopping behavior. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The collection and use
of electronic information about users is an important element of our data intelligence technology and solutions. However, consumers
may become increasingly resistant to the collection, use and sharing of information, including information used to deliver
advertising and to attribute credit to publishers in performance marketing programs, and take steps to prevent such collection, use
and sharing of information. For example, consumer complaints and/or lawsuits regarding advertising or other tracking technologies in
general and our practices specifically could adversely impact our business. In addition to this change in consumer preferences, if
retailers or brands perceive significant negative consumer reaction to targeted advertising or the tracking of consumers’
activities, they may determine that such advertising or tracking has the potential to negatively impact their brand. In that case,
advertisers may limit or stop the use of our solutions, and our operating results and financial condition would be adversely
affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Government regulation of the Internet,
e-commerce and m-commerce is evolving, and unfavorable changes or failure by us to comply with these laws and regulations could substantially
harm our business and results of operations. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to general business regulations
and laws as well as regulations and laws specifically governing the Internet, e-commerce and m-commerce in a number of jurisdictions around
the world. Existing and future regulations and laws could impede the growth of the Internet, e-commerce, m-commerce or other online services.
These regulations and laws may involve taxation, tariffs, privacy and data security, anti-spam, data protection, content, copyrights,
distribution, electronic contracts, electronic communications and consumer protection. It is not clear how existing laws and regulations
governing issues such as property ownership, sales and other taxes, libel and personal privacy apply to the Internet as the vast majority
of these laws and regulations were adopted prior to the advent of the Internet and do not contemplate or address the unique issues raised
by the Internet, e-commerce or m-commerce. It is possible that general business regulations and laws, or those specifically governing
the Internet, e-commerce or m-commerce may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another
and may conflict with other rules or our practices. We cannot assure you that our practices have complied, comply or will comply fully
with all such laws and regulations. Any failure, or perceived failure, by us to comply with any of these laws or regulations could result
in damage to our reputation, a loss in business, and proceedings or actions against us by governmental entities or others. Any such proceeding
or action could hurt our reputation, force us to spend significant resources in defense of these proceedings, distract our management,
increase our costs of doing business, and cause consumers and retailers to decrease their use of our marketplace, and may result in the
imposition of monetary liability. We may also be contractually liable to indemnify and hold harmless third parties from the costs or consequences
of noncompliance with any such laws or regulations. In addition, it is possible that governments of one or more countries may seek to
censor content available on our websites and mobile applications or may even attempt to completely block access to our marketplace. Adverse
legal or regulatory developments could substantially harm our business. In particular, in the event that we are restricted, in whole or
in part, from operating in one or more countries, our ability to retain or increase our customer base may be adversely affected and we
may not be able to maintain or grow our net revenues as anticipated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We may be required to invest
significant monies upfront in capital intensive project(s) which we may be unable to recover</i></b><i>. </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Failure to recover significant, up-front
capital investments required by certain client contracts could be harmful to the Company’s financial condition and operating results.
Certain of our client contracts require significant investment in the early stages, which we expect to recover through billings over the
life of the contract. These contracts may involve the construction of new computer systems and communications networks or the development
and deployment of new technologies. Substantial performance risk exists in each contract with these characteristics, and some or all elements
of service delivery under these contracts are dependent upon successful completion of the development, construction and deployment phases.
Failure to successfully meet our contractual requirements under these contracts over their life increases the possibility that we may
not recover our capital investments in these contracts. Failure to recover our capital investments could be detrimental to the particular
engagement as well as our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We are subject to payment-related risks
and, if our customers do not pay or dispute their invoices, our business, financial condition and operating results may be adversely affected.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be involved in disputes with agencies
and their advertisers over the operation of our platform, the terms of our agreements or our billings for purchases made by them through
our platform. If we are unable to collect or make adjustments to bills to customers, we could incur write-offs for bad debt, which could
have a material adverse effect on our results of operations for the periods in which the write-offs occur. In the future, bad debt may
exceed reserves for such contingencies and our bad debt exposure may increase over time. Any increase in write-offs for bad debt could
have a materially negative effect on our business, financial condition and operating results. Even if we are not paid by our customers
on time or at all, we are still obligated to pay for the advertising inventory we have purchased for the advertising campaign, and as
a consequence, our results of operations and financial condition would be adversely impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>If we default on our
credit obligations, our operations may be interrupted, and our business and financial results could be adversely affected.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Publishers extend us credit terms for the
purchase of advertising inventory. We currently have outstanding payables to existing publishers. If we are unable to pay our publishers
in a timely fashion, they may elect to no longer sell us inventory to provide for sale to advertisers. Also, it may be necessary for us
to incur additional indebtedness to maintain operations of the Company. If we default on our credit obligations, our lenders and debt
financing holders may, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">require repayment of any outstanding obligations or amounts drawn on our credit facilities;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">terminate our credit;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">stop delivery of ordered equipment;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">discontinue our ability to acquire inventory that is sold to advertisers;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">require us to accrue interest at higher rates; or</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">require us to pay significant damages.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If
some or all of these events were to occur, our operations may be interrupted and our ability to fund our operations or obligations, as
well as our business, financial results, and financial condition, could be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our failure to recruit or the
loss of management and highly trained and qualified personnel could adversely affect our operations. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success depends in large part
on our current senior management team and our ability to attract and retain additional high-quality management and operating personnel.
Our senior management team’s in-depth knowledge of and deep relationships with the participants in our industry are extremely valuable
to us. Our business also requires skilled technical and marketing personnel, who are in high demand and are often subject to competing
offers. Our failure to recruit and retain qualified personnel could hinder our ability to successfully develop and operate our business,
which could have a material adverse effect on our financial position and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The complexity of our data products, processing
functionality, software systems and services require highly trained professionals to operate, maintain, improve and repair them. While
we presently have a sophisticated, dedicated and experienced team of associates who have a deep understanding of our business, some of
whom have been with Mobiquity for years, the labor market for these individuals has historically been, and is currently, very competitive
due to the limited number of people available with the necessary technical skills and understanding, compensation strategies, general
economic conditions and various other factors. As the business information and marketing industries continue to become more technologically
advanced, we anticipate increased competition for qualified personnel. The loss of the services of highly trained personnel like the Company’s
current team of associates, or the inability to recruit and retain additional, qualified associates, could have a material adverse effect
on our business, financial position or operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our substantial amount of indebtedness
may adversely affect our cash flow and our ability to operate our business, remain in compliance with debt covenants and make payments
on our indebtedness.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our substantial level of indebtedness increases
the possibility that we may be unable to generate cash sufficient to pay, when due, the principal of, interest on or other amounts due
with respect to our indebtedness. Our indebtedness could have other important consequences to you as a shareholder. For example, it could:</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">make it more difficult for us to satisfy our obligations with respect to our indebtedness and any failure to comply with the obligations of any of our debt instruments could result in an event of default under our debt financing agreements;</td></tr>

<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">make us more vulnerable to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flows to fund working capital, capital expenditures, acquisitions and other general corporate purposes;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">place us at a competitive disadvantage compared to our competitors that have less debt; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">limit our ability to borrow additional amounts for working capital, capital expenditures, acquisitions, debt service requirements, execution of our business strategy or other purposes.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of the above listed factors could materially adversely affect
our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to An Investment in Our Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our common stock and warrants are listed
on the Nasdaq Capital Market. There can be no assurance that we will be able to comply with Nasdaq Capital Market’s continued listing
standards.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock in the past
has been thinly traded on the over -the- counter OTCQB market. As a condition to consummating our December 2021 public offering of over
$10 million, our common stock and warrants have become listed on the Nasdaq Capital Market. There can be no assurance any broker will
be interested in trading our stock and warrants. Therefore, it may be difficult to sell your shares of common stock or warrants if you
desire or need to sell them. Our underwriters of our December 2021 offering in which we raised over $10 million in gross proceeds are
not obligated to make a market in our common stock or warrants, and even if it makes a market, it can discontinue market making at any
time without notice. We can provide no assurance that an active and liquid trading market in our common stock and/or warrants will develop
or, if developed, that such market will continue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
common stock and warrants are listed on the Nasdaq Capital Market. However, there is no guarantee that we will be able to maintain such
listing for any period of time by perpetually satisfying Nasdaq Capital Market’s continued listing requirements. Our failure to
continue to meet these requirements may result in our common stock and warrants being delisted from Nasdaq Capital Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>The market price
of our common stock and warrants is likely to be highly volatile because of several factors, including a limited public float.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The
market price of our common stock has been volatile in the past and the market price of our common stock and our warrants is likely to
be highly volatile in the future. You may not be able to resell shares of our common stock or our warrants following periods of volatility
because of the market’s adverse reaction to volatility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other
factors that could cause such volatility may include, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">actual or anticipated fluctuations in our operating results;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the absence of securities analysts covering us and distributing research and recommendations about us;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">we may have a low trading volume for a number of reasons, including that a large portion of our stock is closely held;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">overall stock market fluctuations;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">announcements concerning our business or those of our competitors;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">actual or perceived limitations on our ability to raise capital when we require it, and to raise such capital on favorable terms;</td></tr>
</tbody></table>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="text-align: justify; width: 48px">&nbsp;</td>
    <td style="text-align: justify; width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">conditions or trends in the industry;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">litigation;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">changes in market valuations of other similar companies;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">future sales of common stock;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">departure of key personnel or failure to hire key personnel; and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">general market conditions.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of these factors could
have a significant and adverse impact on the market price of our common stock and/or warrants. In addition, the stock market in general
has at times experienced extreme volatility and rapid decline that has often been unrelated or disproportionate to the operating performance
of particular companies. These broad market fluctuations may adversely affect the trading price of our common stock and/or warrants,
regardless of our actual operating performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our future sales of common stock by
management and other stockholders may have an adverse effect on the then prevailing market price of our common stock. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event a public market for our common
stock is sustained in the future, sales of our common stock may be made by holders of our public float or by holders of restricted securities
in compliance with the provisions of Rule 144 of the Securities Act of 1933. In general, under Rule 144, a non-affiliated person who has
satisfied a six-month holding period in a fully reporting company under the Securities Exchange Act of 1934, as amended, may, sell their
restricted common stock without volume limitation, so long as the issuer is current with all reports under the Exchange Act in order for
there to be adequate common public information. Affiliated persons may also sell their common shares held for at least six months, but
affiliated persons will be required to meet certain other requirements, including manner of sale, notice requirements and volume limitations.
Non-affiliated persons who hold their common shares for at least one year will be able to sell their common stock without the need for
there to be current public information in the hands of the public. Future sales of shares of our public float or by restricted common
stock made in compliance with Rule 144 may have an adverse effect on the then prevailing market price, if any, of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>A significant portion of our total
outstanding shares are eligible to be sold into the market in the near future, which could cause the market price of our common shares
to drop significantly, even if our business is doing well.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently have approximately 4.2 million shares
of common stock free trading out of a total of 6.5 million outstanding common shares. Any increase in freely trading shares or the perception
that such securities will or could come onto the market could have an adverse effect on the trading price of the securities. No prediction
can be made as to the effect, if any, that sales of these securities, or the availability of such securities for sale, will have on the
market prices prevailing from time to time. Nevertheless, the possibility that substantial amounts of common stock and warrants may be
sold in the public market may adversely affect prevailing market prices for our common stock and could impair our ability to raise capital
through the sale of our equity securities or impair our shareholders’ ability to sell on the open market. Additionally, any substantial
increase of our shares that are eligible to be sold into the market in the near future could cause the market price of our common shares
to drop significantly, even if our business is doing well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our common stock <span style="background-color: white">and
our warrants (forming part of the units offered hereby)</span> may be subject to the “penny stock” rules in the future. It
may be more difficult to resell securities classified as “penny stock.”</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock and warrants may be subject
to “penny stock” rules (generally defined as non-exchange traded stock with a per-share price below $5.00) in the future.
While our common stock and warrants are currently not considered “penny stock” since they are listed on the Nasdaq Capital
Market, if we are unable to maintain that listing and our common stock and warrants are no longer listed on the Nasdaq Capital Market,
unless we maintain a per-share price above $5.00, our common stock and warrants will become “penny stock.” These rules impose
additional sales practice requirements on broker-dealers that recommend the purchase or sale of penny stocks to persons other than those
who qualify as “established customers” or “accredited investors.” For example, broker-dealers must determine the
appropriateness for non-qualifying persons of investments in penny stocks. Broker-dealers must also provide, prior to a transaction in
a penny stock not otherwise exempt from the rules, a standardized risk disclosure document that provides information about penny stocks
and the risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the
penny stock, disclose the compensation of the broker-dealer and its salesperson in the transaction, furnish monthly account statements
showing the market value of each penny stock held in the customer’s account, provide a special written determination that the penny
stock is a suitable investment for the purchaser, and receive the purchaser’s written agreement to the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Legal remedies available to an investor
in “penny stocks” may include the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">If a “penny stock” is sold to the investor in violation of the requirements listed above, or other federal or states securities laws, the investor may be able to cancel the purchase and receive a refund of the investment.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">If a “penny stock” is sold to the investor in a fraudulent manner, the investor may be able to sue the persons and firms that committed the fraud for damages.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These
requirements may have the effect of reducing the level of trading activity, if any, in the secondary market for a security that becomes
subject to the penny stock rules. The additional burdens imposed upon broker-dealers by such requirements may discourage broker-dealers
from effecting transactions in our securities, which could severely limit the market price and liquidity of our securities. These requirements
may restrict the ability of broker-dealers to sell our common stock or our warrants and may affect your ability to resell our common stock
and our warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many brokerage firms will discourage or refrain
from recommending investments in penny stocks. Most institutional investors will not invest in penny stocks. In addition, many individual
investors will not invest in penny stocks due, among other reasons, to the increased financial risk generally associated with these investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For these reasons, penny stocks may have
a limited market and, consequently, limited liquidity. We can give no assurance at what time, if ever, our common stock or our warrants
will not be classified as a “penny stock” in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We do not intend to pay dividends for
the foreseeable future and thus you must rely on stock appreciation for any return on your investment.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not anticipate paying cash dividends
on our common stock in the foreseeable future. We may not have sufficient funds to legally pay dividends. Even if funds are legally available
to pay dividends, we may nevertheless decide in our sole discretion not to pay dividends. The declaration, payment and amount of any future
dividends will be made at the discretion of our board of directors, and will depend upon, among other things, the results of our operations,
cash flows and financial condition, operating and capital requirements, and other factors our board of directors may consider relevant.
There is no assurance that we will pay any dividends in the future, and, if dividends are paid, there is no assurance with respect to
the amount of any such dividend. As a result, you must rely on stock appreciation and a liquid trading market for any return on your investment.
If an active and liquid trading market does not develop, you may be unable to sell your shares of common stock at or above the price in
this offering at the time you would like to sell.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our principal stockholders, directors and
executive officers have a material level of control over us, which could delay or prevent a change in our corporate control favored by
our other stockholders. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this Form 10-K, our principal
stockholders, directors and executive officers beneficially own, in the aggregate, approximately 37% of our outstanding common stock.
The interests of our current directors and executive officers may differ from the interests of other stockholders. As a result, these
current directors and officers could have the ability to exercise material influence over all corporate actions requiring stockholder
approval, irrespective of how our other stockholders may vote, including the following actions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">approval of certain mergers and other significant corporate transactions, including a sale of substantially all of our assets and material financing transactions;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>election of directors;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>adoption of or amendments to stock option plans;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>amendment of charter documents; or</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>issuance of “blank check” preferred stock.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our certificate of incorporation grants our board of directors
the authority to issue a new series of preferred stock without further approval by our shareholders, which could adversely affect the
rights of the holders of our common shares.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has the power to fix
and determine the relative rights and preferences of preferred stock. Our board of directors also has the power to issue preferred stock
without further shareholder approval, subject to applicable listing regulations. As a result, our board of directors could authorize the
issuance of new series of preferred stock that would grant to holders thereof certain rights in preference to the rights of our common
stockholders to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">our assets upon liquidation;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">receive dividend payments ahead of holders of common shares;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the redemption of the shares, together with a premium, prior to the redemption of our common shares;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">vote to approve matters as a separate class or have more votes per share relative to shares of common stock.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our board of directors could authorize the issuance
of new series of preferred stock that is convertible into our common shares, or may also authorize the sale of additional shares of authorized
common stock, which could decrease the relative voting power of our common shares or result in dilution to our existing shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&nbsp;</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>As a public company, we are subject to complex
legal and accounting requirements that will require us to incur significant expenses and will expose us to risk of non-compliance. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company, we are subject to numerous
legal and accounting requirements, and the maintenance listing requirements if we become listed on NASDAQ, that do not apply to private companies.
The cost of compliance with many of these requirements is material, not only in absolute terms but, more importantly, in relation to the
overall scope of the operations of a small company. Our management team is relatively inexperienced in complying with these requirements,
and our management resources are limited, which may lead to errors in our accounting and financial statements, and which may impair our
operations. This inexperience and lack of resources may also increase the cost of compliance and may also increase the risk that we will
fail to comply. Failure to comply with these requirements can have numerous adverse consequences including, but not limited to, our inability
to file required periodic reports on a timely basis or comply with NASDAQ listing requirements, resulting in loss of market confidence
and/or governmental or private actions against us, or delisting from NASDAQ. We cannot assure you that we will be able to comply with
all of these requirements or that the cost of such compliance will not prove to be a substantial competitive disadvantage vis-à-vis
our privately held and larger public competitors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We could become subject to shareholder litigation,
thereby diverting our resources that may have a material effect on our profitability and results of operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for our securities may be characterized
by significant price volatility when compared to seasoned issuers, and we expect that our share price may continue to be more volatile
than a seasoned issuer for the indefinite future.&nbsp; In the past, plaintiffs have often initiated securities class action litigation
against a company following periods of volatility in the market price of its securities. We may become the target of similar litigation.
Securities litigation will result in substantial costs and liabilities and will divert management’s attention and resources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>We in the past identified
significant deficiencies in our internal control over financial reporting that, if not corrected, could result in material misstatements
of our financial statements. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span>We have concluded
that we have not maintained effective internal control over financial reporting through the years ended December 31, 2021, and
December 31, 2020. The Company determined that it has deficiencies over financial statements recording in areas of recording revenue
and expenses in proper cut off as well as proper classification of accounts. Significant deficiencies and material weaknesses in our
internal control could have a material adverse effect on us. Due to these deficiencies, there is a reasonable possibility that a
material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely
basis. We are working to remediate these deficiencies and material weaknesses. We are taking steps to enhance our internal control
environment to establish and maintain effective disclosure and financial controls and procedures, internal control over financial
reporting and changes in corporate governance. In this regard, the Company in December 2021 adopted several corporate governance
policies, and it has established various committees of the Board of Directors, including an Audit Committee comprised of three
independent directors in accordance with Nasdaq Rule 5605(c)(2). One of the Audit Committee’s priorities will be to begin the
process of segregating tasks and processes to ensure proper internal controls. In connection with this process, the Company plans to
implement the following initiatives under the oversight of the Audit committee.</span></p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>Hire additional staff to the Finance department with sufficient GAAP experience. </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Implement ongoing training in U.S. GAAP requirements for our CFO and accounting and other finance personnel. </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Hire a consultant to assist in internal control review, testing of procedures and processes, and analysis as described in
    “Item 9A”.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Initiate a preliminary assessment of management’s internal controls over financial reporting. </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Improve documentation of existing internal controls and procedures and train personnel to help ensure they are properly followed. </td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have hired Refidential
One - SOX Consultants who have set up a time table to review testing procedures and analysis as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt; text-align: justify">Phase 1, which shall be completed on or about
the Company filing its form 10-K for December 31, 2021, will be to identify the gaps and suggested remediations in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt; text-align: justify">Phase 2, to be completed on or about June 30,2022,
(contingent upon the Company implementing remediation plan) will have all the narratives updated and risk control matrixes (“RCM”)
created and available for testing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Phase 3, to commence
on or about July 15th, 2021 and to be completed for the third quarter ending September 30,2022, will include the testing of all the key
controls identified, implemented in Phases 1 and 2 above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Phase 4, if necessary,
will be to retest the failures in Phase 3. Phase 4 testing enables MOBI to rectify any fails from Phase 3 testing, thus reducing the likelihood
of significant deficiencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we plan to undertake and complete
this remediation process as quickly as possible, we are unable, at this time to estimate how long it will take; and our efforts may not
be successful in remediating the deficiencies or material weaknesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A material weakness in our internal control
over financial reporting could adversely impact our ability to provide timely and accurate financial information, and to timely or accurately
report our financial condition, results of operations or cash flows or maintain effective disclosure controls and procedures. If we are
unable to report financial information timely and accurately or to maintain effective disclosure controls and procedures, we could be
subject to, among other things, regulatory or enforcement actions by the SEC, any one of which could adversely affect our business prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>If an active, liquid trading
market for our publicly held warrants does not develop, you may not be able to sell your warrants quickly or at a desirable price.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
publicly held warrants are immediately exercisable and expire on December 13, 2026. The warrants will have an initial exercise price per
share equal to $4.98. In the event that the stock price of our common stock does not exceed the exercise price of the warrants during
the period when the warrants are exercisable, the warrants may not have any value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There
is no established trading market for the warrants sold in this offering, and the market for the warrants may be highly volatile or may
decline regardless of our operating performance. Our warrants trade on the Nasdaq Capital Market under the symbol “MOBQW”.
However, an active public market for our warrants may not develop or be sustained. We cannot predict the extent to which investor interest
in our company will lead to the development of an active trading market in our warrants or how liquid that market might become. If a market
does not develop or is not sustained, it may be difficult for you to sell your warrants at the time you wish to sell them, at a price
that is attractive to you, or at all.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Holders
of our publicly held warrants will have no rights as a common stockholder until they acquire our common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until
you acquire shares of our common stock upon exercise of your publicly held warrants, you will have no rights with respect to the common
stock issuable upon exercise of such warrants. Upon exercise of your warrants, you will be entitled to exercise the rights of a common
stockholder only as to matters for which the record date occurs after the exercise date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General Risk Factors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Certain
provisions of our certificate of incorporation, bylaws and New York law make it more difficult for a third party to acquire us and make
a takeover more difficult to complete, even if such a transaction were in the stockholders’ interest.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our restated certificate of incorporation,
as amended, and by-laws&nbsp;and New York law contain provisions that are intended to deter coercive takeover practices and inadequate
takeover bids by making such practices or bids unacceptably expensive to the raider and to encourage prospective acquirers to negotiate
with our board of directors rather than to attempt a hostile takeover. In addition, provisions of our restated certificate of incorporation,
as amended, by-laws&nbsp;and New York law impose various procedural and other requirements, which could make it more difficult for shareholders
to effect certain corporate actions. These provisions include, among others:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the inability of our shareholders to call a special meeting;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the right of our Board to issue preferred stock without shareholder approval; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the ability of our directors, and not shareholders, to fill vacancies on our Board.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
believe these provisions may help protect our shareholders from coercive or otherwise unfair takeover tactics by requiring potential acquirers
to negotiate with our Board and by providing our Board with more time to assess any acquisition proposal. These provisions are not intended
to make our Company immune from takeovers. In addition, although we believe these provisions collectively provide for an opportunity to
receive higher bids by requiring potential acquirers to negotiate with our Board, they would apply even if the offer may be considered
beneficial by some shareholders. These provisions may also frustrate or prevent any attempts by our shareholders to replace or remove
our current management team by making it more difficult for shareholders to replace members of our Board, which is responsible for appointing
the members of our management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Our bylaws provide for limitations
of director liability and indemnification of directors and officers and employees.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide that we will indemnify
our directors, officers and employees to the fullest extent permitted by law. Our bylaws also provide that we are obligated to advance
expenses incurred by a director or officer in advance of the final disposition of any action or proceeding. We believe that these provisions
are necessary to attract and retain qualified persons as directors and officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;402(b) of the BCL permits a
New York corporation to include in its certificate of incorporation a provision eliminating the potential monetary liability of a director
to the corporation or its shareholders for breach of fiduciary duty as a director; provided that this provision may not eliminate the
liability of a director (i)&nbsp;for acts or omissions in bad faith or which involve intentional misconduct or a knowing violation of
law, (ii) for any transaction from which the director receives an improper personal benefit or (iii) for any acts in violation of Section&nbsp;719
of the BCL. Section 719 provides that a director who votes or concurs in a corporate action will be liable to the corporation for the
benefit of its creditors and shareholders for any damages suffered as a result of an action approving (i)&nbsp;an improper payment of
a dividend, (ii) an improper redemption or purchase by the corporation of shares of the corporation, (iii)&nbsp;an improper distribution
of assets to shareholders after dissolution of the corporation without adequately providing for all known liabilities of the corporation
or (iv) the making of an improper loan to a director of the corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The limitation of liability in our bylaws
may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood
of derivative litigation against directors and officers, even though an action, if successful, might provide a benefit to us and our stockholders.
Our results of operations and financial condition may be harmed to the extent we pay the costs of settlement and damage awards against
directors and officers pursuant to these indemnification provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_006"></span>Item 1B. Unresolved Staff Comments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a_007"></span><span style="text-decoration: underline">Item 2. Properties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is presently utilizing the office space
of its Chief Financial Officer as its principal executive office located at 35 Torrington Lane, Shoreham, NY 11786. The Company was leasing
on a month-to-month basis a fully furnished executive suite in Manhattan at a monthly cost of approximately $9,000. The executive suite
was located at 61 Broadway, 11<sup>th</sup> Floor, Suite 1105, New York, NY 10006. Since COVID-19 we have not been able to use the space
nor been responsible to pay rent for the period April 2020 through January 2021 when we terminated this office lease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_008"></span>Item 3. Legal Proceedings </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not a party to any
pending material legal proceedings. The following matters were settled in the past two fiscal years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Washington Prime Group, Inc. (“WPG”),
a successor in interest to Simon Property Group, L.P., commenced an action in the Marion Superior Court, County of Marion, State of Indiana
against the Company in February 2020 alleging default on 36 commercial leases which the Company had entered into in 36 separate shopping
mall locations across the United States for the placement of Mobiquity’s Bluetooth messaging system equipment in the shopping malls
to send advertisements through to shoppers’ phones as they walked through mall common areas. WPG alleged damages from unpaid rent
of $892,332. WPG sought a judgment from the court to collect the claimed unpaid rent plus attorneys’ fees and other costs of collection.
The Company disputed the claim. On September 18, 2020, the parties entered into a settlement agreement with respect to this lawsuit. Under
the settlement agreement, Mobiquity paid WPG $100,000.00 in five $20,000 monthly installments ending in January 2021 and mutual general
releases were exchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2019, Carter, Deluca &amp; Farrell
LP, a law firm, commenced an action in the Supreme Court of New York, County of Nassau, against the Company seeking $113,654 in past due
legal fees allegedly owed. The Company disputed the amount owed to that firm. On March 13, 2021 the Company entered into a settlement
agreement with the law firm and paid them $60,000 to settle the lawsuit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2020, Fyber Monetization, an Israeli
company in the business of digital advertising, commenced an action against the Company’s wholly-owned subsidiary Advangelists LLC
in the Magistrate’s Court in Tel Aviv, Israel. In its statement of claim, Fyber alleged that Advangelists owes Fyber license fees
of $584,945 invoiced in June through November 3, of 2019 under a February 1, 2017 license agreement for the use of Fyber’s RTB technology
and e-commerce platform with connects digital advertising media buyers and media sellers. In March 2022, this lawsuit was settled with
the Company paying $120,000 to Plaintiff.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2020, FunCorp Limited, a Cypriot company
which owns and operates social networking websites and mobile applications, commenced an action against the Company’s wholly-owned
subsidiary Advangelists LLC in Superior Court, State of Washington, County of King alleging Advangelists owed FunCorp for unpaid amounts
due under an insertion order for placement of Advangelists’ advertisements on FunCorp’s iFunny website totaling $42,464 plus
legal fees. Advangelists disputed the claim. In September, 2021 the action was settled in payment of $44,000 and the exchange of general
releases, without Advangelists admitting any liability. The settlement agreement provides that the terms of the settlement agreement and
FunCorp’s allegations are confidential, and may not be disclosed except as required by law, court order or subpoena with certain
limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="a_009"></span>Item 4. Mine Safety Disclosures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="a_010"></span>PART II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_011"></span>Item 5. Market for Common Equity, Related Stockholder
Matters, and Issuer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Common Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the past, our Common Stock traded on the OTCQB
under the symbol "MOBQ" on a limited basis. In October 2021, our Board of Directors approved the filing, and we submitted an
application in compliance with the NASDAQ rules and regulations to list and trade our Company’s securities on the NASDAQ Capital
Market. Trading commenced for our common stock and warrants on December 9, 2021. The following table sets forth the range of high and
low sales prices of our Common Stock for the last two fiscal years. On September 9, 2020, the Company effected a one-for-400 reverse stock
split. All share and per share amounts set forth herein give retroactive effect to the stock split unless the context indicates otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left">Quarters Ended</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">High</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Low</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">March 31, 2020</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">48.00</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">8.00</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 30, 2020</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">16.00</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">8.00</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">June 30, 2020</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">16.00</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">4.00</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">December 31, 2020</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">11.00</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">5.50</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">March 31, 2021</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">10.95</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">6.15</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">June 30, 2021</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">9.50</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">5.50</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">September 30, 2021</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">10.25</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">6.45</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">December 31, 2021</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">9.50</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">2.01</td><td style="text-align: left">&nbsp;</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The closing sales price on December 31, 2021, was
$2.13 per share. All quotations provided herein reflect inter-dealer prices, without retail mark-up, markdown or commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event a public market for our common
stock is sustained in the future, sales of our common stock may be made by holders of our public float or by holders of restricted securities
in compliance with the provisions of Rule 144 of the Securities Act of 1933. In general, under Rule 144, a non-affiliated person who has
satisfied a six-month holding period in a fully reporting company under the Securities Exchange Act of 1934 may, sell their restricted
Common Stock without volume limitation, so long as the issuer is current with all reports under the Exchange Act in order for there to
be adequate public information disclosed. Affiliated persons may also sell their common shares held for at least six months, but affiliated
persons will be required to meet certain other requirements, including manner of sale, notice requirements and volume limitations. Non-affiliated
persons who hold their common shares for at least one year will be able to sell their shares without the need for there to be current
public information in the hands of the public. Future sales of shares of our public float or by restricted common stock made in compliance
with Rule 144 may have an adverse effect on the then prevailing market price, if any, of our common stock. See “Item 1A.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Publicly Held Warrants</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our publicly held
warrants commenced trading on the NASDAQ Capital Market on December 9, 2021, under the symbol “MOBQW.” The high and low
sales price of our warrants was $.915 and $.50, respectively, for the period December&nbsp;9, 2021, through December 31, 2021. The
closing sales price of on December 31, 2021, was $.55 per warrant. All quotations provided herein reflect inter-dealer prices,
without retail mark-up, markdown or commissions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Holders of Record</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As
of March 11, 2022, there were 257 active holders of record of our common stock. The number of record holders was determined from the records
of our transfer agent and does not include beneficial owners of common stock whose shares are held in the names of various security brokers,
dealers, and registered clearing agencies. As of March 1, 2022, the Company has a list consisting of 1,211 beneficial (“NOBO”)
holders who do not object to having their names provided to the Company. The transfer agent of our common stock is Continental Stock Transfer
&amp; Trust Company, New York NY.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DIVIDEND POLICY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has not paid any
cash dividends to date and does not anticipate or contemplate paying cash dividends on our capital stock in the foreseeable future. It
is the present intention of management to utilize all available funds and future earnings for the development of the Company’s business.
Any future determination to declare cash dividends will be made at the discretion of our Board of Directors, subject to applicable laws,
and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors
that our Board of Directors may deem relevant. Our future ability to pay cash dividends on our capital stock may be limited by any future
debt instruments or preferred securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">RECENT SALES OF UNREGISTERED SECURITIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) In fiscal 2020 and 2021, we made sales or issuances
of unregistered securities listed in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 5%"><b>Date of Sale</b></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; width: 18%"><b>Title of Security</b></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; width: 18%"><b>Number Sold</b></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; width: 23%"><b>Consideration Received and Description of Underwriting or Other Discounts to Market Price or Convertible Security, Afforded to Purchasers</b></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; width: 13%"><b>Exemption from<br>
Registration Claimed</b></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; width: 18%"><b>If Option, Warrant or Convertible Security, terms of exercise or conversion</b></td></tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top">2020</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Common Stock</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">340,786 shares</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash consideration</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$3,600,424</p></td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Rule 506; Section 4(2)</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">N/A</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top">2020</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Common stock </td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">38,125 shares</p></td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Services rendered; no commissions paid</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Services rendered, valued at $547,451</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">N/A </td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top">2020</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Common stock</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">9,843 shares and 4,921 warrants</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Preferred stock Series E conversion resulting in transfer from preferred stock to common stock of $324,802</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Section 3(a)(9)</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Converted 3,937 Series E preferred shares</td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td></tr>
  <tr style="background-color: #EEEEEE">
    <td style="vertical-align: top">2020</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Warrant conversion</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">warrants converted to 77,220 common shares</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash consideration $873,473</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Section 4(2)</td>
    <td style="vertical-align: bottom">&nbsp;</td>
    <td style="vertical-align: top">Warrants exercised at $13.00 to $16.00 per share including some cashless exercise</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tbody><tr style="background-color: #EEEEEE"><td style="vertical-align: top; width: 5%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2020</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">$50,000 Convertible note</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1,919 common shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Paid $20,000 cash; converted $30,000 balance to common stock</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 4(2)/Section 3(a)(9)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Conversion of notes into common stock at an effective price of $26.05
    per share</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common stock</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">265,000 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Services rendered</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rule 506; Section 4(2)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">236,768 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note conversion</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 3(a)(9)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable</p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">49,384 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant conversions cashless exercise</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 3(a)(9)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each warrant exercise</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Price$5.395, expiration</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date 9/17/2026</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">375,000 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Series C Preferred Stock conversion</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 3(a)(9)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)</p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2,631,764 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares sold for cash</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rule 506; Section 4(2)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">92,900 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Original issue discount</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rule 506;Section 4(2)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable</p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="background-color: #EEEEEE">
    <td style="vertical-align: top; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2021</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6,250 shares</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 23%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Series AAA Preferred Stock conversion</p></td>
    <td style="vertical-align: bottom; width: 1%">&nbsp;</td>
    <td style="vertical-align: top; width: 13%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rule 506;Section 4(2)</p></td>
    <td style="vertical-align: bottom; width: 1%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></td>
    <td style="vertical-align: top; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable</p></td></tr>
  </tbody></table>
<p style="margin: 0">&nbsp;&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.3in">(1)</td><td><span style="text-decoration: underline">1,500 Series C Warrants were converted into 375,000 common shares and a like number of warrants, exercisable at $48.00 per share
through September 2023.</span></td></tr></tbody></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.05in; text-align: justify; text-indent: -0.05in"><span style="text-decoration: underline">RECENT
PURCHASES OF SECURITIES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In 2021 and 2020, we had no repurchases of our
Common Stock, except as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="a_012"></span>Item 6. Selected Financial Data</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information required by Item 6 is not required
by issuers that satisfy the definition of “smaller reporting company” under SEC rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="text-decoration: underline"><span id="a_013"></span>Item 7. Management's Discussion and Analysis
of Financial Condition and Results of Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion should
be read in conjunction with our financial statements and the notes thereto appearing elsewhere in this Form 10-K. All statements contained
herein that are not historical facts, including, but not limited to, statements regarding anticipated future capital requirements, our
future plan of operations, our ability to obtain debt, equity or other financing, and our ability to generate cash from operations, are
based on current expectations. These statements are forward-looking in nature and involve a number of risks and uncertainties that may
cause the Company's actual results in future periods to differ materially from forecasted results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Company Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mobiquity
Technologies, Inc. is a next-generation marketing and advertising technology and data intelligence company which operates through our proprietary
software platforms in the programmatic advertising space.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our product solutions are comprised of two
proprietary software platforms:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Our advertising technology operating system (or ATOS) platform; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Our data intelligence platform.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
ATOS platform blends artificial intelligence (or AI) and machine learning (ML) based optimization technology for automatic ad serving
that manages digital advertising inventory and campaigns. Our data intelligence platform provides precise data and insights on consumer’s
real-world behavior and trends for use in marketing and research.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
operate our business through two wholly-owned subsidiaries. Advangelists LLC operates our ATOS platform business, and Mobiquity Networks,
Inc. operates our data intelligence platform business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Critical Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our
discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been
prepared in accordance with generally accepted accounting principles in the United States. The preparation of financial statements requires
management to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates
including, but not limited to, those related to revenue recognition. We use authoritative pronouncements, historical experience and other
assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical
accounting policies affect our more significant judgments and estimates in the preparation of our financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Revenue Recognition </i>–On May
28, 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), to update the financial reporting
requirements for revenue recognition. Topic 606 outlines a single comprehensive model for entities to use in accounting for revenue arising
from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The guidance
is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount
that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also
requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts,
including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. This guidance
became effective for the Company beginning on January 1, 2018, and entities have the option of using either a full retrospective or a
modified retrospective approach for the adoption of the new standard. The Company adopted this standard using the modified retrospective
approach on January 1, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparation for adoption of the standard,
the Company evaluated each of the five steps in Topic 606, which are as follows: (1) Identify the contract with the customer; (2) Identify
the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to the performance
obligations; and (5) Recognize revenue when (or as) performance obligations are satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reported revenue will not be affected materially
in any period due to the adoption of ASC Topic 606 because: (1) the Company expects to identify similar performance obligations under
Topic 606 as compared with deliverables and separate units of account previously identified; (2) the Company has determined the transaction
price to be consistent; and (3) the Company records revenue at the same point in time, upon delivery of services, under both ASC Topic
605 and Topic 606, as applicable under the terms of the contract with the customer. Additionally, the Company does not expect the accounting
for fulfillment costs or costs incurred to obtain a contract to be affected materially in any period due to the adoption of Topic 606.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are also certain considerations related
to accounting policies, business processes and internal control over financial reporting that are associated with implementing Topic 606.
The Company has evaluated its policies, processes, and control framework for revenue recognition, and identified and implemented the changes
needed in response to the new guidance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lastly, disclosure requirements under the
new guidance in Topic 606 have been significantly expanded in comparison to the disclosure requirements under the current guidance, including
disclosures related to disaggregation of revenue into appropriate categories, performance obligations, the judgments made in revenue recognition
determinations, adjustments to revenue which relate to activities from previous quarters or years, any significant reversals of revenue,
and costs to obtain or fulfill contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenue from service
contracts with certain customers. These contracts are accounted for under the proportional performance method. Under this method, revenue
is recognized in proportion to the value provided to the customer for each project as of each reporting date. We recognize revenues in
the period in which the data transmission is provided to the licensee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Allowance for Doubtful Accounts</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
are required to make judgments as to the realizability of our accounts receivable. We make these assessments based on the following factors:
(a) historical experience, (b) customer concentrations, (c) customer credit worthiness, (d) current economic conditions, and (e) changes
in customer payment terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Accounting for Stock Based Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stock
based compensation cost is measured at the grant date fair value of the award and is recognized as expense over the requisite service
period. The Company uses the Black-Sholes option-pricing model to determine fair value of the awards, which involves certain subjective
assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising
them (“expected term”), the estimated volatility of the company’s common stock price over the expected term (“volatility”)
and the number of options for which vesting requirements will not be completed (“forfeitures”). Changes in the subjective
assumptions can materially affect estimates of fair value stock-based compensation, and the related amount recognized on the consolidated
statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Goodwill and Intangible Assets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Goodwill
represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized.
The goodwill arising from the Company’s acquisitions is attributable to the value of the potential expanded market opportunity with
new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives
are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible
assets consist of customer relationships and non-compete agreements. Their useful lives range from 1.5 to 10 years. The Company’s
indefinite-lived intangible assets consist of trade names.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Goodwill and indefinite-lived assets
are not amortized but are subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs
an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in
circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing is a two-step
process performed at the reporting unit level. Step one compares the fair value of the reporting unit to its carrying amount. The fair
value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under
the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach,
the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value
using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset
pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the
Company’s risk relative to the overall market, the Company’s size and industry and other Company specific risks. Other significant
assumptions used in the income approach include the terminal value, growth rates, future capital expenditures and changes in future working
capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public
market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s
carrying amount exceeds its fair value, then the second step must be completed to measure the amount of impairment, if any. Step two calculates
the implied fair value of goodwill by deducting the fair value of all tangible and intangible net assets of the reporting unit from the
fair value of the reporting unit as calculated in step one. In this step, the fair value of the reporting unit is allocated to all of
the reporting unit’s assets and liabilities in a hypothetical purchase price allocation as if the reporting unit had been acquired
on that date. If the carrying amount of goodwill exceeds the implied fair value of goodwill, an impairment loss is recognized in an amount
equal to the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Determining the fair value of a reporting
unit is judgmental in nature and requires the use of significant estimates and assumptions, including revenue growth rates, strategic
plans and future market conditions, among others. There can be no assurance that the Company’s estimates and assumptions made for
purposes of the goodwill impairment testing will prove to be accurate predictions of the future. Changes in assumptions and estimates
could cause the Company to perform impairment testing prior to scheduled annual impairment tests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company performed its
annual fair value assessment at December 31, 2021, there was a $3,600,000 impairment during the year. For the year ended December 31,
2020, there was a $4,000,000 impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Plan of Operation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mobiquity
intends to hire several new sales and sales support individuals to help generate additional revenue through the use of the Advangelists
platform. Mobiquity’s sales team will focus on Advertising Agencies, Brands and publishers to help increase both supply and demand
across the Advangelists platform. The Advangelists platform creates three revenue streams for Mobiquity. The first is licensing the Advangelists
platform as a white-label product for use by Advertising Agencies, DSP’s, Publishers and Brands. Under the White-Label scenario,
the user licenses the technology and is responsible for running its own business operations and is billed a percentage of volume run through
the platform. The second revenue stream is a managed services model in which the user is billed a higher percentage of revenue run through
the platform, but all services are managed by the Mobiquity/Advangelists team. The third revenue model is a seat model, where the user
is billed a percentage of revenue run through the platform and business operations are shared between the user and the Mobiquity/Advangelists
team. The goal of the sales team is to inform potential users of the benefits in efficiency and effectiveness of utilizing the end-to-end,
fully integrated ATOS created by Advangelists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Year Ended December 31, 2021, versus Year Ended
December 31, 2020</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b></b>The following table sets forth certain
selected condensed statement of operations data for the periods indicated in dollars. In addition, we note that the period-to-period
comparison may not be indicative of future performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Year Ended</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br> 2021</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, <br> 2020</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%">Revenue</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">2,672,615</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">6,184,010</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of Revenues</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">1,954,383</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">4,360,645</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Gross Income</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">718,232</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">1,823,365</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating Expenses</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">16,707,231</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">13,204,465</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">(Loss) from operations</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(15,988,999</td><td style="text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(11,381,100</td><td style="text-align: left">)</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generated revenues of $2,672,615
in 2021 as compared to $6,184,010 in the same period for 2020, a change in revenues of $3,511,395. The nationwide economic shutdown due
to COVID-19 during 2021 severely reduced current operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenues was
$1,954,383 or 73.1% of revenues in 2021 as compared to $4,360,645 or 70.5% of revenues in the same fiscal period of fiscal 2020. Cost
of revenues include web services for storage of our data and web engineers who are building and maintaining our platforms. Our ability
to capture and store data for sales does not translate to increased cost of sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gross Income was $718,232
or 26.9% of revenues for 2021 as compared to $1,823,365 in the same fiscal period of 2020 or 29.5% of revenues. When the country comes
out of COVID-19 and the economy begins to turn around we anticipate income to increase.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Operating expenses were $16,707,231
for 2021 compared to $13,204,465 in the comparable period of the prior year, an increase of $3,502,766. Increased operating costs include
cash and non-cash expense for professional fees of $1,141,848, non-cash operating costs also include option-based compensation of $2,787,648,
and origination fees of $692,430.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net loss from operations
for 2021 was $15,988,999 as compared to $11,381,100 for the comparable period of the prior year. The loss from operations includes the non-cash warrant expense of $18,543,154,
stock-based compensation of $4,134,696 and impairment expense of $3,600,000. The continuing operating loss is attributable
to the focused effort in creating the infrastructure required to move forward with our Mobiquity and Advangelists network business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No benefit for income taxes
is provided for in the reported periods due to the full valuation allowance on the net deferred tax assets. Our ability to be profitable
in the future is dependent upon the successful introduction and usage of our data collection and analysis including Advertising, Data
Licensing, Footfall Reporting, Attribution Reporting, Real Estate Planning, Financial Forecasting and Custom Research services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have a history of
operating losses and our m<span style="background-color: white">anagement has concluded that factors raise substantial doubt about
our ability to continue as a going concern and our auditor has included an explanatory paragraph relating to our ability to continue
as a going concern in </span>its audit report for the fiscal years ended December 31, 2021, and 2020</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had cash
and cash equivalents of $5,385,245 at December 31, 2021. Cash used by operating activities for the year ended December 31, 2021, was $6,136,477.
This resulted from a net loss of $34,947,699, partially offset by non-cash expenses, including depreciation and amortization of $808,300,
stock-based compensation of $4,134,696, warrant expense of $18,794,607 and impairment expense of $3,600,000. Cash provided by financing
activities of $2,037,995 was the result of issuance of notes and cash payments on notes outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had cash
and cash equivalents of $602,182 at December 31, 2020. Cash used by operating activities for the year ended December 31, 2020 was $4,750,442.
This resulted from a net loss of $15,032,404, partially offset by non-cash expenses, including depreciation and amortization of $1,807,007,
stock-based compensation of $1,347,048, warrant expense of $1,472,367 and impairment expense of $4,000,000. Cash provided by financing
activities of $485,033 was the result of issuance of notes and cash payments on notes outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our company commenced operations
in 1998 and was initially funded by our three founders, each of whom has made demand loans to our company that have been repaid. Since
1999, we have relied on equity financing and borrowings from outside investors to supplement our cash flow from operations and expect
this to continue in 2022 and beyond until cash flow from our proximity marketing operations become substantial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Financings</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 19, 2021, the Company
filed a Form S-1 Registration Statement (File no. 333-260364) with the Securities and Exchange Commission to raise over $10 million dollars
in an underwritten public offering. The next day the Company filed an application to list our common stock on the NASDAQ Capital
Market under the symbol “MOBQ.” This offering was completed on December 13, 2021, and the Company retired the loans of Talos
Victory Fund, LLC and Blue Lake Partners LLC out of the gross proceeds it received of approximately $10.3 million. Also, Talos Victory
Fund, LLC and Blue Lake Partners, LLC converted all of their warrants on a cashless basis into 24,692 common shares and 24,692 common
shares, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have completed various other financings as described
under the Notes to Consolidated Financial Statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Off-Balance Sheet Arrangements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2021, we did not have any off-balance-sheet
arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_014"></span>Item 7A. Qualitative and Qualitative Disclosures
about Market Risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Market risk is the risk of
loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates and commodity prices.
Our primary exposure to market risk is interest rate risk associated with our short-term money market investments. The Company does not
have any financial instruments held for trading or other speculative purposes and does not invest in derivative financial instruments,
interest rate swaps or other investments that alter interest rate exposure. The Company does not have any credit facilities with variable
interest rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_015"></span>Item 8. Financial Statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Financial Statements and Supplementary Data</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The report of the Independent
Registered Public Accounting Firm, Financial Statements and Schedules are set forth herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the shareholders and the board of directors
of Mobiquity Technology, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying
consolidated balance sheets of Mobiquity Technology, Inc. as of December 31, 2021, and 2020, the related statements of operations, stockholders'
equity (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the "financial statements").
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2021, and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles
generally accepted in the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Substantial
Doubt about the Company’s Ability to Continue as a Going Concern</b></span><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The accompanying
financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial
statements, the Company has suffered recurring losses from operations and has a significant accumulated deficit. In addition, the Company
continues to experience negative cash flows from operations. These factors raise substantial doubt about the Company's ability to continue
as a going concern. Management's plans in regard to these matters are also described in Note 1. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audit in accordance with
the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audit included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Audit Matter</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The critical audit matter communicated
below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated
to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved
our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our
opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate
opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Revenue recognition —
identification of contractual terms in certain customer arrangements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Note 2 to the consolidated
financial statements, management assesses relevant contractual terms in its customer arrangements to determine the transaction price and
recognizes revenue upon transfer of control of the promised goods or services in an amount that reflects the consideration the Company
expects to receive in exchange for those products or services. Management applies judgment in determining the transaction price which
is dependent on the contractual terms. In order to determine the transaction price, management may be required to estimate variable consideration
when determining the amount and timing of revenue recognition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal considerations for our determination
that performing procedures relating to the identification of contractual terms in customer arrangements to determine the transaction price
is a critical audit matter are there was significant judgment by management in identifying contractual terms due to the volume and customized
nature of the Company’s customer arrangements. This in turn led to significant effort in performing our audit procedures which were
designed to evaluate whether the contractual terms used in the determination of the transaction price and the timing of revenue recognition
were appropriately identified and determined by management and to evaluate the reasonableness of management’s estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Addressing the matter involved performing
procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These
procedures included testing the effectiveness of controls relating to the revenue recognition process, including those related to the
identification of contractual terms in customer arrangements that impact the determination of the transaction price and revenue recognition.
These procedures also included, among others, (i) testing the completeness and accuracy of management’s identification of the contractual
terms by examining customer arrangements on a test basis, and (ii) testing management’s process for determining the appropriate
amount and timing of revenue recognition based on the contractual terms identified in the customer arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>/S/ <span id="xdx_907_edei--AuditorName_c20210101__20211231_zY6qJuyYdRDP"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:AuditorName">BF Borgers CPA PC</ix:nonnumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company's auditor since
2018</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_908_edei--AuditorLocation_c20210101__20211231_zRbpbEIhNacL"><ix:nonnumeric contextref="From2021-01-01to2021-12-31" name="dei:AuditorLocation">Lakewood, CO</ix:nonnumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">March 29, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_902_edei--AuditorFirmId_c20210101__20211231_zZ1mJFTw0SuX"><b style="display: none"><span style="-sec-ix-hidden: xdx2ixbrl0045">5041</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Mobiquity Technology, Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Consolidated Balance Sheets</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" id="xdx_305_111_z3F1qj8cnXAW" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td id="xdx_495_20211231_zhrgG1xY68Lc" style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_494_20201231_zVCSa2mZWYbs" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">December 31,</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: center">December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsAbstract_iB_zEjccaCSkeZX" style="vertical-align: bottom">
    <td style="text-align: left">Assets</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-weight: bold">&nbsp;</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: center">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--AssetsCurrentAbstract_iB_zAdV3xEBL5Px" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Current Assets</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maCzjrZ_zRTHNcF4QsEc" style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; padding-left: 10pt">Cash</td><td style="width: 2%; font-weight: bold">&nbsp;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 13%; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,385,245</ix:nonfraction></td><td style="width: 1%; font-weight: bold; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">602,182</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsReceivableNetCurrent_i01I_maCzjrZ_zfB7Kp8SUyYm" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable, net</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AccountsReceivableNetCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">388,112</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AccountsReceivableNetCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,698,719</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseAndOtherAssets_i01I_maCzjrZ_zKFiXZlWL63k" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:PrepaidExpenseAndOtherAssets" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">11,700</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:PrepaidExpenseAndOtherAssets" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">46,396</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_i01TI_mtCzjrZ_maCzmLb_zr64mAySSMqq" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total Current Assets</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,785,057</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AssetsCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,347,297</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzmLb_zrHvetQzkw2E" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Property and equipment (net of accumulated depreciation of $<span id="xdx_902_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20211231_pp0p0_z6140iqjclsv" title="Accumulated depreciation, property and equipment"><ix:nonfraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">20,200</ix:nonfraction></span> and $<span id="xdx_903_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20201231_pp0p0_zhiAkiDxjXRf" title="Accumulated depreciation, property and equipment"><ix:nonfraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">12,635</ix:nonfraction></span>, respectively)</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">20,335</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:PropertyPlantAndEquipmentNet" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">21,428</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_i01I_maCzmLb_z1YfDzmXkDAD" style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:Goodwill" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,352,865</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:Goodwill" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,352,865</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_406_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_i01I_maCzmLb_zT21WCuDdYX7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Intangible assets (net of accumulated amortization of $<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0_zPAR9HZsPEgu" title="Accumulated amortization, intangible assets"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">4,156,657</ix:nonfraction></span> and $<span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20201231_pp0p0_ztCJHYVlYU0A" title="Accumulated amortization, intangible assets"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">3,355,922</ix:nonfraction></span>, respectively)</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,247,019</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,647,754</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsAbstract_i01B_zkEzCxaTLSMc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other assets</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--SecurityDeposit_i01I_d0_maCzmLb_z6WCPzmvstFY" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Security deposits</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:SecurityDeposit" contextref="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:SecurityDeposit" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">9,000</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--Investments_i01I_d0_maCzmLb_zojdl8Di4koC" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Investment in corporate stock</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:Investments" contextref="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:Investments" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">91</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&nbsp;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_i01TI_mtCzmLb_z33s6Lf9w7LM" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:Assets" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">8,405,276</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:Assets" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">9,378,435</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zJid250CIT8X" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Liabilities and Stockholders' Equity</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesCurrentAbstract_iB_zKhB6cNjOICK" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current Liabilities</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableCurrent_i01I_maCz5fR_z3KGBQORTNhA" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AccountsPayableCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,676,048</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AccountsPayableCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,055,175</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_i01I_maCz5fR_zfJSKlksnkLu" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accrued expenses</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AccruedLiabilitiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">691,552</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AccruedLiabilitiesCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,085,292</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--LongTermDebtCurrent_i01I_maCz5fR_z2PioiKgPWOM" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Notes payable</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:LongTermDebtCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">519,004</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:LongTermDebtCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">901,283</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrent_i01TI_mtCz5fR_maCz7gt_zQAvhkmVL5b_zgFqsLFDynQX" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total Current Liabilities</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,886,604</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:LiabilitiesCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,041,750</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermDebtNoncurrent_i01I_maCz7gt_zQTBsIBmhhs9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Long term portion convertible notes, net</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:LongTermDebtNoncurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,600,000</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:LongTermDebtNoncurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,450,000</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&nbsp;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40B_eus-gaap--Liabilities_i01TI_mtCz7gt_maCzjky_zLg8cjbtpqFm" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,486,604</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:Liabilities" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">6,491,750</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockholdersEquityAbstract_iB_zwbhmDRFEv1m" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stockholders' Deficit</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">AAA Preferred stock; <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_c20211231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_zDzPmhJrpxoF" title="Preferred Stock shares authorized"><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2021-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">4,930,000</ix:nonfraction></span> and <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_c20201231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_znXcR11qVeKS" title="Preferred Stock shares authorized"><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2020-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">5,000,000</ix:nonfraction></span> authorized; $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_z0mOWditNoug" title="Preferred Stock par value"><span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_zBLxfSFhgj3t" title="Preferred Stock par value"><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AsOf2021-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares"><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AsOf2020-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">0.0001</ix:nonfraction></ix:nonfraction></span></span> par value <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_c20211231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_zupsXdLJvT4U" title="Preferred Stock shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_z2HdQw6X6UvV" title="Preferred stock shares outstanding"><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2021-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" contextref="AsOf2021-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">31,413</ix:nonfraction></ix:nonfraction></span></span>
    and <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_c20201231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_zglE2uWWNDXh" title="Preferred Stock shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_c20201231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_pdd_zkXpsISoErEb" title="Preferred stock shares outstanding"><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2020-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" contextref="AsOf2020-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">56,413</ix:nonfraction></ix:nonfraction></span></span> shares issued and outstanding at December 31, 2021 and December 31, 2020</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td id="xdx_98B_eus-gaap--PreferredStockValue_pp0p0_maCzpdi_c20211231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_zb7B0FFibJjW" title="Preferred Stock, Value, Issued" style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2021-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">493,869</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_982_eus-gaap--PreferredStockValue_pp0p0_maCzpdi_c20201231__us-gaap--StatementClassOfStockAxis__custom--AaaPreferredStockMember_zJY7HnNh8NNR" title="Preferred Stock, Value, Issued" style="text-align: right"><ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2020-12-31_custom_AaaPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">868,869</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Preferred stock Series C; $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zZ5TrGVSzR3Q" title="Preferred Stock par value"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zvFvNnWKCTc2" title="Preferred Stock par value"><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AsOf2021-12-31_custom_PreferredStockSeriesCMember" decimals="INF" unitref="USDPShares"><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AsOf2020-12-31_custom_PreferredStockSeriesCMember" decimals="INF" unitref="USDPShares">.0001</ix:nonfraction></ix:nonfraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zGNTxt8IhrFH" title="Preferred Stock shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zDXSq04SfKaN" title="Preferred Stock shares authorized"><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2021-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2020-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,500</ix:nonfraction></ix:nonfraction></span></span> shares authorized <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zq8dTYIXbdP5" title="Preferred Stock shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zgc0e9jjMDZ8" title="Preferred stock shares outstanding"><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2021-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" contextref="AsOf2021-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">0</ix:nonfraction></ix:nonfraction></span></span> and <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zbuRGNUcAxVM" title="Preferred Stock shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_pdd_zomOXDNrm5nQ" title="Preferred stock shares outstanding"><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2020-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" contextref="AsOf2020-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,500</ix:nonfraction></ix:nonfraction></span></span>
    shares issued and outstanding at December 31, 2021 and December 31, 2020</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td id="xdx_982_eus-gaap--PreferredStockValue_iI_pp0p0_d0_maCzpdi_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_zyF24Tou9ros" title="Preferred Stock, Value, Issued" style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2021-12-31_custom_PreferredStockSeriesCMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98B_eus-gaap--PreferredStockValue_pp0p0_maCzpdi_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredStockSeriesCMember_zhzXmKtZPIa7" title="Preferred Stock, Value, Issued" style="text-align: right"><ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2020-12-31_custom_PreferredStockSeriesCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">15,000</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Preferred stock Series E; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zv3yIjJaFpwF" title="Preferred Stock shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_z2bnAtehSk4Y" title="Preferred Stock shares authorized"><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2021-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesAuthorized" contextref="AsOf2020-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">70,000</ix:nonfraction></ix:nonfraction></span></span> authorized; $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zocRv5vS6KmF" title="Preferred Stock par value"><span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zU4G83GssfOI" title="Preferred Stock par value"><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AsOf2021-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares"><ix:nonfraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AsOf2020-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">80</ix:nonfraction></ix:nonfraction></span></span> par value <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zST0WoU8KFDl" title="Preferred Stock shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zQZHYfNpB1Rj" title="Preferred stock shares outstanding"><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2021-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" contextref="AsOf2021-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">61,688</ix:nonfraction></ix:nonfraction></span></span> and <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zj2FOIfAkTHr" title="Preferred Stock shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_pdd_zQATuaOPBOac" title="Preferred stock shares outstanding"><ix:nonfraction name="us-gaap:PreferredStockSharesIssued" contextref="AsOf2020-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:PreferredStockSharesOutstanding" contextref="AsOf2020-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">61,688</ix:nonfraction></ix:nonfraction></span></span> shares
    issued and outstanding at December 31, 2021 and December 31, 2020</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td id="xdx_984_eus-gaap--PreferredStockValue_pp0p0_maCzpdi_c20211231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_z3KnMKjgYo8_zkgPzoglhMo4" title="Preferred Stock, Value, Issued" style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2021-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">4,935,040</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98B_eus-gaap--PreferredStockValue_pp0p0_maCzpdi_c20201231__us-gaap--StatementClassOfStockAxis__custom--PreferredSeriesEMember_zFpB417Fp9eD" title="Preferred Stock, Value, Issued" style="text-align: right"><ix:nonfraction name="us-gaap:PreferredStockValue" contextref="AsOf2020-12-31_custom_PreferredSeriesEMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">4,935,040</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_iI_maCzpdi_zOQERaaWGkI7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Common stock: <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd_zZiyQG3lJhR4" title="Common stock shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20201231_pdd_zQJqkJFAiV7f" title="Common stock shares authorized"><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:CommonStockSharesAuthorized" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">100,000,000</ix:nonfraction></ix:nonfraction></span></span> authorized; $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd_zyltMXH3PH6d" title="Common stock par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_c20201231_pdd_zJq1HXmZy4Sy" title="Common stock par value"><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares"><ix:nonfraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">0.0001</ix:nonfraction></ix:nonfraction></span></span> par value <span id="xdx_901_eus-gaap--CommonStockSharesIssued_c20211231_pdd_zhxKf5MIBbOV" title="Common stock shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20211231_pdd_zBEKHgIKVPhG" title="Common stock outstanding"><ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,460,751</ix:nonfraction></ix:nonfraction></span></span> and <span id="xdx_900_eus-gaap--CommonStockSharesIssued_c20201231_pdd_z0N0cCMxUnBz" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20201231_pdd_zX248eTjugg2" title="Common stock outstanding"><ix:nonfraction name="us-gaap:CommonStockSharesIssued" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares"><ix:nonfraction name="us-gaap:CommonStockSharesOutstanding" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,803,685</ix:nonfraction></ix:nonfraction></span></span>
    shares issued and outstanding at December 31, 2021 and December 31, 2020</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">650</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:CommonStockValue" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">282</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--TreasuryStockValue_iNI_di_msCzpdi_zouC0Eg51tYv" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Treasury stock $<span id="xdx_90D_ecustom--TreasuryStockParOrStatedValuePerShare_c20211231_pdd_zPfBz6NMuMul" title="Treasury Stock par value"><span id="xdx_90C_ecustom--TreasuryStockParOrStatedValuePerShare_c20201231_pdd_zNSpTMe86y0R" title="Treasury Stock par value"><ix:nonfraction name="MOBQ:TreasuryStockParOrStatedValuePerShare" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares"><ix:nonfraction name="MOBQ:TreasuryStockParOrStatedValuePerShare" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">0.0001</ix:nonfraction></ix:nonfraction></span></span> par value <span id="xdx_906_eus-gaap--TreasuryStockShares_c20211231_pdd_zROgG00Gaf8S" title="Treasury Stock shares outstanding"><ix:nonfraction name="us-gaap:TreasuryStockShares" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">37,500</ix:nonfraction></span> and <span id="xdx_901_eus-gaap--TreasuryStockShares_c20201231_pdd_z3pn2Ef2hvdQ" title="Treasury Stock shares outstanding"><ix:nonfraction name="us-gaap:TreasuryStockShares" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">37,500</ix:nonfraction></span> shares outstanding at December 31, 2021 and
    December 31, 2020</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:TreasuryStockValue" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,350,000</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:TreasuryStockValue" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,350,000</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--AdditionalPaidInCapital_iI_maCzpdi_zvbM1KXZlIPB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Additional paid in capital</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AdditionalPaidInCapital" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">219,955,738</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AdditionalPaidInCapital" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">184,586,420</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maCzpdi_zkOdZOFhjJ7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">221,116,625</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">186,168,926</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquity_iTI_mtCzpdi_maCzjky_z4PWbIWfzKZb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total Stockholders' Equity</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,918,672</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,886,685</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzjky_z4rfphe0qVFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total Liabilities and Stockholders' Equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">8,405,276</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">9,378,435</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>


<p style="margin: 0">&nbsp;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b><i>See notes to consolidated financial statements</i></b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b><i>&nbsp;</i></b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><b><i>&nbsp;</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Mobiquity Technology, Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Consolidated Statements of Operations</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_zVclwOdS0lbC" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td id="xdx_49F_20210101_20211231_zaFa9aK97cUX" style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_495_20200101__20201231_zJLMkChpLtT4" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year Ended</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td><td style="text-align: center; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: center">2020</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_400_eus-gaap--Revenues_maCz2z6_zkR6ja4c6sNc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Revenue</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:Revenues" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,672,615</ix:nonfraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><ix:nonfraction name="us-gaap:Revenues" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">6,184,010</ix:nonfraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_406_eus-gaap--CostOfRevenue_msCz2z6_z0Z6qC3Wucs9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Cost of Revenues</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:CostOfRevenue" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,954,383</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:CostOfRevenue" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,360,645</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40F_eus-gaap--GrossProfit_iT_mtCz2z6_maCztN5_zrJ97c54f4d9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Gross Profit</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:GrossProfit" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">718,232</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:GrossProfit" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,823,365</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpensesAbstract_iB_z1KtZ2r7ZxSb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Operating Expenses</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzGQE_zbtyFh5BFRyK" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Selling, general and administrative</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">6,575,365</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,226,300</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40A_eus-gaap--SalariesAndWages_i01_maCzGQE_zkAd9x5Oyq1Z" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Salaries</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:SalariesAndWages" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,397,170</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:SalariesAndWages" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,631,117</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--ShareBasedCompensation_i01_maCzGQE_z4h7jHrUlm0Y" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Stock based compensation</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensation" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,134,696</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensation" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,347,048</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--ExplorationAbandonmentAndImpairmentExpense_i01_maCzGQE_z9lH7Yrayux6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Impairment expense</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:ExplorationAbandonmentAndImpairmentExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,600,000</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:ExplorationAbandonmentAndImpairmentExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,000,000</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--OperatingExpenses_iT_mtCzGQE_msCztN5_zk4Bfyu4kQyG" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total Operating Expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">16,707,231</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:OperatingExpenses" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">13,204,465</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iT_mtCztN5_maCz3J7_z4Kt9HkwAKbY" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:OperatingIncomeLoss" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,988,999</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:OperatingIncomeLoss" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">11,381,100</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherIncomeAndExpensesAbstract_iB_zopVpNigPkwV" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other Income (Expenses)</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestExpense_i01N_di_msCzFtY_z6HCNqg5Y6Vz" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Interest Expense</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:InterestExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">817,430</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:InterestExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">715,262</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--OriginalIssueDiscount_i01N_di0_msCzFtY_zhYMC8fMXVoT" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Original issue discount</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="MOBQ:OriginalIssueDiscount" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">692,430</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="MOBQ:OriginalIssueDiscount" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" sign="-" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_d0_maCzFtY_zIkhfDwMB7fi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Loan forgiveness SBA PPP</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">265,842</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_ecustom--GainOnSaleOfWarrants_i01_maCzFtY_zXNjwUBgXrfl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Proceeds from the sale of warrants</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:GainOnSaleOfWarrants" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">251,453</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="MOBQ:GainOnSaleOfWarrants" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">662,758</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_ecustom--WarrantExpense_i01N_di_msCzFtY_zHvgFIl8I6cm" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Warrant expense</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="MOBQ:WarrantExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">18,794,607</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="MOBQ:WarrantExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">598,894</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--GainOrLossOnSaleOfStockInSubsidiary_i01_maCzFtY_zvza84dLk7aZ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Income (Loss) on settlement of debt with sale of company
    stock</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:GainOrLossOnSaleOfStockInSubsidiary" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">828,472</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:GainOrLossOnSaleOfStockInSubsidiary" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">2,996,897</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzFtY_maCz3J7_zt0uVtYxIPco" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total Other Income (Expense)</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:NonoperatingIncomeExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">18,958,700</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:NonoperatingIncomeExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">3,648,295</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i01T_mtCz3J7_maCzuUx_z9aFgkeM20fZ" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Loss from continuing operations</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">34,947,699</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,029,395</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossTaxAbstract_iB_zaZGMJQxwpNe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Other Comprehensive Income (loss)</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_i01_d0_maCznEb_zu3seuPDoPk4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Unrealized holding gain (loss) arising during period</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">3,009</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--OtherComprehensiveIncomeLossNetOfTax_i01T_d0_mtCznEb_maCzuUx_z76DtdpspVq6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt"><b style="display: none">Total other Comprehensive Income (loss)</b></td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">3,009</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_iT_mtCzuUx_zCJHoI13tSBb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net Comprehensive Loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">34,947,699</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,032,404</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB_z1DYE5Jdyhlu" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Comprehensive Loss Per Common Share:</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_ecustom--ForContinuedOperationsBasicAndDiluted_i01_zW5ChAnzgEe2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">For continued operations, basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonfraction name="MOBQ:ForContinuedOperationsBasicAndDiluted" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">10.43</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonfraction name="MOBQ:ForContinuedOperationsBasicAndDiluted" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="USDPShares">5.92</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_ecustom--WeightedAverageCommonSharesOutstandingBasicAndDiluted_zD2e3cCyUiCg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted Average Common Shares Outstanding, basic and diluted</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:WeightedAverageCommonSharesOutstandingBasicAndDiluted" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,351,335</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="MOBQ:WeightedAverageCommonSharesOutstandingBasicAndDiluted" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,537,811</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>


<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><i>See notes to consolidated
financial statements</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Mobiquity Technology,
Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Consolidated Statement of Stockholders' Equity</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_114_zBZtTWT4s0zq" summary="xdx: Statement - Consolidated Statement of Stockholders Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_custom--MezzaninePreferredStockMember_z8u7GGlKF2fV" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_custom--SeriesEPreferredStocksMember_zHrVHZcElDFU" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--SeriesCPreferredStocksMember_zlmhcckKECay" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zLq8e2iDQJr9" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zd7cXGq6x7tu" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt">Mezzanine</span></td><td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt">Series E Preferred Stock</span></td><td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt">Series C Preferred Stock</span></td><td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">Additional</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">Paid-in</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Capital</span></td></tr>
  <tr id="xdx_437_c20210101__20211231_eus-gaap--StockholdersEquity_iS_zmgRud26sOeK" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; width: 28%; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at January 1, 2021</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_zuA22x0Vvn1v" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">56,413</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">868,869</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--SeriesEPreferredStocksMember_zYye5Q5xnXOQ" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">61,688</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt"></span>$</td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,935,040</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zJ3tZq9mwSZ_zq1TRpVyCj9H" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,500</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">15,000</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zT4hgzJEiYnf" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,803,685</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">282</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">184,586,420</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_i_pp0p0_z4edtvM0vtKw" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Common stock issued for services</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0315">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0316">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0317">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsXWJ8AVu1nA" title="Common stock issued for services, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">265,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">24</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,158,001</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_i_pp0p0_zmzzf7sQU0XU" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Common stock issued for cash</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0323">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0324">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0325">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZShmgaT5r1E" title="Common stock issued for cash, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,631,764</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">264</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">7,866,894</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zg9HpIaBi1Qn" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Stock based option
    and warrant compensation</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0331">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0332">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0333">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0334">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">22,929,303</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40E_ecustom--StockIssuedForNoteConversionValue_zvS9QcU6wfb5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Note conversion</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0337">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0338">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0339">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98A_ecustom--StockIssuedForNoteConversionShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKVJtAdhDIrm" title="Note conversions, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForNoteConversionShares" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">236,768</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">23</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,004,408</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedForOriginalIssueDiscountValue_zeKyBZzyi0eD" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Original Issue Discount</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0345">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0346">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0347">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_986_ecustom--StockIssuedForOriginalIssueDiscountShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCb5SJ2J60lH" title="Original issue discount shares, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountShares" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">92,900</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">14</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">700,567</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_406_ecustom--StockIssuedForWarrantConversionValue_z1Ihz5f1aTOW" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Warrant conversion</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0353">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0354">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0355">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98B_ecustom--StockIssuedForWarrantConversionShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxxd8cLv5AQt" title="Warrant conversions, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionShares" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">49,384</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">4</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">320,184</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_401_ecustom--ConversionSeriesCPreferredStock_i_pp0p0_zSIgv7MIsIfR" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Conversion of preferred stock series C</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0361">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0362">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_986_ecustom--ConversionSeriesCPreferredStockShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zVuPInGBXoVQ" title="Conversion Series C preferred stock, shares" style="text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStockShares" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="Shares">1,500</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_988_ecustom--ConversionSeriesCPreferredStockShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2Z0UrtnYPbq" title="Conversion Series C preferred stock, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStockShares" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">375,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">38</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:ConversionSeriesCPreferredStock" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">14,962</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_407_ecustom--ConversionOfPreferredStockSeriesAAA_zJryBE9waKdx" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Conversion of preferred stock series AAA</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98C_ecustom--ConversionOfPreferredStockSeriesAaaShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_zSSoi1y2hyaT" title="Conversion of preferred stock series AAA, shares" style="text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAaaShares" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="Shares">25,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">375,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0372">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0373">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98E_ecustom--ConversionOfPreferredStockSeriesAaaShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zryBYxjX4oXX" title="Conversion of preferred stock series AAA, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAaaShares" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,250</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAAA" contextref="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">374,999</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zPpKhmNncada" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Net Loss</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0381">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0382">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0383">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0384">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0385">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_433_c20210101__20211231_eus-gaap--StockholdersEquity_iE_zf5z375EBo3M" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at December 31, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_z8ILt9NkRoah" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">31,413</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">493,869</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--SeriesEPreferredStocksMember_znl0aGlKdCm5" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">61,688</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,935,040</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zHiwPrKlEcge" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0397">–</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0389">–</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zql8ss4gIskh" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,460,751</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">650</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">219,955,738</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt">Mezzanine</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt">Series E Preferred Stock</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="text-align: center"><span style="font-size: 8pt">Series C Preferred Stock</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="text-align: center"><span style="font-size: 8pt">Additional</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Preferred Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Common Stock</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">Paid-in</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Capital</span></td></tr>
  <tr id="xdx_43D_c20200101__20201231_eus-gaap--StockholdersEquity_iS_zvELjH1aaOf8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; padding-bottom: 2.5pt; width: 28%"><span style="font-size: 8pt">Balance, at January 1, 2020</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_zwH0vqMsn2M1" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2019-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">46,413</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">714,869</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--SeriesEPreferredStocksMember_zRAdt9NU3gy_zvJ1kvvsedOY" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2019-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">65,625</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,250,000</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zerDtmdDrngg" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2019-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,500</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">15,000</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvYtvk5WdQH7" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,335,792</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">234</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 1%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 5%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">177,427,524</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zfqnutVPsdSr" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Common stock issued for services</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0415">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0416">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0417">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zExc109rZm5J" title="Common stock issued for services, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">38,125</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">3</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">547,448</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40E_ecustom--CommonStockIssuedForNoteConversionValue_iP3us-gaap--StockIssuedDuringPeriodSharesIssuedForServices_z06jtSMcmmTQ" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Common stock issued for note conversion</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0423">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0424">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0425">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_989_ecustom--CommonStockIssuedForNoteConversionShares_iP3us-gaap--ConversionOfStockAmountConverted1_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsCVQSpGhBGH" title="Common stock issued for note conversion, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionShares" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,919</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0426">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">30,694</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zTdwh5gFDjFl" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Common stock issued for cash</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0431">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0432">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0433">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zu979Ir1MQ9_zXtK5FdV8stD" title="Common stock issued for cash, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">340,786</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">40</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,600,384</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_400_ecustom--PreferredStockIssuedDuringPeriodValueNewIssues_iP3us-gaap--StockIssuedDuringPeriodSharesNewIssues_zdkaN6GEVsdL" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Preferred stock series E</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_983_ecustom--PreferredStockIssuedDuringPeriodSharesNewIssues_iP3custom--PreferredStockIssuedDuringPeriodValueNewIssues_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_zVJybLZJFQMm" title="Preferred stock series E, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodSharesNewIssues" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">154,000</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98B_ecustom--PreferredStockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--SeriesEPreferredStocksMember_zM7MsFV6AY0G" title="Preferred stock series E, shares" style="text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodSharesNewIssues" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="Shares">3,937</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">314,960</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0441">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98A_ecustom--PreferredStockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zz8XqKdsleTr" title="Preferred stock series E, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodSharesNewIssues" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">9,843</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:PreferredStockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">160,959</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_402_ecustom--StockIssuedForWarrantConversionValue_z6crTZ1LeFGz" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Warrant conversions</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0452">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0453">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_983_ecustom--StockIssuedForWarrantConversionShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjahcWGP3ayE" title="Warrant conversions, shares" style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionShares" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">77,220</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">4</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">873,469</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iP3us-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_z53R5MTElms_zgjG8964tXlf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Warrants issued</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0459">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0460">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0461">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0462">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">598,894</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zWPxu2Z2Uu3X" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Stock based compensation</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0465">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0466">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0467">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0468">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,347,048</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_zhvOvh1dqlIB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; text-align: left"><span style="font-size: 8pt">Net Loss</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0471">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0472">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0475">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_43E_c20200101__20201231_eus-gaap--StockholdersEquity_iE_z1ssZhwNqvb4" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at December 31, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_zigWrkBNQH8P" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">56,413</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">868,869</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--SeriesEPreferredStocksMember_zutKQHwhom7b" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">61,688</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_custom_SeriesEPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,935,040</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_znWX1i9nfG6v" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,500</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_custom_SeriesCPreferredStocksMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">15,000</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2l07j76LSBl" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,803,685</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">282</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">184,586,420</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_z2HdfVfZNhNX" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zd4N2PxA2RJ1" style="text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" id="xdx_4B6_z3Ql5ARCcPCq" style="text-align: center"><span style="font-size: 8pt">Total</span></td><td><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="6" style="text-align: center"><span style="font-size: 8pt">Treasury Shares</span></td><td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Accumulated</span></td><td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt">Stockholders’</span></td><td><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_437_c20210101__20211231_eus-gaap--StockholdersEquity_iS_ztnIupdO4PCP" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at January 1, 2021</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zg0tvEN4Dizy" style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">37,500</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">1,350,000</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">186,168,926</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,886,685</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zoHrJQ0u8d41" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Common stock issued for services</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0496">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0497">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,158,025</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zSM6Flb7cmcZ" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Common stock issued for cash</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0500">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0501">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">7,867,158</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zznVo3tOx1WW" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Stock based compensation</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0504">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0505">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">22,929,303</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedForNoteConversionValue_z6fqAFxnZ1mv" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Note conversion</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0508">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0509">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForNoteConversionValue" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,004,431</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedForOriginalIssueDiscountValue_zBo6kZrPoONP" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Original Issue Discount</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0513">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForOriginalIssueDiscountValue" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">700,581</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_405_ecustom--StockIssuedForWarrantConversionValue_zATQ6d7Ie3YM" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Warrant conversion</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0516">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0517">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">320,188</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_401_ecustom--ConversionSeriesCPreferredStock_i_pp0p0_z82d2z5zzruo" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Conversion of preferred stock series C</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0520">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0521">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0522">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_407_ecustom--ConversionOfPreferredStockSeriesAAA_zPuxK1mMVuCN" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Conversion of preferred stock series AAA</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0524">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0525">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0526">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_z3X65kVW6sRZ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 8pt">Net Loss</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0528">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">34,947,699</ix:nonfraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">34,947,699</ix:nonfraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_433_c20210101__20211231_eus-gaap--StockholdersEquity_iE_z3iYcfiYCQjI" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at December 31, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zYSd5ke64viP" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2021-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">37,500</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">1,350,000</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">221,116,625</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,918,672</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  </tbody></table>


<p style="margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Treasury Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">Accumulated</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">Total Stockholders’</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Amount</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Deficit</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_43D_c20200101__20201231_eus-gaap--StockholdersEquity_iS_z73MmyiS9z0D" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at January 1, 2020</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zDbXl5ASbeBA" style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">37,500</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">1,350,000</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">171,136,522</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">10,921,105</ix:nonfraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zZK36GbKMNuJ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Common stock issued for services</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0542">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0543">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">547,451</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_409_ecustom--CommonStockIssuedForNoteConversionValue_iP3us-gaap--StockIssuedDuringPeriodSharesIssuedForServices_z9oTXdyhGRXb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Common stock issued for note conversion</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0546">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0547">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:CommonStockIssuedForNoteConversionValue" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">30,694</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_ztnzYjeUgrLl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Common stock issued for cash</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0550">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0551">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,600,424</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40C_ecustom--PreferredStockIssuedDuringPeriodValueNewIssues_iP3us-gaap--StockIssuedDuringPeriodSharesNewIssues_zrJvRVr891BW" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Preferred stock series E</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0554">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0555">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0556">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_407_ecustom--StockIssuedForWarrantConversionValue_zSCi438gGaLL" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Warrant conversions</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0558">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0559">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="MOBQ:StockIssuedForWarrantConversionValue" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">873,473</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_iP3us-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_z5Td2DXbjW97" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Warrants issued</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0562">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0563">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">598,894</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zKRPK72PHYc_zudke3saaDj4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 8pt">Stock based compensation</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">–</span></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,347,048</ix:nonfraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_zlsodqxvQtun" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-size: 8pt">Net Loss</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">–</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0570">–</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,032,404</ix:nonfraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:NetIncomeLoss" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,032,404</ix:nonfraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr id="xdx_43E_c20200101__20201231_eus-gaap--StockholdersEquity_iE_zafeeLT7q1QV" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">Balance, at December 31, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockMember_zGBNLaVhxm5j" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:SharesOutstanding" contextref="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">37,500</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">1,350,000</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt">(<ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">186,168,926</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 8pt"><ix:nonfraction name="us-gaap:StockholdersEquity" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,886,685</ix:nonfraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td></tr>
  </tbody></table>



<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><i>See notes to consolidated
financial statements</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Mobiquity Technology, Inc.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Consolidated Statements of Cash Flows</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_112_zBrwYMKPVAvW" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td id="xdx_49B_20210101__20211231_zPQ5KAwpRv57" style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_493_20200101__20201231_z3k5Gc4ClLTl" style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Year Ended</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&nbsp;</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: right">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="3" style="font-weight: bold; text-align: right">&nbsp;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z5eUyx5k7Zfc" style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_i01_maCzZwq_zdJLx2sZEv2j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left; padding-bottom: 1pt">Net loss</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:ProfitLoss" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">34,947,699</ix:nonfraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(<ix:nonfraction name="us-gaap:ProfitLoss" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">15,032,404</ix:nonfraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zbTkUUdDdqwU" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_eus-gaap--Depreciation_i01_maCzgQ5_zp3XZYaVyMco" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Depreciation expense</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:Depreciation" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">7,565</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:Depreciation" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">6,271</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--AmortizationOfIntangibleAssets_i01_maCzgQ5_zfddBe2KsjsV" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Amortization Intangible Assets</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AmortizationOfIntangibleAssets" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">800,735</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AmortizationOfIntangibleAssets" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,800,736</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_i01_maCzgQ5_zonagH7ETL_ziwXmiU4O4WG" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Allowance for uncollectible receivables</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">434,390</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">306,000</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i01_maCzgQ5_zLpWgOb2jUYP" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Common stock issued for services</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,158,025</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">547,451</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--FairValueAdjustmentOfWarrants_i01_maCzgQ5_z8pcBMIp2nKc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Warrant expense</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:FairValueAdjustmentOfWarrants" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">18,794,607</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:FairValueAdjustmentOfWarrants" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,472,368</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--ExplorationAbandonmentAndImpairmentExpense_i01_maCzgQ5_zRiWPrYIAGTp" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Impairment expense</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:ExplorationAbandonmentAndImpairmentExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,600,000</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:ExplorationAbandonmentAndImpairmentExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,000,000</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_406_ecustom--StockBasedCompensationOptions_i01_maCzgQ5_zt6GHgBtOpS7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Stock based compensation-Options</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:StockBasedCompensationOptions" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,134,696</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="MOBQ:StockBasedCompensationOptions" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,347,048</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_iB_zfFLsPLoYq6a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Changes in operating assets and liabilities</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzgQ5_zaVIAz4j7lD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">876,217</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">1,606,659</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i01N_di_msCzgQ5_z1ualrk2UnM8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Prepaid expenses and other assets</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">43,697</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">26,196</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzgQ5_zXob4CRErZWv" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">372,314</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">902,933</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_maCzgQ5_zyZeg44RvlFu" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Accrued expenses and other current liabilities</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">393,559</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">138,367</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01N_di0_msCzgQ5_zMpuPP5w3gY1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Loan forgiveness SBA PPP</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">265,842</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" sign="-" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInInterestPayableNet_i01_maCzgQ5_zglqfU3sRpqG" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accrued interest</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">6,995</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">262,925</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_i01T_mtCzgQ5_maCzZwq_zIcS2PFz9MVC" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total Adjustments</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">28,811,222</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">10,281,962</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzZwq_maCzakB_z21FirpEYlC5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net Cash used in Operating activities</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">6,136,477</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">4,750,442</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zqMNIPoeDj6_zw9pHNFSFlAD" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash Flows from Investing Activities</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_ecustom--CommonStockIssuedForCash_i01_maCzEkw_zr4UggFEUp2b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Common stock issued for cash, net</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:CommonStockIssuedForCash" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">7,867,158</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="MOBQ:CommonStockIssuedForCash" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,600,424</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzEkw_zKrm1bChFeW_z31TQGuvu2M0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Purchase of property and equipment</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">6,472</ix:nonfraction></td><td style="font-weight: bold; text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">6,599</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--OriginalIssueDiscountShares_i01N_di0_msCzEkw_zp9uOouMOgmX" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Original Issue Discount shares</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:OriginalIssueDiscountShares" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">700,582</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="MOBQ:OriginalIssueDiscountShares" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" sign="-" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantConversionToCommonStock_i01_pp0p0_d0_maCzEkw_zzgD9w31DOao" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 10pt">Warrant conversion to common stock</td><td style="padding-bottom: 1pt; font-weight: bold">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:WarrantConversionToCommonStock" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">320,186</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="MOBQ:WarrantConversionToCommonStock" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzEkw_maCzakB_zxP9sVS4kSHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by Investing Activities</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">8,881,454</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,593,825</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zuUownZQfKRm" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash Flows from Financing Activities</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromConvertibleDebt_i01_maCztnf_zOrq18aSBVgU" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Proceeds from the issuance of notes, net</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:ProceedsFromConvertibleDebt" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,125,000</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:ProceedsFromConvertibleDebt" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,005,842</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40B_ecustom--ProceedsFromNoteConversionsToCommonStock_i01_maCztnf_zi9hrs7oaoE9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Note conversions to common stock</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:ProceedsFromNoteConversionsToCommonStock" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,004,432</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="MOBQ:ProceedsFromNoteConversionsToCommonStock" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">30,694</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--RepaymentsOfBankDebt_i01N_di_msCztnf_zEJXTGHMycZr" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Cash paid on notes</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonfraction name="us-gaap:RepaymentsOfBankDebt" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,091,437</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:RepaymentsOfBankDebt" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">520,809</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCztnf_maCzakB_zG0bD4xW6hQl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by in Financing Activities</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,037,995</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">515,727</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCzakB_zhazEuRLrc8_zASZpmGasjTC" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net change in Cash and Cash Equivalents</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,782,972</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">(<ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitref="USD">640,891</ix:nonfraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zrsLnaxft9qO" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Cash and Cash Equivalents, Beginning of period</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">602,182</ix:nonfraction></td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,240,064</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_ecustom--UnrealizedHoldingChangeOnSecurities_zPolxLxtGie1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Unrealized holding change on securities</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:UnrealizedHoldingChangeOnSecurities" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">91</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="MOBQ:UnrealizedHoldingChangeOnSecurities" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,009</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zFO3n3Teox53" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Increase in cash and cash equivalents, end of period</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">5,385,245</ix:nonfraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">602,182</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40E_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zDW3qc5WFElL" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Supplemental Disclosure Information</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestPaidNet_i01_zsKrv8zIOxhg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Cash paid for interest</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:InterestPaidNet" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">424,616</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:InterestPaidNet" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">442,326</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxesPaidNet_i01_z62JRztfhmHF" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Cash paid for taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="us-gaap:IncomeTaxesPaidNet" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,065</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:IncomeTaxesPaidNet" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">7,272</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right">&nbsp;</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z9L9UfPzlVHv" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Non-cash investing and financing activities:</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">&nbsp;</td><td style="font-weight: bold; text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_ecustom--CommonStockIssuedForInterest_i01_d0_zjIrSbgtFTrj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Common stock issued for conversion of convertible notes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:CommonStockIssuedForInterest" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,348,600</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="MOBQ:CommonStockIssuedForInterest" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_40F_ecustom--OriginalIssueDiscounts_i01_d0_z783Gq8Xaze5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Original issue discounts</td><td style="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonfraction name="MOBQ:OriginalIssueDiscounts" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">692,430</ix:nonfraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="MOBQ:OriginalIssueDiscounts" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>


<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">See notes to consolidated financial statements</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MOBIQUITY TECHNOLOGIES, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br>
YEARS ENDED DECEMBER 31, 2021 AND 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zl69Us3mQHAq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 1<b><i>: </i></b><span id="xdx_82A_zdhfCPHTqpJG">ORGANIZATION <span>AND
GOING CONCERN</span></span><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">We
operate our business through two wholly owned subsidiaries, Advangelists, LLC and Mobiquity Networks, Inc. Our corporate structure is
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="Diagram

Description automatically generated" style="height: 337px; width: 602px" data-src="https://www.sec.gov/Archives/edgar/data/1084267/000168316822002082/image_002.jpg" src="https://www.sec.gov/Archives/edgar/data/1084267/000168316822002082/image_002.jpg"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:exclude><p id="xdx_23A_z85ScE77tQOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_235_z3ToC3wDR2Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zU6R0oiqD65G" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 49 -->
    <div id="xdx_23D_zrDy9Svi0aE8" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td id="xdx_23E_znDtiWjuKmcb" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_234_zkv8QpRabNVU" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_zNJ5CFI67dtw" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zQUIgyyGXUKU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Subsidiaries</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Advangelists, LLC</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Advangelists LLC operates our ATOS platform business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">We originally acquired a 48% membership interest
and Glen Eagles Acquisition LP acquired a 52% membership interest in Advangelists in a merger transaction in December 2018 for consideration
valued at $20 Million. At the time Glen Eagles was a shareholder of the Company, owning 412,500 shares of our common stock. The Company
became, and remains, the sole manager of Advangelists following the merger with sole management power. In consideration for the merger:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Mobiquity issued warrants for 269,384 shares of common stock at an exercise price of $56 per share to the pre-merger Advangelists’ members, and, in February 2019, upon the attainment of the vesting threshold of Advangelists’ combined revenues for the months of December 2018 and January 2019 being at least $250,000, the Company transferred 9,209,722 shares of Gopher Protocol, Inc. common stock to the pre-merger Advangelists members. The Mobiquity warrants were valued at a total of $3,844,444, and the Gopher shares of common stock were valued at a total of $6,155,556.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">Glen Eagles paid the pre-merger Advangelists members $10 million. $500,000 was paid at closing in cash (which the Company advanced on behalf of Glen Eagles without any agreement regarding repayment of the advance), and $9,500,000 was paid by Glen Eagles’ promissory note to Deepankar Katyal, as representative of pre-merger Advangelists members, payable in 19 monthly installments of $500,000 each.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The
Company acquired 3% of the Advangelists’ membership interests from Glen Eagles in April 2019 in satisfaction of the Company’s
$500,000 closing payment advance to Glen Eagles, resulting in Mobiquity owning 51% and Glen Eagles owning 49% of Advangelists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In May 2019 the Company acquired the
remaining 49% of Advangelists’ membership interests from Glen Eagles, becoming the 100% owner of Advangelists, in a transaction
involving the Company, Glen Eagles, and Gopher Protocol, Inc. In that transaction, Gopher acquired the 49% Advangelists membership interest
from Glen Eagles and assumed Glen Eagles’ promissory note to Deepankar Katyal, as representative of the pre-merger Advangelists
owners, which had a remaining balance of $7,512,500, in satisfaction of indebtedness owed by Glen Eagles to Gopher. Concurrently with
that transaction, the Company acquired the 49% of Advangelists membership interest from Gopher and assumed the promissory note in consideration.
Additionally, warrants for 300,000 shares of Company common stock which are issuable upon the conversion of Mobiquity Class AAA preferred
stock owned by Gopher were amended to provide for a cashless exercise. In September 2019, the assumed note, which then had a principal
balance of $6,780,000, was amended and restated to provide that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">$5,250,000 of the principal was payable in 65,625 shares of the Company’s Class E Preferred Stock, which is convertible into 164,062.50 shares the Company’s common stock, plus warrants to purchase 82,031.25 Company shares of common stock, at an exercise price of $48 per share: and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">$1,530,000 of the principal balance, plus all accrued and unpaid interest under the promissory note was payable in three monthly installments of $<span id="xdx_904_ecustom--UnpaidInterest_c20210101__20211231__us-gaap--BusinessAcquisitionAxis__custom--AdvangelistsLLCMember_zO5CqiGYOCNK" title="Unpaid interest"><ix:nonfraction name="MOBQ:UnpaidInterest" contextref="From2021-01-012021-12-31_custom_AdvangelistsLLCMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">510,000</ix:nonfraction></span> each.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The promissory note was paid in full in November 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<ix:exclude><p id="xdx_236_zZov6WojBvdq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zSndOPTs9aHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zAot8HWXQGir" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 50 -->
    <div id="xdx_230_zCNHuW4yPkHu" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td id="xdx_23E_zphQaFIjNmqk" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_234_z5moAxwEv4zc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23B_zMmSwf1EmqWR" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zF9P6tbPb2Jc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Mobiquity Networks, Inc.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">We
have established Mobiquity Networks, Inc and have operated it since January 2011. Mobiquity Networks started and developed as a mobile
advertising technology company focused on driving foot-traffic throughout its indoor network and has evolved and grown into a next generation
data intelligence company. Mobiquity Networks operates our data intelligence platform business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>Going
Concern</i></b></span><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span>&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span>These
condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize
its assets and discharge its liabilities in the normal course of business. We have a history of losses and may continue to incur losses
in the future, which could negatively impact the trading value of our common stock. The continuation of the Company as a going concern
is dependent upon the continued financial support from its shareholders, the ability of management to raise additional equity capital
through private and public offerings of its common stock, and the attainment of profitable operations. As of December 31, 2021, and December
31, 2020, the Company had an accumulated deficit of $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_zF7mOmWlLlla"><ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitref="USD">221,116,625</ix:nonfraction></span><span style="display: none"></span> and $<span id="xdx_90B_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20201231_zh3zTioblu5p" title="Accumulated deficit"><ix:nonfraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitref="USD">186,168,926</ix:nonfraction></span>. These factors raise substantial doubt regarding the
Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements. We may
continue to incur operating and net losses in future periods. These losses may increase, and we may never achieve profitability for a
variety of reasons, including increased competition, decreased growth in the unified advertising industry and other factors described
elsewhere in this “Risk Factors” section. If we cannot achieve sustained profitability, our stockholders may lose all or a
portion of their investment in our company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span>&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span>These
consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its
assets and discharge its liabilities in the normal course of business. The recently acquired Advangelists LLC has also incurred losses
and experienced negative cash flows from operations during the most recent fiscal year. The continuation of the Company as a going concern
is dependent upon the continued financial support from its shareholders, the ability of management to raise additional capital through
private and public offerings of its common stock, and the attainment of profitable operations. These financial statements do not include
any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary
should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reverse Stock Split</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In September 2020, the Company filed a Certificate
of Amendment the Articles of Incorporation with the Secretary of State of the state of New York to implement a <span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20200908__20200909_zloyVYFKXUJJ"><ix:nonnumeric contextref="From2020-09-082020-09-09" name="us-gaap:StockholdersEquityReverseStockSplit">1 for 400 reverse stock-split</ix:nonnumeric></span> of its common stock effective September 9, 2020. The reverse stock split did not cause an adjustment to the par value of common
stock. As a result of the reverse stock split, the Company adjusted the share amounts under its employee incentive plans, outstanding
options and common stock warrant agreements, treasury shares and preferred shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:exclude><p id="xdx_231_zg3d1yO8CVXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zaQi5eJfElUZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zKxzHNSQskcX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 51 -->
    <div id="xdx_23D_zjhN8WJ1b5Uj" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td id="xdx_23F_zwpfgMJejice" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_239_zT7FltuytkrK" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_z5tBEnV6XpEF" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zEB4FFMKyFmZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Impacts of COVID-19 to Business and
the general economy</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The
Company’s financial condition and results of operations have been and may continue to be adversely affected by the COVID-19
pandemic. Since March 2020, COVID -19 has caused a material and substantial adverse impact on our general economy and our business
operations. It has caused there to be a substantial decrease in our sales, cancellations of purchase orders and has resulted in
accounts receivables not being timely paid as anticipated. Further, it has caused us to have concerns about our ability to meet our
obligations as they become due and payable. In this respect, our business is directly dependent upon and correlates closely to the
marketing levels and ongoing business activities of our existing clients. If material adverse developments in domestic and global
economic and market conditions adversely affect our clients’ businesses, such as COVID-19, our business and results of
operations could (and in the case of COVID-19) equally suffer. Our results of operations are affected directly by the level of
business activity of our clients, which in turn is affected by the level of economic activity in the industries and markets that
they serve. COVID-19 future widespread economic slowdowns in any of these markets, particularly in the United States, may negatively
affect the businesses, purchasing decisions and spending of our clients and prospective clients, and payment of accounts receivable
due us, which could result in reductions in our existing business as well as our new business development and difficulties in
meeting our cash obligations as they become due. In the event of continued widespread economic downturn caused by COVID-19, we will
likely continue to experience a reduction in projects, longer sales and collection cycles, deferral or delay of purchase commitments
for our data products, processing functionality, software systems and services, and increased price competition, all of which could
substantially adversely affect revenue and our ability to remain a going concern. In the event we remain a going concern, the
impacts of the global emergence of Coronavirus disease (COVID-19) on our business, sources of revenues and then general economy, are
currently not fully known. We are conducting business as usual with some modifications to employee work locations, and cancellation
of certain marketing events, among other modifications. We lost a purchase order of more than one million dollars with major US
sports organization. We have observed other companies taking precautionary and preemptive actions to address COVID-19 and companies
may take further actions that alter their normal business operations. We will continue to actively monitor the situation and may
take further actions that alter our business operations as may be required by federal, state, or local authorities or that we
determine are in the best interests of our employees, customers, partners, suppliers and stockholders. It is not clear what the
potential effects any such alterations or modifications may have on our business, including the effects on our customers and
prospects, although we do anticipate it to continue to negatively impact our financial results during fiscal years 2022 and
2023.<b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b><i>&nbsp;</i></b></p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_znOGz2UZglXz" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 2: <span id="xdx_825_zCxvWldvP6Av">SIGNIFICANT ACCOUNTING POLICIES</span>&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_846_eus-gaap--NatureOfOperations_zzbibYei8l7W" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_863_zOuIOB8WFdEu">NATURE
OF OPERATIONS</span> – Mobiquity Technologies, Inc., a New York corporation (the “Company”), is the parent company
of its operating subsidiaries; Mobiquity Networks, Inc. (“Mobiquity Networks”) and Advangelists, LLC (Advangelists).
Mobiquity Networks has evolved and grown from a mobile advertising technology company focused on driving Foot-traffic throughout its
indoor network, into a next generation location data intelligence company. Mobiquity Networks provides precise unique, at-scale
location data and insights on consumer’s real-world behavior and trends for use in marketing and research. Mobiquity Networks
provides one of the most accurate and scaled solution for mobile data collection and analysis, utilizing multiple geo-location
technologies. Mobiquity Networks is seeking to implement several new revenue streams from its data collection and analysis,
including, but not limited to, Advertising, Data Licensing, Footfall Reporting, Attribution Reporting, Real Estate Planning,
Financial Forecasting and Custom Research. Advangelists&nbsp;is a developer of advertising and marketing technology focused on
the creation, automation, and maintenance of an advertising technology operating system (or ATOS). Advangelists’ ATOS platform
blends artificial intelligence (or AI) and machine learning (ML) based optimization technology for automatic ad serving that manages
and runs digital advertising campaigns.</p>

<ix:exclude><p id="xdx_231_zPNz5mCsOhgy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_238_z7UwUbW6fKGU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zAlNTOajmxpE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zBspNZdJ1nKc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 52 -->
    <div id="xdx_230_zh0NvIYyFBUx" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td id="xdx_236_z6gEEqvbPSci" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23F_zBEgaMbxyrdW" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_zgNwpTpIPBnq" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zP2vKZsst8Sl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The ATOS platform:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px; text-align: center"><span style="font-family: Symbol">· </span></td>
    <td style="text-align: justify">creates an automated marketplace of advertisers and publishers on digital media outlets to host online auctions to facilitate the sale of ad time slots (known as&nbsp;digital real estate) targeted at users while engaged on their connected TV, computer or mobile device, and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Symbol">· </span></td>
    <td style="text-align: justify">gives advertisers the capability to understand and interact with their audiences and engage them in
    a meaningful way by using ads in both image and video formats (known as rich media) to increase their customer base and foot
    traffic to their physical locations.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Advangelists’ marketplace engages with approximately 10
billion advertisement opportunities per day. Our sales and marketing strategy is focused on creating a de-fragmented operating system
that makes it considerably more efficient and effective for advertisers and publishers to transact with each other. Our goal is to create
a standardized and transparent medium.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Advangelists' technology is proprietary
and has been developed internally. We own our technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Risks Related to Our Financial Results and Financing Plans</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Management has plans to address the Company’s
financial situation as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In the near term, management plans to continue
to focus on raising the funds necessary to implement the Company’s business plan related to technology. Management will continue
to seek out equity and/or debt financing to obtain the capital required to meet the Company’s financial obligations. There is no
assurance, however, that lenders and investors will continue to advance capital to the Company or that the new business operations will
be profitable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In the long term, management believes that
the Company’s projects and initiatives will be successful and will provide cash flow to the Company that will be used to finance
the Company’s future growth. However, there can be no assurances that the Company’s efforts to raise equity and debt at acceptable
terms or that the planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s
long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the
continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations
to sustain its operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Related Parties</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Related parties are any entities or individuals
that, through employment, ownership or other means, possess the ability to direct or cause the direction of the management and policies
of the Company. We disclose related party transactions that are outside of normal compensatory agreements, such as salaries or board of
director fees. We consider the following individuals / companies to be related parties as of December 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dean Julia - Principal Executive Officer President and Director</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sean McDonnell - Chief Financial Officer</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deepanker Katyal, Chief Executive Officer of Advangelists</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sean Trepeta – President of Mobiquity Networks and Secretary
of the Company</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Gene Salkind – Chairman of the Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michael Wright – Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anthony Iacovone – Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Peter Zurkow – Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zASsSXhIh6vg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_860_zO8Vwk9cxFzD">PRINCIPLES OF CONSOLIDATION</span> – The
accompanying condensed consolidated financial statements include the accounts of Mobiquity Technologies, Inc., formerly known as Ace Marketing&amp;
Promotions, Inc., and its wholly owned subsidiary, Mobiquity Networks, Inc. and its wholly- owned subsidiary, Advangelists, LLC. All intercompany
accounts and transactions have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_845_eus-gaap--UseOfEstimates_zlciT0ZVLfq_zNWnL8gBwHm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_86A_zll52oQ9jyk2">ESTIMATES</span> – The preparation
of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_844_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zT0sWYLnBUuA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_860_zFMlVuaxNYJ5">CASH
AND CASH EQUIVALENTS</span> – The Company considers all highly liquid debt instruments with a maturity of three months or less
at the time of issuance to be cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zhRc9s9DTTYW" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zhX9cYuYuLEt">CONCENTRATION OF CREDIT RISK</span> – Financial
instruments, which potentially subject the Company to concentrations of credit risk, consist principally of trade receivables and cash
and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Concentration of credit risk with respect
to trade receivables is generally diversified due to the large number of entities comprising the Company’s customer base and their
dispersion across geographic areas principally within the United States. The Company routinely addresses the financial strength of its
customers and, consequently, believes that its receivable credit risk exposure is limited. Our current receivables at December 31, 2021
consist of <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SixCustomersMember_z4R2x55fyBRh" title="Concentration risk percentage"><ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1" contextref="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_SixCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">55</ix:nonfraction></span>% held by six of our largest customers. Our current receivables at December 31, 2020 consist of <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SixCustomersMember_zgxrjVFKnyyq" title="Concentration risk percentage"><ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1" contextref="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_SixCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">58</ix:nonfraction></span>% held by six of our largest
customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The Company places its temporary cash
investments with high credit quality financial institutions. At times, the Company maintains bank account balances which exceed FDIC
limits. As of December 31, 2021, and December 31, 2020, the Company exceeded FDIC limits by $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0_zwfbt8GGcBsn" title="Cash over FDIC insurance limits"><ix:nonfraction name="us-gaap:CashUninsuredAmount" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,103,273</ix:nonfraction></span>, and $<span id="xdx_906_eus-gaap--CashUninsuredAmount_c20201231_pp0p0_zsggQHPPktPZ" title="Cash over FDIC insurance limits"><ix:nonfraction name="us-gaap:CashUninsuredAmount" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">114,986</ix:nonfraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_z9mMogkA5sTh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_861_zB9tjl5YsXWt">REVENUE
RECOGNITION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for revenue recognition in
accordance with accounting guidance codified as FASB ASC 606 “Revenue from Contracts with Customers” (“ASC 606”),
as amended, regarding revenue from contracts with customers. Under the standard an entity is required to recognize revenue to depict the
transfer of promised goods to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange
for those goods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 606, revenue is recognized at the same
point in time, upon delivery of services, under both ASC Topic 605 and Topic 606, as applicable under the terms of the contract (i.e.,
performance obligations). In evaluating our contracts with our customers under ASC 606, we have determined that there is no future performance
obligation once delivery has occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><br>
The Company’s revenues are primarily derived from consideration paid by customers. There are no material upfront costs for operations
that are incurred from contracts with customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s rights to payments for services
transferred to customers are conditional only on the passage of time and not on any other criteria. Payment terms and conditions vary
by contract, although terms generally include a requirement of payment within 30 to 90 days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"><p id="xdx_849_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_z3ofLmn1KB4v" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span id="xdx_86D_zSZBgeflP1vI">ALLOWANCE FOR DOUBTFUL ACCOUNTS</span> –
Management must make estimates of the collectability of accounts receivable. Management specifically analyzes accounts receivable and
analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends and changes in customer payment
terms when evaluating the adequacy of the allowance for doubtful accounts. As of December 31, 2021, and December 31, 2020, allowance for
doubtful accounts were $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20211231_zyfihy9gwS4_zBICDMOaO7XZ" title="Allowance for doubtful accounts"><ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">820,990</ix:nonfraction></span>, and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_c20201231_pp0p0_zms0x47XQOHz" title="Allowance for doubtful accounts"><ix:nonfraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">386,600</ix:nonfraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<ix:exclude><p id="xdx_23A_z7SBTGQNBQAq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zFi98JkqhwSc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zlGyOWG4nsAm" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 54 -->
    <div id="xdx_239_zdDjtdHrgusu" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td id="xdx_23E_zt49pinyjVyv" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_230_zYDd64RbVtyg" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zc44yWIRFw7c" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zVnuAbQ9UiRv" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_845_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zjk0IzprUXRA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_867_zpjG6l8UN4gl">PROPERTY AND EQUIPMENT</span> – Property
and equipment are stated at cost. Depreciation is expensed using the straight-line method over the estimated useful lives of the related
assets. Leasehold improvements are being amortized using the straight-line method over the estimated useful lives of the related assets
or the remaining term of the lease. The costs of additions and improvements, which substantially extend the useful life of a particular
asset, are capitalized. Repair and maintenance costs are charged to expense. When assets are sold or otherwise disposed of, the cost and
related accumulated depreciation are removed from the account and the gain or loss on disposition is reflected in operating income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zjOG6pK9Nmu_ziE4lX2PF0vT" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_862_z1RbIcHz0APz">LONG LIVED ASSETS</span> – In accordance
with ASC 360, “<i>Property, Plant and Equipment</i>”, the Company tests long-lived assets or asset groups for recoverability
when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger
a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business
climate or legal factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction
of the asset; current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated
with the use of the asset; and current expectation that the asset will more likely than not be sold or disposed significantly before the
end of its estimated useful life. Recoverability is assessed based on the carrying amount of the asset and its fair value, which is generally
determined based on the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset, as
well as specific appraisal in certain instances. An impairment loss is recognized when the carrying amount is not recoverable and exceeds
fair value. The Company recognized an impairment charge of $<span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_pp0p0_c20210101__20211231_zyP1Iy5BJgOQ" title="Impairment charge"><ix:nonfraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">3,600,000</ix:nonfraction></span> and $<span id="xdx_903_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20200101__20201231_zyDypJ6WWs51" title="Impairment charge"><ix:nonfraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">4,000,000</ix:nonfraction></span> for the periods ended December 31, 2021, and December
31, 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions with major customers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021,
four customers accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zJsG3YYbbCZ7" title="Concentration risk percentage"><ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1" contextref="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FourCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">31</ix:nonfraction></span>% of revenues. During the year ended December 31, 2020, five customers accounted for approximately
<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FiveCustomersMember_zBmWM0TosOO1" title="Concentration risk percentage"><ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1" contextref="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_FiveCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">42</ix:nonfraction></span>% of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, five
customers accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FiveCustomersMember_zqgZqXtmaNAf"><ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1" contextref="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_FiveCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">55</ix:nonfraction></span>% of receivables. During the year ended December 31, 2020, six customers accounted for approximately
<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SixCustomersMember_zn5XszeVWqmQ"><ix:nonfraction name="us-gaap:ConcentrationRiskPercentage1" contextref="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_SixCustomersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">58</ix:nonfraction></span>% of receivables.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zwaEc82fjqrW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86C_zjTr2xCQ79CB">ADVERTISING COSTS</span> – Advertising costs
are expensed as incurred. For the year ended December 31, 2021, and for the year ended December 31, 2020, there were advertising
costs of $<span id="xdx_903_eus-gaap--AdvertisingExpense_c20210101__20211231_pp0p0_zzm0XbbAx40G" title="Advertising costs"><ix:nonfraction name="us-gaap:AdvertisingExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,454</ix:nonfraction></span> and $<span id="xdx_90E_eus-gaap--AdvertisingExpense_c20200101__20201231_pp0p0_zNyx1rqjnSzp" title="Advertising costs"><ix:nonfraction name="us-gaap:AdvertisingExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,400</ix:nonfraction></span> respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_842_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zel65BUF2doW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86C_zzDdxc355LCX">ACCOUNTING FOR STOCK BASED COMPENSATION</span>
– Stock based compensation cost is measured at the grant date fair value of the award and is recognized as expense over the requisite
service period. The Company uses the Black-Sholes option-pricing model to determine fair value of the awards, which involves certain subjective
assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising
them (“expected term”), the estimated volatility of the Company’s common stock price over the expected term (“volatility”)
and the number of options for which vesting requirements will not be completed (“forfeitures”). Changes in the subjective
assumptions can materially affect estimates of fair value stock-based compensation, and the related amount recognized on the consolidated
statements of operations. Refer to Note 9 “Stock Option Plans” in the Notes to Consolidated Financial Statements in this report
for a more detailed discussion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="MOBQ:BeneficialConversionsPolicyTextBlock"><p id="xdx_846_ecustom--BeneficialConversionsPolicyTextBlock_zy2e1NzZGHZX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86B_zVY21qvbXy1y">BENEFICIAL CONVERSION FEATURES</span> –
Debt instruments that contain a beneficial conversion feature are recorded as deemed interest to the holders of the convertible debt instruments.
The beneficial conversion is calculated as the difference between the fair values of the underlying common stock less the proceeds that
have been received for the debt instrument limited to the value received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_z40Yesp2PifN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86A_zozQBVzQzVoU">INCOME TAXES</span> – Deferred income taxes
are recognized for temporary differences between financial statement and income tax basis of assets and liabilities for which income tax
or tax benefits are expected to be realized in future years. A valuation allowance is established to reduce deferred tax assets, if it
is more likely than not, that all or some portion of such deferred tax assets will not be realized. The effect on deferred taxes of a
change in tax rates is recognized in income in the period that includes the enactment date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:exclude><p id="xdx_232_zRgBLF2zTua0" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_232_z3y3JHIw0Xhv" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zQl897BuhoAB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 55 -->
    <div id="xdx_23D_zclPIFxvQmeu" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td id="xdx_234_zUTSMFcp29GS" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23E_z6d0BBKoEWLA" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_z9usGbDdtQA_zJH8gl34fdm0" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zjxM5cbtdRtF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9y8U8xUgRg0" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_z8KyG9WOgLp8">RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We adopted the lease standard ACS 842 effective
January 1, 2019, and have elected to use January 1, 2019, as our date of initial application. Consequently, financial information will
not be updated, and disclosures required under the new standard will not be provided for periods presented before January 1, 2019, as
these prior periods conform to the Accounting Standards Codification 840. We elected the package of practical expedients permitted under
the transition guidance within the new standard. By adopting these practical expedients, we were not required to reassess (1) whether
an existing contract meets the definition of a lease; (2) the lease classification for existing leases; or (3) costs previously capitalized
as initial direct costs. As of December 31, 2021, we are not a lessor or lessee under any lease arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have reviewed the FASB issued Accounting
Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods
reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting
principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial
position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management
and certain standards are under consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has implemented all new accounting
pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting
pronouncements that have been issued that might have a material impact on its financial position or result of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zFo3BFZ0UVlI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NET LOSS PER SHARE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net loss per share is computed by dividing
income available to common shareholders by the weighted-average number of common shares outstanding. Diluted earnings per share reflect,
in periods in which they have a dilutive effect, the impact of common shares issuable upon exercise of stock options and warrants. The
number of common shares potentially issuable upon the exercise of certain options and warrants that were excluded from the diluted loss
per common share calculation was approximately <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_zfkSTTijca4B"><ix:nonfraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">4,925,000</ix:nonfraction>
</span>because they are anti-dilutive, as a result of a net loss for the year ended December 31, 2021.</p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

</ix:nonnumeric></ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_800_eus-gaap--IntangibleAssetsDisclosureTextBlock_zAsSEr7XabLX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 3: <span id="xdx_826_zecATMeyaPFo">INTANGIBLE ASSETS</span></p>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The ATOS platform:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px; text-align: center"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">creates an automated marketplace of advertisers and publishers on digital media outlets to host online auctions to facilitate the sale of ad time slots (known as digital real estate) targeted at users while engaged on their connected TV, computer, or mobile device, and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">gives advertisers the capability to understand and interact with their audiences and engage them in
    a meaningful way by the using ads in both image and video formats (known as rich media) to increase their customer base and foot
    traffic to their physical locations.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company tests goodwill for impairment
at least annually on December 31<sup>st</sup> and whenever events or circumstances change that indicate impairment may have occurred.
A significant amount of judgement is involved in determining if an indicator of impairment has occurred. Such indicators may include,
among others: a significant decline in the Company’s expected future cash flows; a significant adverse change in legal factors or
in the business climate; unanticipated competition; and slower growth rates. Any adverse change in these factors could have a significant
impact on the recoverability of goodwill and the Company’s consolidated financial results.</p>

<ix:exclude><p id="xdx_23F_zeZrcmQIAbMy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zlWLy7aWvkNY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z4nim2gobRJI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 56 -->
    <div id="xdx_23B_zBM8ajFcUN5q" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23B_zAy3nUGWQqmA" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zqfWmvLncj4y" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our goodwill balance is not amortized to
expense, instead it is tested for impairment at least annually. We perform our annual goodwill impairment analysis at the end of the
fourth quarter. If events or indicators of impairment occur between annual impairment analyses, we perform an impairment analysis of
goodwill at that date. These events or circumstances could include a significant change in the business climate, legal factors,
operating performance indicators, competition, or sale or disposition of a significant asset. In testing for a potential impairment
of goodwill, we: (1)&nbsp;verify there are no changes to our reporting units with goodwill balances; (2)&nbsp;allocate goodwill to
our various reporting units to which the acquired goodwill relates; (3)&nbsp;determine the carrying value, or book value, of our
reporting units, as some of the assets and liabilities related to each reporting unit are held by a corporate function;
(4)&nbsp;estimate the fair value of each reporting unit using a discounted cash flow model; (5)&nbsp;reconcile the fair value of our
reporting units in total to our market capitalization adjusted for a subjectively estimated control premium and other identifiable
factors; (6)&nbsp;compare the fair value of each reporting unit to its carrying value; and (7)&nbsp;if the estimated fair value of a
reporting unit is less than the carrying value, we must estimate the fair value of all identifiable assets and liabilities of that
reporting unit, in a manner similar to a purchase price allocation for an acquired business to calculate the implied fair value of
the reporting unit’s goodwill and recognize an impairment charge if the implied fair value of the reporting unit’s
goodwill is less than the carrying value. The Company recognized an impairment charge of $<span id="xdx_90D_eus-gaap--GoodwillImpairmentLoss_pp0p0_c20210101__20211231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AtosMember_zwLDBvbfYbGc" title="Goodwill impairment"><ix:nonfraction name="us-gaap:GoodwillImpairmentLoss" contextref="From2021-01-012021-12-31_custom_AtosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">3,600,000</ix:nonfraction></span>
and $<span id="xdx_90E_eus-gaap--GoodwillImpairmentLoss_pp0p0_c20200101__20201231__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--AtosMember_zLNb9sOlkXWq" title="Goodwill impairment"><ix:nonfraction name="us-gaap:GoodwillImpairmentLoss" contextref="From2020-01-012020-12-31_custom_AtosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">4,000,000</ix:nonfraction></span>
for the periods ended December 31, 2021, and December 31, 2020 respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At each balance sheet date herein, definite-lived
intangible assets primarily consist of customer relationships which are being amortized over their estimated useful lives of five years.
The Company periodically evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they
will be removed from the accounts. These assets are reviewed for impairment or obsolescence when events or changes in circumstances indicate
that the carrying amount may not be recoverable. If impaired, intangible assets are written down to fair value based on discounted cash
flows or other valuation techniques. The Company has no intangibles with indefinite lives.&nbsp;</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z0l3s4feljfy" summary="xdx: Disclosure - ACQUISITION OF ADVANGELISTS (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BB_zpJ1XUmmtXeD" style="display: none">Schedule of intangible assets</span></td><td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Useful Lives</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 30, 2021</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2020</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td colspan="3" style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 51%; text-align: justify">Customer relationships</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 13%; text-align: center"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zZz86T8xjlCI" title="Useful life"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonnumeric></span> years</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0_zRuTwVwFPZhi" title="Intangible asset, gross" style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AsOf2021-12-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">3,003,676</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0_zYSZ91O7MN6p" title="Intangible asset, gross" style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AsOf2020-12-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">3,003,676</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">ATOS Platform</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AtosPlatformMember_zhG8dcmVFJVP" title="Useful life"><ix:nonnumeric contextref="From2021-01-012021-12-31_custom_AtosPlatformMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonnumeric></span> years</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AtosPlatformMember_pp0p0_z5ZMr3kMHLVs" title="Intangible asset, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AsOf2021-12-31_custom_AtosPlatformMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">2,400,000</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--AtosPlatformMember_pp0p0_zIldm0himBd6" title="Intangible asset, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AsOf2020-12-31_custom_AtosPlatformMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">6,000,000</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0_zQys8C78KC8u" title="Intangible asset, gross" style="text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,403,676</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231_pp0p0_zbUd8q11n4JK" title="Intangible asset, gross" style="text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">9,003,676</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Less accumulated amortization</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: justify; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20211231_zrAUafjtJZdl" title="Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">4,156,657</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_c20201231_zAKOhyDLklzP" title="Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">3,355,922</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net carrying value</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0_zuwv2PquTMEO" title="Intangible assets, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,247,019</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20201231_pp0p0_zodtsKBSmYmI" title="Intangible assets, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,647,754</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8A7_zs2xM0ndG0xF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future amortization, for the years ending December
31, is as follows:</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zd38uhg8xr9_ztOGr48pnIFc" summary="xdx: Disclosure - ACQUISITION OF ADVANGELISTS (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BA_zL0WZbYv6pKd" style="display: none">Schedule of future accumulated amortization schedule</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_49B_20211231_zrloSDyNz75v" style="text-align: center">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_zmDTQYv9jBsg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">2022</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">603,976</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_zzTGHqxoH1Q2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">572,584</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_zVrjqJuF9RuI" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left">2024</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">70,459</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_z6NK65vh4WUj" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Total</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,247,019</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8A2_z9TBl36MrFx9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:exclude><p id="xdx_23E_z16lgGqqS99w" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zsmsFCdCrAO_zXvzJkAdKNh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zlv2PlyIgG62" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 57 -->
    <div id="xdx_236_z13SzEAhSdbP" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23C_zJOU9SzKyiKl" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_z4gXhH491VmJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE
4: <span id="xdx_826_zFujeGeXqDJJ">NOTES PAYABLE</span></p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfDebtTableTextBlock_zr641j4yxMd_zVeKEM9R2X6X" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zn3G7SNubZPY">Summary of Notes payable:</span></span></td>
    <td>&nbsp;</td>
    <td colspan="3" id="xdx_49D_20211231_zFNkBCFhJc1_z0Bbeo0Tja6R" style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="3" id="xdx_494_20201231_zsWsKeYyrzX6" style="text-align: right">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br>
2021</span></td>
    <td>&nbsp;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br>
2020</span></td></tr>
  <tr id="xdx_405_eus-gaap--LongTermDebt_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--MobFoxUSLLCMember_zx9OqY8XbKL3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mob-Fox US LLC (b)</span></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_MobFoxUSLLCMember" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></span></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31_custom_MobFoxUSLLCMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">30,000</ix:nonfraction></span></td>
    <td style="width: 1%">&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebt_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--DrSalkindMember_zlRcHYAwORZZ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Salkind, et al (f)</span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_DrSalkindMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,562,500</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31_custom_DrSalkindMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,550,000</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermDebt_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zCqTBgD76XfQ" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Small Business Administration (a)</span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_SmallBusinessAdministrationMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">150,000</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31_custom_SmallBusinessAdministrationMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">415,842</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebt_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--SubscriptionAgreementsMember_zdC99ZKxxSmr" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Agreements (d)</span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_SubscriptionAgreementsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">250,000</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31_custom_SubscriptionAgreementsMember" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_405_eus-gaap--LongTermDebt_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--BlueLakePartnersTalosVictoryFundMember_zL20dcGz5ptj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blue Lake Partners LLC Talos Victory Fund LLC (e)</span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_BlueLakePartnersTalosVictoryFundMember" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31_custom_BlueLakePartnersTalosVictoryFundMember" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebt_iI_d0_hus-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember_zJir5A0wQrLn" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Capital Providers (c)</span></td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 1pt solid">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_BusinessCapitalProvidersMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">156,504</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 1pt solid">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31_custom_BusinessCapitalProvidersMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">355,441</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebt_iI_d0_zspWhWmG19nq" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Debt</span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,119,004</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">3,351,283</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--LongTermDebtCurrent_iI_zueh5nGohAtY" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current portion of debt</span></td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 1pt solid">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebtCurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">519,004</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 1pt solid">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebtCurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">901,283</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  <tr id="xdx_400_eus-gaap--LongTermDebtNoncurrent_iI_zN1T3qHFMkEF" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term portion of debt</span></td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebtNoncurrent" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,600,000</ix:nonfraction></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonfraction name="us-gaap:LongTermDebtNoncurrent" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">2,450,000</ix:nonfraction></span></td>
    <td>&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8AE_zM5ACqE8Fsyx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">__________________&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px; text-align: center">&nbsp;</td>
    <td style="width: 24px">(a)</td>
    <td style="text-align: justify">In May of 2020, the Companies applied and received Small Business Administration Cares Act loans due to the COVID-19 Pandemic. Each loan carries a five-year term, carrying a one percent interest rate. The loans turn into grants if the funds are use the for the SBA accepted purposes. The window to use the funds for the SBA specific purposes is a twenty-four-week period. If the funds are used for the allotted expenses the loans turn into grants with each loan being forgiven. The Company also received an Economic Injury Disaster Loan from the SBA which carries a thirty-year term, carrying a three-point seven five percent interest rate. During second quarter 2021 the Company applied for and received forgiveness for $<span id="xdx_90F_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20210701__20210930__us-gaap--LongtermDebtTypeAxis__custom--SmallBusinessAdministrationMember_zGluUThIogiO" title="Debt forgiveness"><ix:nonfraction name="us-gaap:DebtInstrumentDecreaseForgiveness" contextref="From2021-07-012021-09-30_custom_SmallBusinessAdministrationMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">265,842</ix:nonfraction></span>.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&nbsp;</td>
    <td>(b) </td>
    <td style="text-align: justify">In October of 2020, the Company entered into an agreement with a vendor to accept $65,000 in full settlement of our payable due. A down payment of $15,000 at the signing of the agreement and five payments of $10,000 each, the loan was paid in full.</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 24px"></td><td style="width: 24px; text-align: left">(c)</td><td style="text-align: justify">Business Capital Providers, Inc. purchased certain future receivables
from the Company at a 26% discount under the following agreements on the following terms:</td>
</tr>
<tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px">&nbsp;</td>
    <td style="padding-left: 0.5in; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Pursuant to a Merchant Agreement dated July 28, 2021, Business Capital Providers purchased $405,000 of future receivables for a purchase price of $300,000. Under the agreement, the Company agrees to have all receivables collected be deposited into a bank account from which the purchased receivables are remitted to Business Capital Providers daily, at the daily percentage of 9% of the daily banking deposits, or daily amounts of $2,531.25, for the term of 160 days. The Company is responsible for ensuring there are sufficient funds in the account to cover the daily payments. Under the agreement, the Company paid an origination fee of 5% of the purchase price. In the event of a default under the agreement, Business Capital Providers may institute an action to enforce its rights, including recovery of its costs of enforcement. Events of default under the agreement include, among others: the Company’s breach of any provision or representation under the agreement; failure to give 24 hours’ notice there will be insufficient funds to cover a daily remittance; the Company offers for sale or sells a substantial portion of its assets or its business; the Company uses other depository accounts, or closes or changes its depository account from which daily remittances are made; a material change in the Company’s operations; loss of a key employee, customer or supplier of the Company; any change in stock float, voting rights or issuance of voting shares; the Company’s failure to renew a real property lease; any Company default under another agreement with Business Capital Providers; or any form of bankruptcy filing or declaration by or for the Company. The Agreement further provides that in the event of a default, lieu of personal guarantees by any Company principals, or if otherwise mutually agreed, Business Capital Providers may convert any portion of amounts payable to it into shares of common stock of the Company at a price equal to 85% of the lowest volume weighted average price for each of the five trading days preceding the conversion date; provided that Business Capital Providers will not convert into shares that will result in it owning more than 4.99% of the Company’s then outstanding shares of common stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="padding-left: 0.5in; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Pursuant to a Merchant Agreement dated April 29, 2021, purchased $405,000 of future receivables for a purchase price of $300,000 on terms which are substantially the same as the July 28, 2021, Merchant Agreement, except that the daily percentage is 13% and the daily payment is $2,700 per day for a term of 150 business days all of which is fully satisfied.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="padding-left: 0.5in; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The Company previously entered into separate Merchant Agreements with Business Capital Providers on eight occasions prior to the April 29, 2021, Merchant Agreement, starting in June 2019, for an aggregate of $2,100,000 in financing, for a total cost of $2,835,000 at daily percentages, and daily payments, all of which were satisfied in full.</span></td></tr>
  </tbody></table>
<ix:exclude><p id="xdx_232_zICvUntOhWLp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zNdphRk7XzO5" style="margin-top: 0; margin-bottom: 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zvVtsThzj510" style="margin-top: 0; margin-bottom: 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zziX9pIcIxyw" style="margin-top: 0; margin-bottom: 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 58 -->
    <div id="xdx_23B_z5XaMTRl38Lt" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_233_zgMAbWAlG4VI" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td id="xdx_238_z102dS8Tb4TH" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_231_zCnKHIbrJ3uL" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_z2fkXUUwpgj9" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zIsnF7gcVdoT" style="margin-top: 0; margin-bottom: 0">&nbsp;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="text-align: center; width: 24px">&nbsp;</td>
    <td style="width: 24px">&nbsp;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 20, 2020, the Company entered into
    a fourth merchant agreement with Business Capital Providers, Inc. in the amount of $250,000 payable daily at $2,556.82, per payment for
    the term of 132 business days, loan paid in full.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 12, 2020, the Company entered into
    a fifth merchant agreement with Business Capital Providers, Inc. in the amount of $250,000 payable daily at $2,556.82, per payment for
    the term of 132 business days.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 11, 2020, the Company entered
    into a sixth merchant agreement with Business Capital Providers, Inc. in the amount of $250,000 payable daily at $2,556.82, per payment
    for a term of 132 business days, loan paid in full.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 25, 2020, the Company entered
    into a seventh merchant agreement with Business Capital Providers, Inc. in the amount of $310,000 payable daily at $2,700.00, per payment
    for the term of 155 business days.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 19, 2021, the Company entered
    into an eight-merchant agreement with Business Capital Providers, Inc. in the amount of $250,000 payable daily at $2,556.82, per payment
    for the term of 132 business days, loan is paid in full.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 29, 2021, the Company entered into
    a ninth-merchant agreement with Business Capital Providers, Inc. in the amount of $300,000 payable daily at $2,700.00, per payment for
    the term of 150 business days.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 28, 2021, the Company entered into
    a tenth-merchant agreement with Business Capital Providers, Inc. in the amount of $300,000 payable daily at $2,531.25, per payment for
    the term of 160 business days.</p></td></tr>

</tbody></table>

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Nineteen private investors, who were unaffiliated shareholders of the Company and accredited investors as provided under Regulation D Rule 501 promulgated under the Securities Act of 1933, provided us convertible debt financing during the period May 2021 through September 2021 pursuant to subscription agreements as described below. (Certain of these investors provided us multiple investments in one or more of these convertible debt structures.):</span></td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 40px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Nine
of the lender-investors provided us an aggregate of $668,000 in convertible debt financing on the following terms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The lender-investors were
issued shares of Company common stock valued at $6 per share equal to 5% of their investments as original issue discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The debt maturity date is
October 31, 2021. If the Company receives debt of equity financing of $200,000 or more, the debt is payable within two business days
after the Company receives those funds. The maturity dates of six of these investors’ convertible debt was extended to December
31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The debt is convertible into
shares of Company common stock at a conversion price of $6 per share at any time at the investor’ option until the maturity date.</p>

<ix:exclude><p id="xdx_238_zj1hNhZfk490" style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zaK0CwMfW0P6" style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zRdvshdM7NCv" style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"></p>

<ix:exclude><!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zZcZeUEumACy" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_235_zjCogXIK9cC6" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 40px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Three
of the lender-investors provided us an aggregate of $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ThreeLenderInvestorsMember_zmQZU1qkhzKQ"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ThreeLenderInvestorsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">200,000</ix:nonfraction></span> in convertible debt financing on the following terms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The lender-investors were
issued shares of Company common stock valued at $6 per share equal to 6,000 per $100,000 of principal loan, or on a pro-rata basis is
less than $100,000 is loaned (effectively 6% of the amount loaned) as original issue discount.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The debt is convertible into
shares of Company common stock at a conversion price of $6 per share at any time at the investor’s option until the maturity date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">These investors converted
all of this convertible debt into a total of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ThreeLenderInvestorsMember_zUMkHFk9PYcf"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ThreeLenderInvestorsMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">40,000</ix:nonfraction></span> shares of common stock generating a non-cash charge to the financials of $<span id="xdx_906_eus-gaap--DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ThreeLenderInvestorsMember_zlwbZfldFel7"><ix:nonfraction name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ThreeLenderInvestorsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">154,500</ix:nonfraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 40px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Eleven
of the lender-investors provided us an aggregate of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20210630__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ElevenLenderInvestorsMember_zSJywrN9yxhq"><ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount" contextref="AsOf2021-06-30_custom_BusinessCapitalProvidersMember_custom_ElevenLenderInvestorsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">819,500</ix:nonfraction></span> in convertible debt financing on the following terms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The investment amounts included
10% original issue discount. Accordingly, the total net principal proceeds of this debt that we received was $<span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ElevenLenderInvestorsMember_zKkHH9NM4U9X"><ix:nonfraction name="us-gaap:ProceedsFromConvertibleDebt" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ElevenLenderInvestorsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">745,000</ix:nonfraction></span>. The maturity date
is June 30, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The
investor may convert the debt at any time through the maturity date at a 30% discount to the volume weighted average price per share
over the 60-day period prior to conversion, with a floor conversion price of $4 per share. The debt will automatically convert on July
1, 2022, at $4 per share if it is not repaid, or converted by the investor, prior to then. All of these investors converted a total of
$<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ElevenLenderInvestorsMember_zAIeoouRVGCP"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ElevenLenderInvestorsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">819,500</ix:nonfraction></span> of this convertible debt into a total of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--ElevenLenderInvestorsMember_zLjyLMcwaI6H"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_ElevenLenderInvestorsMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">156,761</ix:nonfraction></span> shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 40px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Four
of the lender-investors provided us $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20210630__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--FourLenderInvestorsMember_zqD72RlBG5MC"><ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount" contextref="AsOf2021-06-30_custom_BusinessCapitalProvidersMember_custom_FourLenderInvestorsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">130,000</ix:nonfraction></span> in convertible debt financing on the following terms:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"></span>Interest at the annual rate
of 10%, debt maturity date is June 30, 2022. The investor may convert the debt at any time through the maturity date at a 30% discount
to the volume weighted average price per share over the 60-day period prior to conversion, with a floor conversion price of $4 per share.
The debt will automatically convert on July 1, 2022, at $4 per share if it is not repaid, or converted by the investor, prior to then.
One of these investors converted a total of $<span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--FourLenderInvestorsMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--OneOutOfFourLenderInvestorMember_zqLIrn9mJ5GS"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_FourLenderInvestorsMember_custom_OneOutOfFourLenderInvestorMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">30,000</ix:nonfraction></span> of this convertible debt into a total of <span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--FourLenderInvestorsMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--OneOutOfFourLenderInvestorMember_zQNKhYbLUcdD"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_FourLenderInvestorsMember_custom_OneOutOfFourLenderInvestorMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">5,904</ix:nonfraction></span> shares of common stock with a non-cash
charge of $<span id="xdx_901_eus-gaap--DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--FourLenderInvestorsMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--OneOutOfFourLenderInvestorMember_zpqyLjCG4d6c"><ix:nonfraction name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_FourLenderInvestorsMember_custom_OneOutOfFourLenderInvestorMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">17,771</ix:nonfraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</p>

<p style="margin: 0">On April 14, 2021, through September 7, 2021, the Company entered into twenty-nine subscription convertible
note agreements totaling $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210907__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--TransactionTypeAxis__custom--TwentyNineSubscriptionsMember_zzcelvin5l6u"><ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount" contextref="AsOf2021-09-07_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,943,000</ix:nonfraction></span>,
twelve of the notes included original issue discounts totaling $<span id="xdx_900_ecustom--OriginalIssueDiscount1_iI_c20210907__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--TransactionTypeAxis__custom--TwentyNineSubscriptionsMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--TwelveNotesMember_zewRfVPdu9Et" title="Original issue discount"><ix:nonfraction name="MOBQ:OriginalIssueDiscount1" contextref="AsOf2021-09-07_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember_custom_TwelveNotesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">74,500</ix:nonfraction></span>.
During 2021, sixteen of the notes totaling $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--TransactionTypeAxis__custom--TwentyNineSubscriptionsMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--SixteenNotesMember_z9rUAe03OEIT"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember_custom_SixteenNotesMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,149,500</ix:nonfraction></span>
were converted to common stock, one note of $<span id="xdx_90B_eus-gaap--RepaymentsOfConvertibleDebt_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--TransactionTypeAxis__custom--TwentyNineSubscriptionsMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--OneNoteMember_zMMLAPeCRdJO"><ix:nonfraction name="us-gaap:RepaymentsOfConvertibleDebt" contextref="From2021-01-012021-12-31_custom_BusinessCapitalProvidersMember_custom_TwentyNineSubscriptionsMember_custom_OneNoteMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">100,000</ix:nonfraction></span>
was paid in full.</p>

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center; width: 24px">&nbsp;</td>
    <td style="font-size: 10pt; width: 24px"><span style="font-size: 10pt">(e)</span></td>
    <td style="text-align: justify">In September 2021, the Company entered into securities purchase agreements 2021, with two accredited investors, Talos Victory Fund, LLC, and Blue Lake Partners LLC, pursuant to which the Company issued 10% promissory notes with a maturity date of September 20, 2022, in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20210907__us-gaap--LongtermDebtTypeAxis__custom--BlueLakePartnersTalosVictoryFund1Member_zKsYUXTMAiA9"><ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount" contextref="AsOf2021-09-07_custom_BlueLakePartnersTalosVictoryFund1Member" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,125,000</ix:nonfraction></span>. In addition, the Company issued warrants to purchase an aggregate of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210907__us-gaap--LongtermDebtTypeAxis__custom--BlueLakePartnersTalosVictoryFundMember_zJesm9pxCx6J" title="Warrants issued"><ix:nonfraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextref="AsOf2021-09-07_custom_BlueLakePartnersTalosVictoryFundMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">56,250</ix:nonfraction></span> shares of its common stock to these holders. Spartan Capital Securities LLC and Revere Securities LLC acted as placement agents on this transaction. The promissory notes include the following terms: </td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">Interest at the annual rate of 10%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The notes carry original issue discount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20210907__us-gaap--LongtermDebtTypeAxis__custom--BlueLakePartnersTalosVictoryFundMember_zqtnsCeg4If7"><ix:nonfraction name="us-gaap:DebtInstrumentFaceAmount" contextref="AsOf2021-09-07_custom_BlueLakePartnersTalosVictoryFundMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">112,500</ix:nonfraction></span> in the aggregate. Accordingly, the total net principal of this debt was $1,012,500.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The Company is required to make interim payments to the holders in the aggregate amount of $225,000, on or before March 18, 2022, towards the repayment of the balance of the notes. The Company may prepay the principal sum under the notes then outstanding plus accrued and unpaid interest in full at any time without any prepayment premium; however, the Company is required to pay a minimum amount of the first 12 months of interest under the notes.</p>

<ix:exclude><p id="xdx_234_zxSlrDdO4ZlQ" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zTMOs76gWzqN" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zxsCw9r5a65s" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt"></p>

<ix:exclude><!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zW9BlgoquoTo" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23F_ztpb72H5UFLW" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The
holders may convert the notes and exercise the warrants into the Company’s common stock (subject to contractual beneficial ownership
limitations of 4.99%). The holders have the right to convert the notes at any time into shares of common stock at a conversion price
of $5.00 per share; provided, however, if the Company consummates a so-called up-listing offering to a national exchange within 180 days
after the closing date, then the Note conversion price shall adjust to equal 70% of the price per share of common stock in that offering.
The warrants may also be exercised at any time from date of issuance over a period of five years at the exercise price then in effect.
The initial warrant exercise price shall equal $10.00 per share; provided however, if the Company consummates the up-listing offering
within the 180-day period noted above, then the exercise price shall adjust to equal 130% of the price per share in that offering. The
warrants contain cashless exercise provisions. Both the notes and the warrants contain customary anti-dilution provisions which could
cause an adjustment to the conversion price of the notes and the exercise price of the warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The note holders were repaid in full in December of 2021. In December of 2021, each note holder exercised their warrants into a total of <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueLakePartnersTalosVictoryFundMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--WarrantsConvertedMember_zHNgxb9S0mIX"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2021-01-012021-12-31_custom_BlueLakePartnersTalosVictoryFundMember_custom_WarrantsConvertedMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">104,262</ix:nonfraction></span> shares of the Company’s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">The notes provide that so long as the Company has any obligations under the Notes, the Company will not, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 40pt"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>Incur or guarantee any indebtedness which is senior or equal to the notes.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 40pt"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>Redeem or repurchase any shares of stock, warrants, rights or options without the holders’ consent.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 40pt"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>Sell, lease or otherwise dispose of a significant portion of its assets without the holders’ consent.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 40pt"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>The notes contain customary events of default relating to, among other things, payment defaults, breach of representations and warranties,
and breach of provisions of the notes or securities purchase agreements.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tbody><tr style="vertical-align: top">
<td style="width: 40pt"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td>In an event of default under the notes, which has not been cured within any applicable cure period, if any, the notes shall become
immediately due and payable and the Company shall pay to the holders an amount equal to the principal sum then outstanding plus accrued
interest, multiplied by 125%. Additionally, upon the occurrence of an event of default, additional interest will accrue from the date
of the event of default at the rate equal to the lower of 16% per annum or the highest rate permitted by law.</td></tr></tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">On
the closing date of this financing, the holders delivered the net amount of $910,000 of the purchase price to the Company in
exchange for the notes (which was net of the original issue discount and other fees, and expenses relate to this financing). On
October 19, 2021, the Company filed a Form S-1 Registration Statement (File no. 333-260364) with the Securities and Exchange
Commission to raise over $10 million dollars in an underwritten public offering. The next day the Company filed an application to
list our common stock on the NASDAQ Capital Market under the symbol “MOBQ.” This offering was completed on
December 13, 2021, and the Company retired the loans of, Talos Victory Fund, LLC and Blue Lake Partners LLC out of the gross
proceeds it received of approximately $10.3 million. Also, all warrants issued to Talos and Blue Lake were converted on a cashless
exercise basis into <span id="xdx_903_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--TalosVictoryFundMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--WarrantsConvertedMember_z3I5SuGg1Q19"><ix:nonfraction name="us-gaap:ConversionOfStockSharesIssued1" contextref="From2021-01-012021-12-31_custom_TalosVictoryFundMember_custom_WarrantsConvertedMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">24,692</ix:nonfraction></span> common shares and <span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--BlueLakePartnersMember__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--WarrantsConvertedMember_zRol8mGTQ4zQ"><ix:nonfraction name="us-gaap:ConversionOfStockSharesIssued1" contextref="From2021-01-012021-12-31_custom_BlueLakePartnersMember_custom_WarrantsConvertedMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">24,692</ix:nonfraction></span> common shares, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 48px; margin-top: 0pt; margin-bottom: 0pt">In
the fourth quarter of 2021, Business Capital Providers assigned one of its Merchant Agreements and related debt described above to
non-affiliated third parties, which subsequently converted $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20211001__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--NonAffiliatedThirdPartyMember_z74yIKg0AvbY"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2021-10-012021-12-31_custom_BusinessCapitalProvidersMember_custom_NonAffiliatedThirdPartyMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">89,100</ix:nonfraction></span> in outstanding indebtedness into <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211001__20211231__us-gaap--LongtermDebtTypeAxis__custom--BusinessCapitalProvidersMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--NonAffiliatedThirdPartyMember_zR1g54EqxonM"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2021-10-012021-12-31_custom_BusinessCapitalProvidersMember_custom_NonAffiliatedThirdPartyMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">13,103</ix:nonfraction></span> common shares pursuant to
their terms. In the fourth quarter of 2021, the Company borrowed from a non-affiliated person $<span id="xdx_907_eus-gaap--LongTermDebt_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NonAffiliatedPersonMember_zYZi1BAAholB"><ix:nonfraction name="us-gaap:LongTermDebt" contextref="AsOf2021-12-31_custom_NonAffiliatedPersonMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">312,500</ix:nonfraction></span> on a non-convertible
three-month loan with 20% original issue discount less fees of $<span id="xdx_90A_ecustom--OriginalIssueDiscount1_iI_c20211231__us-gaap--LongtermDebtTypeAxis__custom--NonAffiliatedPersonMember_zh3uJpQHKLbK"><ix:nonfraction name="MOBQ:OriginalIssueDiscount1" contextref="AsOf2021-12-31_custom_NonAffiliatedPersonMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">30,000</ix:nonfraction></span>.</p>

<ix:exclude><p id="xdx_23B_zbLgxmBaj8W5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zzKg4wVGXTlQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zKgOUqso6OeP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_zvZamAPLfggZ" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_231_zzAkcMWTPubb" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 24px"></td><td style="width: 24px; text-align: left">(f)</td><td style="text-align: justify">On September 13, 2019, Dr. Gene Salkind, who is a director of
the Company, and an affiliate of Dr. Salkind subscribed for 15% Senior Secured Convertible Promissory Notes and loaned the Company an
aggregate of $2,300,000. These notes were amended and restated on December 31, 2019, by Amended and Restated 15% Senior Secured Convertible
Promissory Notes which deferred interest payments from the date of the original notes to December 31, 2020 and added an aggregate interim
payment of $250,000 payable on December 31, 2020 that covered the deferred interest payments. These notes were again amended and restated
on April 1, 2021, by the Second Amended and Restated 15% Senior Secured Convertible Promissory Notes which reflected an additional principal
amount of $150,000 loaned by Dr. Salkind, and also amended the interim payment date to December 31, 2021, and the conversion price from
$32 to $4 per share. The notes are secured by the assets of the Company and its subsidiaries. The total amount loaned under the notes,
as amended and restated, including the principal amount and the interim payment amount is $2,700,000, which was paid down to $2,562,500
in December 2021.</td>
</tr></tbody></table>

<p style="margin: 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notes, as amended and restated, bear
annual interest at 15% which is payable monthly in cash or, at the Salkind lenders’ option, in shares of the Company’s common
stock. The principal amount under the Notes is due on September 30, 2029, and the interim payment is payable on December 31, 2021, unless,
in either case, earlier converted into shares of our common stock under the terms of the notes, as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outstanding principal plus any accrued
and unpaid interest, and the interim payment under the notes, are convertible into shares of Company common stock at a conversion price
of $4 per share at any time, until the notes are fully converted, on the following terms:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 20px">&nbsp;</td>
    <td style="width: 20px"><span style="font-family: Symbol">·</span></td>
    <td>The Salkind lenders may convert the notes at any time.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 20px">&nbsp;</td>
    <td style="width: 20px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The Company may convert the notes at any time that the trailing thirty (30) day volume weighted average price per share (as more particularly described in the Notes) of the Company’s common stock is above $400 per share.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
notes contain customary events of default, which, if uncured, entitle the holders to accelerate payment of the principal and all accrued
and unpaid interest under their notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the subscription of the notes
and upon conversion thereof (if at all),, the Company will issue to each Salkind lender a warrant to purchase one share of the Company’s
common stock for every two shares of common stock issuable upon conversion of the Notes, at an exercise price of $48 per share. The warrant
exercise price was amended to $4 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the second quarter of 2020, we halted required
interest payments under the September 2019 and June 30, 2021, Notes to Dr. Salkind and his affiliate due to economic hardships stemming
from a downturn in our business and the related decline of our revenue resulting from the COVID 19 pandemic. In December 2021, we paid
$400,000 of accrued interest owed to Dr. Salkind and an affiliated entity.</p>

<ix:exclude><p id="xdx_23A_z0BljIJYwzW0" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zzbJtf6RXz4Z" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_z4AEVATR36TL" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_234_zA6O5PHH0Kwa" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zKuOUYJpY3QB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 5: <span id="xdx_82F_z6JSx4CHRji8">INCOME TAXES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The provision for income taxes for the years
ended December 31, 2021, and 2020 is summarized as follows:</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zNoCF9vHftO6" summary="xdx: Disclosure - INCOME TAXES (Details-Provision)" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B7_zY4jhGYjg9A8" style="display: none">Provision for income taxes</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_498_20210101__20211231_zDZxeWo3bUdJ" style="text-align: center">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_49D_20200101_20201231_z6VHj88zUDsw" style="text-align: center">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="text-align: center; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="text-align: center; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: center">2020</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td></tr>
  <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB_zEXwXwjRSkHU" style="vertical-align: bottom">
    <td style="text-align: left">Current:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_d0_zqiewbVt6hdu" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Federal</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_d0_zYCxMvW31Xx9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">State</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01_pp0p0_d0_zK65IN4wyjOG" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="color: rgb(238,238,238); padding-bottom: 1pt; text-align: left">Total Current&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredIncomeTaxesAbstract_iB_zPsg3ZzNIDoZ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred:</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_d0_zZE4cCVw8gOK" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Federal</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01_pp0p0_d0_zAhoSn02s2kl" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">State</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i01_pp0p0_d0_zWMEG4IfytJb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="color: rgb(238,238,238); padding-bottom: 2.5pt; text-align: left">Total Deferred&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextref="From2021-01-01to2021-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextref="From2020-01-012020-12-31" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8AA_zEOKhPzt2tHT" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has federal net operating loss carryforwards
(“NOL’s) of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_c20211231_pp0p0_zCPSzZ13qzeM" title="Net operating loss carryforward"><ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">178,447,460</ix:nonfraction></span> and $<span id="xdx_905_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_c20201231_pp0p0_z0bGcJZSe2Im" title="Net operating loss carryforward"><ix:nonfraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">178,447,460</ix:nonfraction></span>, respectively, which will be available to reduce future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zzS82ODKeU7q" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax effects of temporary differences which
give rise to deferred tax assets (liabilities) are summarized as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; width: 66%"><span id="xdx_8BA_z5gQ4YZTVviv"><b style="display: none">Schedule of deferred tax assets</b></span></td><td style="width: 2%">&nbsp;</td>
    <td style="text-align: left; width: 1%">&nbsp;</td><td id="xdx_491_20211231_zchvKgpT2DBU" style="text-align: right; width: 13%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="text-align: left; width: 1%">&nbsp;</td><td id="xdx_49B_20201231_zDbtuwp1FU4s" style="text-align: right; width: 13%">&nbsp;</td><td style="text-align: left; width: 1%">&nbsp;</td></tr>

<tr style="vertical-align: bottom">
    <td style="text-align: center">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">YEAR ENDED DECEMBER 31,</td><td style="padding-bottom: 1pt">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2020</td><td style="padding-bottom: 1pt">&nbsp;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGross_iNI_di_zJe6x7CGxeps" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Deferred Tax Assets</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(<ix:nonfraction name="us-gaap:DeferredTaxAssetsGross" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">11,888,000</ix:nonfraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(<ix:nonfraction name="us-gaap:DeferredTaxAssetsGross" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">12,528,000</ix:nonfraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_zR2bhLwPJNIT" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: justify">Less: Valuation Allowance</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">11,888,000</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextref="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitref="USD">12,528,000</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_iI_d0_zJvFgUzSlJkd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: justify">Net Deferred Tax Asset</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:DeferredTaxAssetsNet" contextref="AsOf2021-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:DeferredTaxAssetsNet" contextref="AsOf2020-12-31" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>


</ix:nonnumeric><p id="xdx_8AC_znrSRSjMiG63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A reconciliation of the federal statutory rate
to the Company’s effective tax rate is as follows:</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z8Pk7S40mhWX" summary="xdx: Disclosure - INCOME TAXES (Details-Federal Statutory Rate)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B5_z9l9ZJs3buRv" style="display: none">Reconciliation of federal statutory rate</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_491_20210101__20211231_zJR8S7x9FBWJ" style="text-align: center">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_492_20200101__20201231_z5Z7af4qpuJM" style="text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">YEARS ENDED DECEMBER 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2020</td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_z2AT5J2prMQ3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 68%; text-align: justify">Federal Statutory Tax Rate</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">21.00</ix:nonfraction>%&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">21.00</ix:nonfraction>%&nbsp;</td></tr>
  <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_i_pdd_zxBcPfYe9LaI" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">State Taxes, net of Federal benefit</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">5.00</ix:nonfraction>%&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">5.00</ix:nonfraction>%&nbsp;</td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pdd_zYXWg7uDvOIP" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in Valuation Allowance</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitref="Pure">26.00</ix:nonfraction>%)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitref="Pure">26.00</ix:nonfraction>%)</td></tr>
  <tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_i_pdd_zysB66FGi5hq" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total Tax Expense</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">0.00</ix:nonfraction>%&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">0.00</ix:nonfraction>%&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8A7_zICPvna5r7t5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><p id="xdx_232_zAiffTa0v9Yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_236_z2rnlnjkogEQ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 63 -->
    <div id="xdx_233_ziwhSImjV5Xs" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td id="xdx_231_z7vs1jdSv1Of" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_237_z50i1VbZlgWi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_z3WHtzdcfauO" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zNGCDI44s7hx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zA22RPzO219N" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">NOTE 6: <span id="xdx_821_zR6OW8xii8hD">STOCKHOLDERS’ EQUITY (DEFICIT)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><i>Shares Issued for Services</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">During 2020, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVaC58Jj86yd" title="Stock issued for services, shares"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember198564156" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">38,125</ix:nonfraction></span> post-split
shares of common stock, at $7.20 to $40.00 per share for $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20200101__20201231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zg2wp5cJ9XsI" title="Stock issued for services, value"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2020-01-012020-12-31_us-gaap_CommonStockMember198564156" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">547,451</ix:nonfraction></span> in exchange for services rendered. During 2021, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRlHZNFTRHHv" title="Stock issued for services, shares"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember198564171" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">265,000</ix:nonfraction></span>
shares of common stock, at $3.21 to $9.73 per share for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0_zSVomirrHuDt" title="Stock issued for services, value"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember198564171" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,158,025</ix:nonfraction></span> in exchange for services rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><i>Shares issued for interest:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">During
the years ended December 31, 2021 and 2020, the Company did not issue any shares for interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><i>Shares issued for upon conversion of warrants, notes and/or
preferred stock:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">During 2020, one holder of our Series E Preferred
Stock converted <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20200101__20201231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--PreferredSeriesEMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYBrXmHg0GYx" title="Conversion of Stock, Shares Converted"><ix:nonfraction name="us-gaap:ConversionOfStockSharesConverted1" contextref="From2020-01-012020-12-31_custom_PreferredSeriesEMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,937</ix:nonfraction></span> shares to <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20200101__20201231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--PreferredSeriesEMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zT9ZUSJ2D0Z6" title="Stock converted, common shares issued"><ix:nonfraction name="us-gaap:ConversionOfStockSharesIssued1" contextref="From2020-01-012020-12-31_custom_PreferredSeriesEMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">9,843</ix:nonfraction></span> post-split shares of our common stock and <span id="xdx_90E_ecustom--ConversionOfStockWarrantSharesIssued1_c20200101__20201231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--PreferredSeriesEMember__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zyGVNcg8zYa_zXmG4NmBzWGJ" title="Stock converted, warrants issued"><ix:nonfraction name="MOBQ:ConversionOfStockWarrantSharesIssued1" contextref="From2020-01-012020-12-31_custom_PreferredSeriesEMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">4,921</ix:nonfraction></span> warrants at an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--PreferredSeriesEMember__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zC8K6nXNyyp6" title="Warrant exercise price"><ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextref="AsOf2020-12-31_custom_PreferredSeriesEMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">48.00</ix:nonfraction></span> per share
with an expiration date of January 8, 2025. During 2021, the single holder of our Series C Preferred Stock converted 1,500 shares to 375,000
shares of our common stock and 375,000 warrants at an exercise price of $48.00 with an expiration date of September 2023. During 2021,
a shareholder of our Series AAA Preferred Stock converted <span id="xdx_90D_ecustom--ConversionOfPreferredStockSeriesAaaShares_iN_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--MezzaninePreferredStockMember_zI0LU9cv1YlL" title="Conversion of preferred stock series AAA, shares"><ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAaaShares" contextref="From2021-01-012021-12-31_custom_MezzaninePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitref="Shares">25,000</ix:nonfraction></span> shares to <span id="xdx_902_ecustom--ConversionOfPreferredStockSeriesAaaShares_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLZd2QIpkadi" title="Conversion of preferred stock series AAA, shares"><ix:nonfraction name="MOBQ:ConversionOfPreferredStockSeriesAaaShares" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,250</ix:nonfraction></span> shares of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">During 2020, <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20200101__20201231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--WarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zNduJYmi1l7c" title="Conversion of Stock, Shares Converted"><ix:nonfraction name="us-gaap:ConversionOfStockSharesConverted1" contextref="From2020-01-012020-12-31_custom_WarrantsMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">77,220</ix:nonfraction></span>, post-split, warrants
were converted to common stock, at $8.00 to $28.00 per share. During 2021 two Warrant holders converted in a cashless exercise their warrants
into <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwuZc6KlcPjR" title="Warrant conversions"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextref="From2021-01-012021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">49,384</ix:nonfraction></span> common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">During 2020, one note holder converted $<span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200101__20201231__srt--CounterpartyNameAxis__custom--NoteHolderMember_z1xMaVCIQLgS" title="Debt converted, amount converted"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2020-01-012020-12-31_custom_NoteHolderMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">30,695</ix:nonfraction></span>
of their note into <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20200101__20201231__srt--CounterpartyNameAxis__custom--NoteHolderMember_z2SPEvimDGwG" title="Debt converted, shares issued"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2020-01-012020-12-31_custom_NoteHolderMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,919</ix:nonfraction></span> post-split common shares at a conversion rate of $16 per post-split share and cash payment of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pp0p0_c20200101__20201231__srt--CounterpartyNameAxis__custom--NoteHolderMember_zftJ55zj5X9o" title="Proceeds from Other Equity"><ix:nonfraction name="us-gaap:ProceedsFromOtherEquity" contextref="From2020-01-012020-12-31_custom_NoteHolderMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,000</ix:nonfraction></span>. During
2021, seventeen of the lender-investors provided us an aggregate of $1,243,600 in convertible debt financing converted their debt into
a total of 236,768 shares of common stock at a conversion price at $4.81 to $7.25 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<ix:exclude><p id="xdx_230_zgYjwPFcgWRJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zpPsTd1NLQPN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zeieXKrAER6p" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 67 -->
    <div id="xdx_23F_zvcPXaYggl44" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td id="xdx_23D_zIhmzkjZaf4e" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23B_zUviYWqZ4nh1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zTUksnskhFsw" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zCZf764K3geG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><i>Stock and Loan Transactions for Cash</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On April 8, 2021, the Company sold <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20210101__20210408__srt--CounterpartyNameAxis__custom--OneInvestorMember_pdd_zy1wCZbZs75q" title="Number of restricted common stock sold"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextref="From2021-01-012021-04-08_custom_OneInvestorMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">16,667</ix:nonfraction></span>
shares of its restricted common stock at $<span id="xdx_900_eus-gaap--SharePrice_c20210408__srt--CounterpartyNameAxis__custom--OneInvestorMember_pdd_z2fziw0AKyyN" title="Share price"><ix:nonfraction name="us-gaap:SharePrice" contextref="AsOf2021-04-08_custom_OneInvestorMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">6.00</ix:nonfraction></span> per share to one investor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On April 14, 2021, the Company received a
short-term $<span id="xdx_90D_eus-gaap--ProceedsFromShortTermDebt_pp0p0_c20210101__20210414__srt--CounterpartyNameAxis__custom--OneInvestor2Member_zRNORnaIpbFw" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-04-14_custom_OneInvestor2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> loan from one investor. The Company issued a $<span id="xdx_903_eus-gaap--ShortTermBorrowings_c20210414_pp0p0_z5Tf5pUSDxgK" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-04-14" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> note and <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210414__srt--CounterpartyNameAxis__custom--OneInvestor2Member_pdd_zqnQq89nVOeP" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-04-14_custom_OneInvestor2Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,500</ix:nonfraction></span> restricted shares of common stock as a loan origination
fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On April 16, 2021, the Company sold <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20210101__20210416__srt--CounterpartyNameAxis__custom--OneInvestor3Member_pdd_zU71gaSIBJMc" title="Number of restricted common stock sold"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextref="From2021-01-012021-04-16_custom_OneInvestor3Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">41,667</ix:nonfraction></span>
shares of restricted common stock at $<span id="xdx_90F_eus-gaap--SharePrice_c20210416__srt--CounterpartyNameAxis__custom--OneInvestor3Member_pdd_zKug5J8AirT6" title="Share price"><ix:nonfraction name="us-gaap:SharePrice" contextref="AsOf2021-04-16_custom_OneInvestor3Member" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">6.00</ix:nonfraction></span> per share to one investor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On April 21, 2021,
the $<span id="xdx_907_eus-gaap--RepaymentsOfShortTermDebt_c20210101__20210421__srt--CounterpartyNameAxis__custom--OneInvestor2Member_pp0p0_zQtpi0Wnonjm" title="Repayments of Short-term Debt"><ix:nonfraction name="us-gaap:RepaymentsOfShortTermDebt" contextref="From2021-01-012021-04-21_custom_OneInvestor2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> loan from April 14, 2021, was retired out of the proceeds and sale by the Company of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210421__us-gaap--TransactionTypeAxis__custom--SaleOfStockMember_pdd_z7bau5YcdvU6" title="Stock Issued During Period, Shares, New Issues"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextref="From2021-01-012021-04-21_custom_SaleOfStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">41,667</ix:nonfraction></span> shares of its common stock at
$<span id="xdx_903_eus-gaap--SharePrice_c20210421__us-gaap--TransactionTypeAxis__custom--SaleOfStockMember_pdd_ziwFIWfpnssg" title="Share price"><ix:nonfraction name="us-gaap:SharePrice" contextref="AsOf2021-04-21_custom_SaleOfStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">6.00</ix:nonfraction></span> per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On April 30, 2021, the Company issued a two-month
loan to an investor in exchange for $<span id="xdx_900_ecustom--StockIssuedForExchangesOfLoan_c20210101__20210430__srt--CounterpartyNameAxis__custom--OneInvestor4Member_pp0p0_z92oqoQsCJeq" title="Stock issued for exchanges of loan"><ix:nonfraction name="MOBQ:StockIssuedForExchangesOfLoan" contextref="From2021-01-012021-04-30_custom_OneInvestor4Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span>. The principal of the note together with an origination fee and accrued interest thereon
totaling $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20210101__20211231__srt--CounterpartyNameAxis__custom--OneInvestor4Member_pp0p0_zDUr6Vyh4TiD" title="Debt converted, amount converted"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextref="From2021-01-012021-12-31_custom_OneInvestor4Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">105,000</ix:nonfraction></span> and <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__srt--CounterpartyNameAxis__custom--OneInvestor4Member_pdd_ztmDUTuHQeIW" title="Debt converted, shares issued"><ix:nonfraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextref="From2021-01-012021-12-31_custom_OneInvestor4Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000</ix:nonfraction></span> shares of restricted common stock is due on June 30, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On May 10, 2021, the Company received
a short-term $<span id="xdx_900_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210510__srt--CounterpartyNameAxis__custom--OneInvestor5Member_pp0p0_zSu71QOaCQcU" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-05-10_custom_OneInvestor5Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> loan from one investor. The Company issued a $<span id="xdx_902_eus-gaap--ShortTermBorrowings_c20210510__srt--CounterpartyNameAxis__custom--OneInvestor5Member_pp0p0_znsMaZ6qFVkh" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-05-10_custom_OneInvestor5Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">105,000</ix:nonfraction></span> note which includes a $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210510__srt--CounterpartyNameAxis__custom--OneInvestor5Member_pp0p0_zQJeT5oKLiHm" title="Origination fee"><ix:nonfraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextref="AsOf2021-05-10_custom_OneInvestor5Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,000</ix:nonfraction></span> loan origination fee. On September
13, 2021, this Note was exchanged for a short term $110,000 note which includes $10,000 loan origination fee. On September 30, 2021, this
loan was converted into 19,744 shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On May 17, 2021, the Company received a short-term
$<span id="xdx_909_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210517__srt--CounterpartyNameAxis__custom--OneInvestor6Member_pp0p0_zRrMYAVOSK58" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-05-17_custom_OneInvestor6Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> loan from one investor. The Company issued a $<span id="xdx_90B_eus-gaap--ShortTermBorrowings_c20210517__srt--CounterpartyNameAxis__custom--OneInvestor6Member_pp0p0_zy6NNIvlTMuu" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-05-17_custom_OneInvestor6Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> note and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210517__srt--CounterpartyNameAxis__custom--OneInvestor6Member_pdd_zrOfurQswdlQ" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-05-17_custom_OneInvestor6Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,000</ix:nonfraction></span> restricted common stock as a loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On May 18, 2021, the Company received a short-term
$<span id="xdx_90F_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210518__srt--CounterpartyNameAxis__custom--OneInvestor7Member_pp0p0_zqzCbY6zbZAV" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-05-18_custom_OneInvestor7Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> loan from one investor. The Company issued a $<span id="xdx_909_eus-gaap--ShortTermBorrowings_c20210518__srt--CounterpartyNameAxis__custom--OneInvestor7Member_pp0p0_z2SfzeaClI2Z" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-05-18_custom_OneInvestor7Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">100,000</ix:nonfraction></span> note and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210518__srt--CounterpartyNameAxis__custom--OneInvestor7Member_pdd_z7L7H1L0BcUM" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-05-18_custom_OneInvestor7Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">5,000</ix:nonfraction></span> restricted common stock as a loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On May 19, 2021, the Company received a short-term
$<span id="xdx_90D_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210519__srt--CounterpartyNameAxis__custom--OneInvestor8Member_pp0p0_z64orj2q69P1" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-05-19_custom_OneInvestor8Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> loan from one investor. The Company issued a $<span id="xdx_90F_eus-gaap--ShortTermBorrowings_c20210519__srt--CounterpartyNameAxis__custom--OneInvestor8Member_pp0p0_z6lfyVCCSDTi" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-05-19_custom_OneInvestor8Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> note and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210519__srt--CounterpartyNameAxis__custom--OneInvestor8Member_pdd_zeVjXAKjHfoN" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-05-19_custom_OneInvestor8Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,000</ix:nonfraction></span> restricted common stock as a loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On May 24, 2021, the Company received a short-term
$<span id="xdx_908_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210524__srt--CounterpartyNameAxis__custom--OneInvestor9Member_pp0p0_ze1YMuVF91x3" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-05-24_custom_OneInvestor9Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> loan from one investor. The Company issued a $<span id="xdx_908_eus-gaap--ShortTermBorrowings_c20210524__srt--CounterpartyNameAxis__custom--OneInvestor9Member_pp0p0_zGIPRuhzXuRN" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-05-24_custom_OneInvestor9Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> note and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210524__srt--CounterpartyNameAxis__custom--OneInvestor9Member_pdd_z2mrDrVbejHA" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-05-24_custom_OneInvestor9Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,000</ix:nonfraction></span> restricted common stock as a loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On June 9, 2021, the Company received short-term
$<span id="xdx_90D_eus-gaap--ShortTermBorrowings_c20210609__srt--CounterpartyNameAxis__custom--ThreeInvestorsMember_pp0p0_z3Zam1XDdREL" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-06-09_custom_ThreeInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">400,000</ix:nonfraction></span> loans from three investors. The Company issued $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20210101__20210609__srt--CounterpartyNameAxis__custom--ThreeInvestorsMember_pp0p0_zxH5Y09sWfn1" title="Proceed from issuance of debt"><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextref="From2021-01-012021-06-09_custom_ThreeInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">420,000</ix:nonfraction></span> notes including $<span id="xdx_905_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210609__srt--CounterpartyNameAxis__custom--ThreeInvestorsMember_pp0p0_zNvZ5caEzYOs" title="Origination fee"><ix:nonfraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextref="AsOf2021-06-09_custom_ThreeInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">20,000</ix:nonfraction></span> loan origination fee and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210609__srt--CounterpartyNameAxis__custom--ThreeInvestorsMember_zqm4QkAajxOg" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-06-09_custom_ThreeInvestorsMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000</ix:nonfraction></span> restricted common
stock as a loan origination fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On June 18, 2021, the Company received short-term
$<span id="xdx_906_eus-gaap--ShortTermBorrowings_c20210618__srt--CounterpartyNameAxis__custom--TwoInvestorsMember_pp0p0_zm3aoRyjsdFT" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-06-18_custom_TwoInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">120,000</ix:nonfraction></span> loans from two investors. The Company issued $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfDebt_c20210101__20210618__srt--CounterpartyNameAxis__custom--TwoInvestorsMember_pp0p0_ziUH99oxRUED" title="Proceed from issuance of debt"><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextref="From2021-01-012021-06-18_custom_TwoInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">132,000</ix:nonfraction></span> notes including $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210618__srt--CounterpartyNameAxis__custom--TwoInvestorsMember_pp0p0_zK4y5VV4VXCs" title="Origination fee"><ix:nonfraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextref="AsOf2021-06-18_custom_TwoInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">12,000</ix:nonfraction></span> loan origination fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On July 8, 2021, the Company received short-term
$<span id="xdx_904_eus-gaap--ShortTermBorrowings_c20210708__srt--CounterpartyNameAxis__custom--TwoInvestors1Member_pp0p0_zJmzOAXrzYib" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-07-08_custom_TwoInvestors1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">80,000</ix:nonfraction></span> loans from two investors. The Company issued $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20210101__20210708__srt--CounterpartyNameAxis__custom--TwoInvestors1Member_pp0p0_zPySFbhF1T2o" title="Proceed from issuance of debt"><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextref="From2021-01-012021-07-08_custom_TwoInvestors1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">85,000</ix:nonfraction></span> notes including $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210708__srt--CounterpartyNameAxis__custom--TwoInvestors1Member_pp0p0_zir4NW5ZWx69" title="Origination fee"><ix:nonfraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextref="AsOf2021-07-08_custom_TwoInvestors1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,000</ix:nonfraction></span> loan origination fee and a 10% rate on one of the
notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On July 14, 2021, the Company received short-term
$<span id="xdx_90A_eus-gaap--ShortTermBorrowings_c20210714__srt--CounterpartyNameAxis__custom--TwoInvestors2Member_pp0p0_zi9b0Z1zZaE5" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-07-14_custom_TwoInvestors2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">75,000</ix:nonfraction></span> loans from two investors. The Company issued $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfDebt_c20210101__20210714__srt--CounterpartyNameAxis__custom--TwoInvestors2Member_pp0p0_zLlcrOSVwYLR" title="Proceed from issuance of debt"><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextref="From2021-01-012021-07-14_custom_TwoInvestors2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">82,500</ix:nonfraction></span> notes including $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210714__srt--CounterpartyNameAxis__custom--TwoInvestorsMember_pp0p0_zTee1JbI1A8b" title="Origination fee"><ix:nonfraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextref="AsOf2021-07-14_custom_TwoInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">7,500</ix:nonfraction></span> loan origination fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On July 15, 2021, the Company received short-term
$<span id="xdx_904_eus-gaap--ShortTermBorrowings_c20210715__srt--CounterpartyNameAxis__custom--TwoInvestors3Member_pp0p0_zPjMwsT2fuWJ" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-07-15_custom_TwoInvestors3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">150,000</ix:nonfraction></span> loans from two investors. The Company issued $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20210101__20210715__srt--CounterpartyNameAxis__custom--TwoInvestors3Member_pp0p0_zCZQbath11Zm" title="Proceed from issuance of debt"><ix:nonfraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextref="From2021-01-012021-07-15_custom_TwoInvestors3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">155,000</ix:nonfraction></span> notes including $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210715__srt--CounterpartyNameAxis__custom--TwoInvestors3Member_pp0p0_zAaeLMs0Xuiy" title="Origination fee"><ix:nonfraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextref="AsOf2021-07-15_custom_TwoInvestors3Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">5,000</ix:nonfraction></span> loan origination fee and 5,000 restricted common
stock as a loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<ix:exclude><p id="xdx_23A_zhXRUt57AbW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zTBQWmuslH9u" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_z7Ca8dmKk6om" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 68 -->
    <div id="xdx_237_zAknldajXccV" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td id="xdx_236_zOrskRTQU2Wc" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_233_zqNqcbsEgHZt" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zkBD2zuZ4sLd" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zh6vC6GnyQMY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On July 29, 2021, the Company received a
short term note of $<span id="xdx_90B_eus-gaap--ShortTermBorrowings_c20210729_pp0p0_zqLJWjDQTbNL" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-07-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">300,000</ix:nonfraction></span> payable at $2,531.25 for 160 payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On August 11, 2021, the Company received
short-term $<span id="xdx_902_eus-gaap--ShortTermBorrowings_c20210811__srt--CounterpartyNameAxis__custom--OneInvestor10Member_pp0p0_zNyYh5fxmyLa" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-08-11_custom_OneInvestor10Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">25,000</ix:nonfraction></span> loan from one investor. The Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210811__srt--CounterpartyNameAxis__custom--OneInvestor9Member_pdd_zBuNaBtGKIrY" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-08-11_custom_OneInvestor9Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,250</ix:nonfraction></span> restricted common stock as a loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On August 12, 2021, the Company received
short-term $<span id="xdx_90A_eus-gaap--ShortTermBorrowings_c20210812__srt--CounterpartyNameAxis__custom--TwoInvestorsMember_pp0p0_zqeHzBxoEzyI" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-08-12_custom_TwoInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">200,000</ix:nonfraction></span> loans from two investors. The Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210801__20210812__srt--CounterpartyNameAxis__custom--TwoInvestorMember_zLbmgP2Etjzl" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-08-012021-08-12_custom_TwoInvestorMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">10,000</ix:nonfraction></span> restricted common stock as loan origination fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On August 16, 2021, the Company received
short-term $<span id="xdx_906_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210816__srt--CounterpartyNameAxis__custom--OneInvestor11Member_pp0p0_z6B9eWtEuUUW" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-08-16_custom_OneInvestor11Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> loan form one investor. The note carries a 10% interest rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On August 25, 2021, the Company received
short-term $<span id="xdx_906_eus-gaap--ShortTermBorrowings_c20210825__srt--CounterpartyNameAxis__custom--TwoInvestorsMember_pp0p0_zytaHuolmMXP" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-08-25_custom_TwoInvestorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">43,000</ix:nonfraction></span> loans from two investors. The Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210825__srt--CounterpartyNameAxis__custom--TwoInvestorMember_pdd_zcRWGgHzutnm" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-08-25_custom_TwoInvestorMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">2,150</ix:nonfraction></span> restricted common stock as loan origination fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On September 2, 2021, the Company received
short-term $<span id="xdx_907_eus-gaap--ShortTermBorrowings_c20210902__srt--CounterpartyNameAxis__custom--OneInvestor12Member_pp0p0_zAnD6muz0s7s" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-09-02_custom_OneInvestor12Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">25,000</ix:nonfraction></span> loan from one investor. The note carries a 10% interest rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On September 7, 2021, the Company
received short-term $<span id="xdx_90A_eus-gaap--ShortTermBorrowings_c20210907__srt--CounterpartyNameAxis__custom--OneInvestor13Member_pp0p0_z9ukSNOM6lNe" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-09-07_custom_OneInvestor13Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> loan from one investor. The Company issued $<span id="xdx_905_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210907__srt--CounterpartyNameAxis__custom--OneInvestor13Member_pp0p0_zjOV13zyol6r" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-09-07_custom_OneInvestor13Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">55,000</ix:nonfraction></span> note including $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210907__srt--CounterpartyNameAxis__custom--OneInvestor13Member_pdd_zbmlWQ5eguYR" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-09-07_custom_OneInvestor13Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">5,000</ix:nonfraction></span> loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On September 10, 2021, the Company received
short-term $<span id="xdx_906_eus-gaap--ShortTermBorrowings_c20210910__srt--CounterpartyNameAxis__custom--OneInvestor14Member_pp0p0_zgY7hlTWpoSX" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-09-10_custom_OneInvestor14Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">25,000</ix:nonfraction></span> loan from one investor. The note carries a 10% interest rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On September 15, 2021, the Company received short-term
$<span id="xdx_90B_eus-gaap--ShortTermBorrowings_c20210915__srt--CounterpartyNameAxis__custom--OneInvestor15Member_pp0p0_zY387dvHLPCF" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-09-15_custom_OneInvestor15Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> loan from one investor. The Company issued $<span id="xdx_902_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210915__srt--CounterpartyNameAxis__custom--OneInvestor15Member_pp0p0_zaTwmApuGqL3" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-09-15_custom_OneInvestor15Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">55,000</ix:nonfraction></span> note including $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210915__srt--CounterpartyNameAxis__custom--OneInvestor15Member_zWYZiKgOmHmi" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-09-15_custom_OneInvestor15Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">5,000</ix:nonfraction></span> loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On September 16, 2021, the Company received
short-term $<span id="xdx_90D_eus-gaap--ShortTermBorrowings_c20210916__srt--CounterpartyNameAxis__custom--OneInvestor16Member_pp0p0_z8zi3OaexQRR" title="Short term loan"><ix:nonfraction name="us-gaap:ShortTermBorrowings" contextref="AsOf2021-09-16_custom_OneInvestor16Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">50,000</ix:nonfraction></span> loan from one investor. The Company issued $<span id="xdx_900_eus-gaap--ProceedsFromShortTermDebt_c20210101__20210916__srt--CounterpartyNameAxis__custom--OneInvestor16Member_pp0p0_z5rZ303XPOJW" title="Proceeds from Short-term Debt"><ix:nonfraction name="us-gaap:ProceedsFromShortTermDebt" contextref="From2021-01-012021-09-16_custom_OneInvestor16Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">55,000</ix:nonfraction></span> note including $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210101__20210916__srt--CounterpartyNameAxis__custom--OneInvestor16Member_pdd_z28BwMw5Kwgl" title="Number of restricted common stock issued for loan origination fee"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-01-012021-09-16_custom_OneInvestor16Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">5,000</ix:nonfraction></span> loan origination fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On September 30, 2021, Dr. Salkind, Chairman
of the Board and principal stockholder, converted his <span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20210101__20211231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--DrSalkindMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zOoawUnh7mTV"><ix:nonfraction name="us-gaap:ConversionOfStockSharesConverted1" contextref="From2021-01-012021-12-31_custom_DrSalkindMember_us-gaap_SeriesCPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1500</ix:nonfraction></span> shares of Series C Preferred Stock into <span id="xdx_903_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--DrSalkindMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVCoUDzNlqs6"><ix:nonfraction name="us-gaap:ConversionOfStockSharesIssued1" contextref="From2021-01-012021-12-31_custom_DrSalkindMember_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">375,000</ix:nonfraction></span> common shares and warrants
to purchase <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20211231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--DrSalkindMember__us-gaap--StatementClassOfStockAxis__custom--WarrantsMember_zfMJk1KAbq76"><ix:nonfraction name="us-gaap:ConversionOfStockSharesIssued1" contextref="From2021-01-012021-12-31_custom_DrSalkindMember_custom_WarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">375,000</ix:nonfraction></span> common shares exercisable at $48.00 per share through September 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">In the fourth quarter of 2021,
Business Capital Providers assigned one of its Merchant Agreements and related debt described above to non-affiliated third parties, which
subsequently converted $89,100 in outstanding indebtedness into 13,103 common shares pursuant to their terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On
October 19, 2021, the Company filed a Form S-1 Registration Statement (File no. 333-260364) with the Securities and Exchange
Commission to raise over $10 million dollars in an underwritten public offering. The next day the Company filed an application to
list our common stock on the NASDAQ Capital Market under the symbol “MOBQ.” This offering was completed on
December 13, 2021 and the Company retired the loans of, Talos Victory Fund, LLC and Blue Lake Partners LLC out of the gross proceeds
it received of approximately $10.3
million. All warrants issued to Talos and Blue Lake were converted on a cashless exercise basis into 24,692
common shares and 24,692 common shares, respectively. The Company issued 2,481,928
common shares and 2,807,937
warrants in connection with the public offering with the warrants exercisable at $4.98
per share. The Company also issued 5-year warrants to purchase 74,458
common shares to the Underwriters exercisable at $5.1875
per share.</p>

<ix:exclude><p id="xdx_230_zFhlgiCKuJBT" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z6CpQ5EgfGrc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zaGdKqqSq1wF" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zjMutQP2OrIv" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 69 -->
    <div id="xdx_233_z5G1wJ0ePomV" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_234_zz8aMxa4d4JV" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are outstanding commitments as of
December 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 20px; font-size: 10pt">&nbsp;</td>
    <td style="width: 20px; font-size: 10pt"><span style="font-family: Symbol; font-size: 10pt">·</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">$5,250,000 of the principal balance remaining due under the Second Amended AVNG Note is payable by the delivery of (i) 65,625 shares of the Company’s newly designated Class E Preferred Stock, which is convertible into 164,063 post-split shares the Company’s common stock, and (ii) common stock purchase warrants to purchase 82,032 shares of the Company’s common stock, at an exercise price of $48.00 post-split per share (the “AVNG Warrant”). In February of 2020 one Class E Preferred Stock shareholder converted 3,937 shares were exchanged for 9,348, post-split shares of the Company’s Common Stock.</span></td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Consulting Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On May 28, 2021, the Company entered into a consulting agreement
with Sterling Asset Management to provide business advisory services. The company will provide assistance and recommendations to help
build strategic partnerships, to provide the Company with advice regarding revenue opportunities, mergers and acquisitions. The six- month
engagement commenced on May 28, 2021. The consultant receives 2,500 restricted common shares each month of the agreement and $75,000 cash
payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">On December 13, 2021, the Company entered into a consulting agreement
with 622 Capital LLC to provide business advisory services over a term of six months. The consultant received <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20211213__20211231__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__srt--CounterpartyNameAxis__custom--Capital622Member_zMPfoqsiJOme"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-12-132021-12-31_custom_ConsultingAgreementMember_custom_Capital622Member" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">100,000</ix:nonfraction></span> shares of restricted
shares after the execution of the agreement. Also in December 2021, the Company entered into a consulting agreement with Alchemy Advisory
LLC to provide business advisory services over a term of six months. The consultant received <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20211213__20211231__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__srt--CounterpartyNameAxis__custom--AlchemyAdvisoryLlcMember_ztpAYprJB7y_zlFfXZ749OW5"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextref="From2021-12-132021-12-31_custom_ConsultingAgreementMember_custom_AlchemyAdvisoryLlcMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">100,000</ix:nonfraction></span> shares of restricted shares after
the execution of the agreement. On December 29, 2021, the Company entered into a consulting agreement with Pastel Holdings Inc. to provide
business advisory services over a term of 18 months commencing January 1, 2022. The Company is required to pay a $5,000 per month consulting
fee during the term of the agreement and it issued five-year warrants to purchase 15,000 common shares at an exercise price of $4.565
per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="MOBQ:OptionsAndWarrantsTextBlock"><p id="xdx_80D_ecustom--OptionsAndWarrantsTextBlock_z7ejnxRSTPlD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 7: <span id="xdx_82A_z0u1RsMWcOd5">OPTIONS AND WARRANTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The Company’s results for the years
ended December 31, 2021, and 2020 include employee share-based compensation expense totaling $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__us-gaap--AwardTypeAxis__custom--OptionsAndWarrantsMember_zMbNqOZJITV_zesdPpw5zflJ"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-012021-12-31_custom_OptionsAndWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">22,929,303</ix:nonfraction></span> and $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--AwardTypeAxis__custom--OptionsAndWarrantsMember_zmxxcT4dyyo5"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31_custom_OptionsAndWarrantsMember" format="ixt:numdotdecimal" decimals="0" unitref="USD">1,945,942</ix:nonfraction></span>, respectively.
Such amounts have been included in the Statements of Operations within selling, general and administrative expenses and other expenses.
No income tax benefit has been recognized in the statement of operations for share-based compensation arrangements due to a history of
operating losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The following
table summarizes stock-based compensation expense for the years ended December 31, 2021, and 2020:</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zyqlcmE0g1T_zXJ86XxzAy8N" summary="xdx: Disclosure - OPTIONS AND WARRANTS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B6_zRhOWeOP1fqW" style="display: none">Schedule of stock based compensation expense</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2020</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Employee stock-based compensation – option grants</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0_zOX0hlYkIYA1" title="Total stock-based compensation expense" style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-012021-12-31_custom_EmployeesMember_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">4,169,841</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYtpRkvYR4RQ" title="Total stock-based compensation expense" style="width: 13%; text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31_custom_EmployeesMember_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,347,048</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Employee stock-based compensation – stock grants</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_d0_c20210101__20211231__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--AwardTypeAxis__custom--StockGrantsMember_zE1BGyzCTrHS" title="Total stock-based compensation expense" style="text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-012021-12-31_custom_EmployeesMember_custom_StockGrantsMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_d0_c20200101__20201231__srt--CounterpartyNameAxis__custom--EmployeesMember__us-gaap--AwardTypeAxis__custom--StockGrantsMember_zeLDkStPJH4l" title="Total stock-based compensation expense" style="text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31_custom_EmployeesMember_custom_StockGrantsMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Non-Employee stock-based compensation – option grants</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_d0_c20210101__20211231__srt--CounterpartyNameAxis__custom--NonEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZesPBnb0cNU" title="Total stock-based compensation expense" style="text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-012021-12-31_custom_NonEmployeesMember_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_d0_c20200101__20201231__srt--CounterpartyNameAxis__custom--NonEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zdnncmtb7k3m" title="Total stock-based compensation expense" style="text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31_custom_NonEmployeesMember_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Non-Employee stock-based compensation – stock grants</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_d0_c20210101__20211231__srt--CounterpartyNameAxis__custom--NonEmployeesMember__us-gaap--AwardTypeAxis__custom--StockGrantsMember_zUDtCgXLiSws" title="Total stock-based compensation expense" style="text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-012021-12-31_custom_NonEmployeesMember_custom_StockGrantsMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_d0_c20200101__20201231__srt--CounterpartyNameAxis__custom--NonEmployeesMember__us-gaap--AwardTypeAxis__custom--StockGrantsMember_zsu0qsBdfve2" title="Total stock-based compensation expense" style="text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31_custom_NonEmployeesMember_custom_StockGrantsMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Non-Employee stock-based compensation – warrants for retirement of debt</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231__srt--CounterpartyNameAxis__custom--NonEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pp0p0_zIl4wE90eaV8" title="Total stock-based compensation expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-012021-12-31_custom_NonEmployeesMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">18,759,462</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__srt--CounterpartyNameAxis__custom--NonEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zoelWU4JOAN_z334c7N3Eehc" title="Total stock-based compensation expense" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31_custom_NonEmployeesMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">598,894</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20211231_pp0p0_zlYQfT9CqmcM" title="Total stock-based compensation expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">22,929,303</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231_zi0G0Vx0vosh" title="Total stock-based compensation expense" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">1,945,942</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table></ix:nonnumeric>

<ix:exclude><p id="xdx_23B_zl9fcZj2LICq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zKe2E7j3SdEE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zabGSAANJyIl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zc6YdsFMN4Zm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 70 -->
    <div id="xdx_237_z08ZNggxXeLJ" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td id="xdx_230_zgNghEgzsUQK" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_230_zSTnqbl64j7F" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_z7kwtpocJVsy" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zCaZOQeEjyHn" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_80C_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z9ceUTVI302d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 8: <span id="xdx_822_zyQ7h4vtXlMl">STOCK OPTION PLANS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During Fiscal 2005, the Company established,
and the stockholders approved, an Employee Benefit and Consulting Services Compensation Plan (the “2005 Plan”) for the granting
of up to 5,000 post-split non-statutory and incentive stock options and stock awards to directors, officers, consultants and key employees
of the Company. On June 9, 2005, the Board of Directors amended the Plan to increase the number of stock options and awards to be granted
under the Plan to 10,000 post-split shares. During Fiscal 2009, the Company established&nbsp;a plan of long-term stock-based compensation
incentives for selected Eligible Participants of the Company covering 10,0000 post-split shares. This plan was adopted by the Board of
Directors and approved by stockholders in October 2009 and shall be known as the 2009 Employee Benefit and Consulting Services Compensation
Plan (the “2009 Plan”). In September 2013, the Company’s stockholders approved an increase in the number of shares covered
by the 2009 Plan to 25,000 post-split shares. In February 2015, the Board approved, subject to stockholder approval within one year, an
increase in the number of shares under the 2009 Plan to 50,000 post-split shares; however, stockholder approval was not obtained within
the requisite one year and the anticipated increase in the 2009 Plan was canceled. In the first quarter of 2016, the Board approved, and
stockholders ratified a 2016 Employee Benefit and Consulting Services Compensation Plan covering 25,000 post-split shares (the “2016
Plan”) and approving moving all options which exceeded the 2009 Plan limits to the 2016 Plan. In December 2018, the Board of Directors
adopted and in February 2019. the stockholders ratified the 2018 Employee Benefit and Consulting Services Compensation Plan covering 75,000
post-split shares (the “2018 Plan”). On April 2, 2019, the Board approved the “2019 Plan” identical to the 2018
Plan, except that the 2019 Plan covers 150,000 post-split shares. The 2019 Plan required stockholder approval by April 2, 2020, in order
to be able to grant incentive stock options under the 2019 Plan. On October 13, 2021, the Board approved the “2021 Plan” identical
to the 2018 Plan, except that the 2019 Plan covers 1,100,000 post-split shares. The 2005, 2009, 2016, 2018, 2019 and 2021 plans are collectively
referred to as the “Plans.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All stock options under the Plans are
granted at or above the fair market value of the common stock at the grant date. Employee and non-employee stock options vest over
varying periods and generally expire either 5 or 10 years from the grant date. The fair value of options at the date of grant was
estimated using the Black-Scholes option pricing model. For option grants, the Company will take into consideration payments subject
to<b>&nbsp;</b>the provisions of ASC 718 “Stock Compensation”, previously Revised SFAS No. 123 “Share-Based
Payment” (“SFAS 123 (R)”). The fair values of these restricted stock awards are equal to the market value of the
Company’s stock on the date of grant, after taking into account certain discounts. The expected volatility is based upon
historical volatility of our stock and other contributing factors. The expected term is based upon observation of actual time
elapsed between date of grant and exercise of options for all employees. Previously, such assumptions were determined based on
historical data. The weighted average assumptions made in calculating the fair values of options granted during the years ended
December 31, 2021, and 2020 are as follows:</p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zY24lAUQ6SNs" summary="xdx: Disclosure - STOCK OPTION PLANS (Details - Assumptions)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B1_zI8vO0KAzRvk" style="display: none">Assumptions used</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ended <br> December 31</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Expected volatility</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zKfWjZcUqz8Y" title="Expected volatility"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">116.39</ix:nonfraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQZZ7zxPsdx3" title="Expected volatility"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextref="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">592.89</ix:nonfraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbzLxaudgpaJ" title="Expected dividend yield"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="INF" scale="-2" unitref="Pure">–</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zeYOAdH85qtY" title="Expected dividend yield"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextref="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="INF" scale="-2" unitref="Pure">–</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Risk-free interest rate</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjEcH4Vkd0Gp" title="Risk-free interest rate"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">1.28</ix:nonfraction></span></td><td style="text-align: left">%</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyvHKTTv3UtF" title="Risk-free interest rate"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextref="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">0.74</ix:nonfraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztyw2fnFIZkV" title="Expected term (in years)"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">10.00</ix:nonnumeric></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zetMxOBS17QV" title="Expected term (in years)"><ix:nonnumeric contextref="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.00</ix:nonnumeric></span></td><td style="text-align: left">&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8A6_z2E2YmFXz6OC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<ix:exclude><p id="xdx_23E_zSm7BlK9zs26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zpUfc1p5IlCO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zAbORBXhzIjy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 71 -->
    <div id="xdx_232_zoHMIPaz7hBL" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td id="xdx_238_zfrq3Ndhoozj" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_239_zcR8xfRYFsei" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_zwlDk08NxYh8" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zJFPoB4lJI8k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p></ix:exclude>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zGpY3fF7yQvd" summary="xdx: Disclosure - STOCK OPTION PLANS (Details- Option Activity)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 10pt"><span id="xdx_8B3_z57rasrGmdFR" style="display: none">Schedule of options outstanding</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Share</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br> Average <br> Exercise <br> Price</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br> Average <br> Remaining Contractual <br> Term</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic <br> Value</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Outstanding, January 1, 2021</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV4l4RLlhBpg" title="Shares outstanding - beginning" style="width: 11%; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextref="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">302,849</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXb3t2dlrVrD" title="Weighted average exercise price - beginning" style="width: 11%; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextref="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">45.85</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2Beginning_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zj3uUIPGZoMw" title="Weighted average contractural term"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="MOBQ:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2Beginning">4.65</ix:nonnumeric></span></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1DVfzBTY03d" title="Aggregate intrinsic value - beginning" style="width: 11%; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextref="AsOf2020-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 10pt">Granted</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_ztjHnYJpkNaE" title="Shares granted" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">835,000</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zntFx4onkFnX" title="Weighted average exercise price - shares granted" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">19.85</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpQwzBo1c7Uq" title="Weighted average contractural term -granted"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="MOBQ:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1">2.90</ix:nonnumeric></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_988_ecustom--AggregateIntrinsicValueGranted_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3EuYCINTpHk" title="Aggregate intrinsic value - granted" style="text-align: right"><ix:nonfraction name="MOBQ:AggregateIntrinsicValueGranted" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: 10pt">Exercised</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBlakMFijbNt" title="Shares exercised" style="text-align: right"><ix:nonfraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="INF" unitref="Shares">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zeym3mOAIyDE" title="Weighted average exercise price - shares Exercised" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="INF" unitref="USDPShares">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98D_ecustom--AggregateIntrinsicValueExercised_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5LZ4iH7eAZb" title="Aggregate intrinsic value - Exercised" style="text-align: right"><ix:nonfraction name="MOBQ:AggregateIntrinsicValueExercised" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Cancelled &amp; Expired</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbuS3Cfj7AGt" title="Shares cancelled and expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,940</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPb6ec2gmtOi" title="Weighted average exercise price - shares Cancelled" style="padding-bottom: 1pt; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="INF" unitref="USDPShares">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td id="xdx_982_ecustom--AggregateIntrinsicValueCancelledExpired_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zghr1OAEfTq7" title="Aggregate intrinsic value - Cancelled &amp; Expired" style="padding-bottom: 1pt; text-align: right"><ix:nonfraction name="MOBQ:AggregateIntrinsicValueCancelledExpired" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Outstanding, December 31, 2021</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0A47NAMwkLR" title="Shares outstanding - ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextref="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,135,909</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zadbjvQInJ4N" title="Weighted average exercise price - ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextref="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">16.69</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVTr03hK3s2j" title="Weighted average contractural term"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">8.39</ix:nonnumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zV5qsOUKNNuH" title="Aggregate intrinsic value - ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextref="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Options exercisable, December 31, 2021</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zu9DhPEQ2HUb" title="Shares exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextref="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">1,124,619</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zE1O2mePmWJS" title="Weighted average exercise price - exercisable" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextref="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">16.59</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyoAmayH1ni_zC6ZGIr8M9kR" title="Weighted average contractural term - exercisable"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">8.39</ix:nonnumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_d0_c20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDIyXfJyoZV0" title="Aggregate intrinsic value - exercisable" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextref="AsOf2021-12-31_us-gaap_StockOptionMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8A8_zJDHV1fH8cen" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted-average grant-date fair value of
options granted during the years ended December 31, 2021, and 2020 was $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pdd_zez35LTQrtVJ" title="Weighted average grant date fair value of options"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="From2021-01-012021-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">19.85</ix:nonfraction></span> and $<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zmibCQrgoy8C" title="Weighted average grant date fair value of options"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="From2020-01-012020-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">35.75</ix:nonfraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate intrinsic value of options
outstanding and options exercisable on December 31, 2021, is calculated as the difference between the exercise price of the underlying
options and the market price of the Company's common stock for the shares that had exercise prices, that were lower than the $<span id="xdx_90C_eus-gaap--SharePrice_c20211231_pdd_zY2WmBS8o51j" title="Common stock closing price"><ix:nonfraction name="us-gaap:SharePrice" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">2.13</ix:nonfraction></span> closing
price of the Company's common stock on December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the fair value
of unamortized compensation cost related to unvested stock option awards is $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20211231_pp0p0_zu86rMFGvZem" title="Unamortized compensation cost related to stock option awards"><ix:nonfraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextref="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">545,458</ix:nonfraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted average assumptions made in calculating
the fair value of warrants granted during the years ended December 31, 2021, and 2020 are as follows:&nbsp;</p>

<ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__us-gaap--WarrantMember_zL1BP4fJKfzn" summary="xdx: Disclosure - STOCK OPTION PLANS (Details - Assumptions)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B9_ziXFlhjnE38m" style="display: none">Assumptions used</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years Ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Expected volatility</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 13%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5zF6mjvB5TL" title="Expected volatility"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">175.52</ix:nonfraction></span>%</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zFIrJalUh9EA" title="Expected volatility"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextref="From2020-01-012020-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">449.47</ix:nonfraction></span>%</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z91W5hutKSKG" title="Expected dividend yield"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" scale="-2" unitref="Pure">–</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp0_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzO9l07431Tc" title="Expected dividend yield"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextref="From2020-01-012020-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" scale="-2" unitref="Pure">–</ix:nonfraction></span></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Risk-free interest rate</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfMByeMWcH6U" title="Risk-free interest rate"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">1.14</ix:nonfraction></span>%</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQKsrpTYidtM" title="Risk-free interest rate"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextref="From2020-01-012020-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitref="Pure">0.91</ix:nonfraction></span>%</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z9f1NWloLeF9" title="Expected term (in years)"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.83</ix:nonnumeric></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zMcbK7fGaA1l" title="Expected term (in years)"><ix:nonnumeric contextref="From2020-01-012020-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.83</ix:nonnumeric></span></td><td style="text-align: left">&nbsp;</td></tr>
  </tbody></table>





</ix:nonnumeric><p id="xdx_8AB_zSZ8u4pvNCA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zECZ6YHn15QT" summary="xdx: Disclosure - STOCK OPTION PLANS (Details-Warrants Outstanding)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 10pt"><span id="xdx_8B2_z2x13so8fEE1" style="display: none">Schedule of warrants outstanding</span></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Share</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br> Average <br> Exercise <br> Price</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br> Average <br> Remaining Contractual <br> Term</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Aggregate</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Intrinsic <br> Value</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Outstanding, January 1, 2021</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zbC4KCnyfQhD" title="Warrants outstanding - beginning" style="width: 11%; text-align: right"><ix:nonfraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextref="AsOf2020-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">471,557</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTFuqFsvUSSP" title="Weighted average exercise price - beginning" style="width: 11%; text-align: right"><ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextref="AsOf2020-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">52.52</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsBeginning_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zLSlUQFoLnhN" title="Weighted average contractural term"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="MOBQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsBeginning">6.31</ix:nonnumeric></span></td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpiXLgErocsT" title="Aggregate intrinsic value - beginning" style="width: 11%; text-align: right"><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextref="AsOf2020-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="0" unitref="USD">–</ix:nonfraction></td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 10pt">Granted</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd_zbG3mkMpmB18" title="Warrants granted" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,439,157</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd_zCzsohO2UMeo" title="Weighted average exercise price - shares granted" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">9.46</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsGranted_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zuFXX222ALu9" title="Weighted average contractural term - granted"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="MOBQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsGranted">4.30</ix:nonnumeric></span></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNrs1dJLli9k" title="Aggregate intrinsic value - granted" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" unitref="USDPShares">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: 10pt">Exercised</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_98E_ecustom--WarrantsExercisedShares_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zMOswdXKg0D6" title="Warrants exercised" style="text-align: right">(<ix:nonfraction name="MOBQ:WarrantsExercisedShares" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">104,262</ix:nonfraction></td><td style="text-align: left">)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zncxb8CAWomy" title="Weighted average exercise price - shares Exercised" style="text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" unitref="USDPShares">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td id="xdx_988_ecustom--AggregateIntrinsicValueExercised_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTFo9dj8j6i_zKB4z7UGsJ67" title="Aggregate intrinsic value - Exercised" style="text-align: right"><ix:nonfraction name="MOBQ:AggregateIntrinsicValueExercised" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 10pt">Expired</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUJT8mhw5sfJ" title="Warrants cancelled and expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">6,250</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zl1E1Xh9P4Tp" title="Weighted average exercise price - shares Cancelled" style="padding-bottom: 1pt; text-align: right"><ix:nonfraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="INF" unitref="USDPShares">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td id="xdx_989_ecustom--AggregateIntrinsicValueExpired_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zlE2ikCtCcM_zPLbaLrgWdVM" title="Aggregate intrinsic value - Expired" style="padding-bottom: 1pt; text-align: right"><ix:nonfraction name="MOBQ:AggregateIntrinsicValueExpired" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">Outstanding, December 31, 2021</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zIQXnd4P5B30" title="Warrants outstanding - ending" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextref="AsOf2021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,800,202</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zrmqDnjQbb2X" title="Weighted average exercise price - ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextref="AsOf2021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">15.19</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zFD0SEuJJA79" title="Weighted average contractural term"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">4.68</ix:nonnumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUZTj56Tbl8w" title="Aggregate intrinsic value - ending" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextref="AsOf2021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left">Warrants exercisable, December 31, 2021</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd_zOaBLCKHS17i" title="Warrants exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonfraction name="MOBQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="Shares">3,800,202</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValueExercisable_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd_z0KmQdlDAiYk" title="Weighted average exercise price - exercisable" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="MOBQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValueExercisable" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitref="USDPShares">15.19</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsExercisable_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zoUbeMt8d9Kc" title="Weighted average contractural term - exercisable"><ix:nonnumeric contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="MOBQ:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsExercisable">4.68</ix:nonnumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pp0p0_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zIhQanr1UqGL" title="Aggregate intrinsic value - exercisable" style="padding-bottom: 2.5pt; text-align: right"><ix:nonfraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextref="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt:zerodash" decimals="0" scale="0" unitref="USD">–</ix:nonfraction></td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

</ix:nonnumeric><p id="xdx_8A7_z9vumvY8k3X_zn1u4gWPzg0D" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<ix:exclude><p id="xdx_231_z8aIxBUlcnnN" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zpxQswXQzJQz" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z9giqa9zH6S_zbTSoR3zN4B4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 72 -->
    <div id="xdx_239_zfR9KjaVXkfl" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_230_z3tpdNj6jdS2" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td id="xdx_234_zFL2757gVkxa" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23D_zq9f879evX4y" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zqMUsLwpeB7K" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zTtYOYyk4Scm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="MOBQ:ExecutiveCompensationTextBlock"><p id="xdx_808_ecustom--ExecutiveCompensationTextBlock_z0S4F4vTvSN0" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note 9: <span id="xdx_823_zn5gUSo59TGp">EXECUTIVE COMPENSATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of Pandemic</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of our declining revenue, during the
COVID-19 pandemic, our management team decided it was necessary to reduce overhead In April of 2020, due to the COVID-19 pandemic all
employees’ salaries were reduced by 40% and we terminated one employee. In October of 2020, the employees pay reduction was reduced
to a 20% reduction through the completion of our December 2021 public offering. Several employees were laid-off or resigned, all travel
and advertising were suspended, and office space rent was suspended, allowing the entire staff to work remotely. As of December 17, 2021,
all employees’ salaries were restored to pre-pandemic levels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Employment Agreements of Executives</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Dean Julia</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dean Julia is employed as the Company’s Chief Executive
Officer under an employment agreement with an initial term of three years which commenced on April 2, 2019. The agreement automatically
renewed for an additional two years in January 2020 since the Company failed to terminate the agreement at least 90 days before termination
of the initial term. Mr. Julia’s annual base salary is $360,000. In addition to his base salary, Mr. Julia is entitled to a quarterly
bonus of at least 1% of gross revenue for each completed fiscal quarter, so long as the Company’s gross revenue meets or exceeds
75% of management’s stated goal. The quarterly bonus may be paid either in cash, common stock or stock options, at Mr. Julia’s
election. Should his employment agreement be terminated prior to the end of any fiscal year for any reason, other than for cause by the
Company, a pro rata portion of the quarterly bonus shall be paid within 30 days of termination. The Company's board of directors will
determine a revenue target each year for the purpose of calculating the quarterly bonus in that year. Mr. Julia also received a signing
bonus of vested 10-year options to purchase 62,500 shares, exercisable at $60 per share. Additionally, he is also entitled to 10-year
options to purchase an additional 12,500 shares of common stock, exercisable at $60 per share, annually on April 1<sup>st</sup> of each
year which commenced on April 1, 2020. Additionally, if the Company is acquired through a board of directors-approved change in control
of at least 50% of the Company’s outstanding voting stock, or the sale of all or substantially all of the Company’s assets,
Mr. Julia shall be entitled to receive a payment in-kind equal to 3% of the consideration paid in connection with that transaction. He
is also entitled to paid disability insurance and term life insurance at an annual cost of not more than $15,000. Additionally, he is
also entitled to receive health, dental and 401(k) benefits as is made available by the Company for its other senior officers, as well
as indemnification by the Company to the fullest extent permitted by law, and the Company’s certificate of incorporation and bylaws.
Mr. Julia also has the use of a Company-leased or -owned automobile. Mr. Julia’s employment agreement contains customary non-competition
and non-solicitation of Company customers or employees’ provisions during the term of the agreement. The Company may terminate Mr.
Julia’s employment for cause, and Mr. Julia may terminate his employment at any time on three-months’ notice. Also, the Company
may terminate Mr. Julia’s employment agreement on Mr. Julia’s death or disability – disability being unable to perform
his essential functions for four consecutive months due to physical, mental or emotional incapacity resulting from sickness, disease,
or injury. In each of these termination cases, the Company is obligated only to pay Mr. Julia amounts that were due or accrued prior to
termination, plus, other than in a for-cause-termination, any pro-rata quarterly bonus described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Paul Bauersfeld</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paul Bauersfeld is employed
as the Company’s Chief Technology Officer under an at-will employment agreement which commenced on April 2, 2019. Mr. Bauersfeld’s
monthly salary is $25,000. Mr. Bauersfeld is entitled to a quarterly bonus of at least 1% of gross revenue for each completed fiscal quarter,
so long as the Company’s gross revenue meets or exceeds management’s stated goal. The quarterly bonus may be paid either in
cash, common stock or stock options, at Mr. Bauersfeld’s election. Should his employment agreement be terminated prior to the end
of any fiscal year for any reason, other than for cause by the Company, a pro rata portion of the quarterly bonus shall be paid within
30 days of termination. The Company's board of directors will determine a revenue target each year for the purpose of calculating the
quarterly bonus in that year. Mr. Bauersfeld also received a signing bonus of 10-year options to purchase 25,000 shares, exercisable at
$60 per share; 35% of which vested immediately, 35% of which vested on April 2, 2020, and 30% of which vested on April 2, 2021. Mr. Bauersfeld
is entitled to participate in the Company’s health plans as well as indemnification by the Company to the fullest extent permitted
by law, and the Company’s certificate of incorporation and bylaws. Mr. Bauersfeld’s employment agreement contains customary
non-competition and non-solicitation of Company customers or employees’ provisions during the term of the agreement. Although Mr.
Bauersfeld’s employment agreement is at-will, the Company may terminate Mr. Bauersfeld’s employment for cause. In the event
Mr. Bauersfeld’s employment agreement is terminated other than for cause by the Company, the Company will pay Mr. Bauersfeld severance
pay equal to three months of his salary.</p>

<ix:exclude><p id="xdx_236_zCPjs7XRq1J1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_238_z0oIt8zX2i4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zSQtyQpAJTVW" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zojZrYFAcJB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 73 -->
    <div id="xdx_233_zc6EGPnLUnaO" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_23B_zZsD1wW8N8XL" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Sean Trepeta</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sean Trepeta is employed as
President of our wholly owned subsidiary, Mobiquity Networks, Inc. under an at-will employment agreement which commenced on April 2, 2019.
Mr. Trepeta’s monthly salary is $20,000. Mr. Trepeta is entitled to a quarterly bonus of at least 1% of gross revenue for each completed
fiscal quarter, so long as the Company’s gross revenue meets or exceeds management’s stated goal. The quarterly bonus may
be paid either in cash, common stock, or stock options, at Mr. Trepeta’s election. Should his employment agreement be terminated
prior to the end of any fiscal year for any reason, other than for cause by the Company, a pro rata portion of the quarterly bonus shall
be paid within 30 days of termination. The Company's board of directors will determine a revenue target each year for the purpose of calculating
the quarterly bonus in that year. Mr. Trepeta also received a signing bonus of 10-year options to purchase 25,000 shares, exercisable
at $60 per share; 35% of which vested immediately, 35% of which vested on April 2, 2020, and 30% of which vested on April 2, 2021. Mr.
Trepeta is entitled to participate in the Company’s health plans as well as indemnification by the Company to the fullest extent
permitted by law, and the Company’s certificate of incorporation and bylaws. Mr. Trepeta’s employment agreement contains customary
non-competition and non-solicitation of Company customers or employees’ provisions during the term of the agreement. Although Mr.
Trepeta’s employment agreement is at-will, the Company may terminate Mr. Trepeta’s employment for cause. In the event Mr.
Trepeta’s employment agreement is terminated other than for cause by the Company, the Company will pay Mr. Trepeta severance pay
equal to three months of his salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Deepankar Katyal</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deepankar
Katyal is employed as Chief Executive Officer of our wholly owned subsidiary, Advangelists, LLC under employment agreement with Advangelists
with a term of three years which commenced on December 7, 2018. The agreement was amended on September 13, 2019. (See Note 12 below.)
Mr. Katyal’s annual base salary is $400,000. Mr. Katyal’s employment agreement, as amended, also provides the following compensation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">a bonus, payable in cash or common stock of the Company, equal to 1% of the Company’s gross revenue for each month during the 2019 fiscal year, subject to certain revenue thresholds as set forth in the agreement. Those revenue thresholds were not attained, and this bonus was not earned;</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">commissions equal to 10% of the net revenues derived from all New Katyal Managed Accounts (as defined in the agreement – being accounts directly introduced by Mr. Katyal or assigned to Employee in writing by the Manager of the Company);</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">options to purchase 37,500 shares of the Company’s common stock at an exercise price of $36.00 per share, of which 25,000 vested on September 13, 2019, the date Mr. Katyal’s employment agreement was amended, and 12,500 vested on September 13, 2020: and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">one share of Company Series B Preferred Stock which was issued to Mr. Katyal. The Series B Preferred Stock, as a class, provided cash dividend rights, payable in cash, to the holders thereof in an aggregate amount equivalent to 10% of the annual gross revenue of Advangelists or the Company, whichever is higher, up to a maximum aggregate annual amount of $1,200,000, for each of its 2019 and 2020 fiscal years. As a holder of 50% of the Series B Preferred Stock, the maximum amount of annual dividends that Mr. Katyal would be entitled to $600,000. The Series B Preferred Stock rights, privileges, preferences, and restrictions was to terminate by its terms as of December 31, 2020; and, immediately upon declaration and payment of the dividend in respect of Mobiquity's 2020 fiscal year, Mobiquity was to withdraw such class from its authorized capital. The Series B Preferred Stock was subject to cancellation if Mr. Katyal terminated his employment without good reason or the Company terminated his employment for cause. Mr. Katyal did not receive any Series B Preferred Stock dividends and the Series B Preferred Stock was redeemed by the Company from Mr. Katyal in consideration for entering into the amendment of his employment agreement on September 13, 2019, and for no other consideration.</td></tr>
  </tbody></table>
<ix:exclude><p id="xdx_23C_zngSkE0VmsUV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zBGIVZGk3qGO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_znweMlXFtAA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zFoyWlpEcyI1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<ix:exclude><!-- Field: Page; Sequence: 74 -->
    <div id="xdx_236_zqtj7XtQS0sX" style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_231_z2f9cCz1k3Bu" style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During
the term of the employment agreement, Mr. Katyal is entitled to a monthly allowance of up to $550 per month to cover lease or purchase
finance costs of an automobile. Mr. Katyal’s employment agreement provides for indemnification by the Company to the fullest extent
permitted by the Company’s certificate of incorporation and bylaws, as well as participation in all benefit plans, programs and
perquisites as are generally provided by Advangelists to its employees, including medical, dental, life insurance, disability and 401(k)
participation. Mr. Katyal’s employment agreement contains customary non-solicitation of Company customers or employees’ provisions
during the term of the agreement and for one year after termination. The agreement provides for termination by Advangelists for cause
upon 30 days’ prior written notice: and without cause after 60 days’ prior written notice. The employment agreement terminates
automatically upon Mr. Katyal’s death, and it may also be terminated by Advangelists if Mr. Katyal is disabled for more than six
consecutive months in any 12-month period—disability being the inability to substantially perform Mr. Katyal's duties and responsibilities
by reason of mental or physical illness or injury. Mr. Katyal is entitled to terminate the agreement for “good reason”. If
Mr. Katyal is terminated by Advangelists for cause, Advangelists is obligated only to pay Mr. Katyal amounts of base salary and expense
reimbursements that were due or accrued prior to the termination date. If Mr. Katyal is terminated by Advangelists without cause, and
provided Mr. Katyal is not in breach under the agreement, Advangelists is obligated to pay Mr. Katyal his compensation and expense reimbursements
that would be payable to Mr. Katyal for the remainder of the contractual employment term had Mr. Katyal remained an employee. If Mr. Katyal’s
employment is terminated as a result of his death, Advangelists is obligated to pay Mr. Katyal his salary though the date of termination,
and his other compensation for the remainder of the contractual employment term had Mr. Katyal remained an employee. If Mr. Katyal’s
employment is terminated as a result of his disability, provided Mr. Katyal provides a general release, Advangelists is obligated to pay
Mr. Katyal his salary though the date of termination, and his other compensation for the remainder of the contractual employment term
had Mr. Katyal remained an employee. If Mr. Katyal terminates his employment for good reason, and provided Mr. Katyal provides a general
release, Advangelists is obligated to pay Mr. Katyal his compensation and expense reimbursements that would be payable to Mr. Katyal for
the remainder of the contractual employment term had Mr. Katyal remained an employee. Mr. Kaytal’s employment agreement provides
for assignment of ownership rights regarding intellectual property created by Mr. Katyal relating to the Company’s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Sean McDonnell</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sean
McDonnell is employed as the Company’s Chief Executive Officer on a non-full-time basis as an employee at-will with no employment
agreement. He has a monthly base salary of $11,000 and he is eligible to receive options and other bonuses at the discretion of the board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LegalMattersAndContingenciesTextBlock"><p id="xdx_80C_eus-gaap--LegalMattersAndContingenciesTextBlock_zGXfqyS1SSda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTE 10: <span id="xdx_82A_zVrTRIuEfy10">LITIGATION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not a party to any pending material legal
proceedings. The following matters were settled in the past two fiscal years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington Prime Group, Inc. (“WPG”), a successor
in interest to Simon Property Group, L.P., commenced an action in the Marion Superior Court, County of Marion, State of Indiana against
the Company in February 2020 alleging default on 36 commercial leases which the Company had entered into in 36 separate shopping mall
locations across the United States for the placement of Mobiquity’s Bluetooth messaging system equipment in the shopping malls to
send advertisements through to shoppers’ phones as they walked through mall common areas. WPG alleged damages from unpaid rent of
$892,332. WPG sought a judgment from the court to collect the claimed unpaid rent plus attorneys’ fees and other costs of collection.
The Company disputed the claim. On September 18, 2020, the parties entered into a settlement agreement with respect to this lawsuit. Under
the settlement agreement, Mobiquity paid WPG $100,000.00 in five $20,000 monthly installments ending in January 2021 and mutual general
releases were exchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, Carter, Deluca &amp; Farrell LP, a law firm,
commenced an action in the Supreme Court of New York, County of Nassau, against the Company seeking $113,654 in past due legal fees allegedly
owed. The Company disputed the amount owed to that firm. On March 13, 2021 the Company entered into a settlement agreement with the law
firm and paid them $60,000 to settle the lawsuit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<ix:exclude><p id="xdx_23C_zHx4EcBfOrPq" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zmgNqHAceSPt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zNVF3IsSWaHK" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 75 -->
    <div id="xdx_235_zd0iIiOwKRBf" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td id="xdx_237_zjNd90BGeYEy" style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div id="xdx_234_zxuY0Rr7E3ey" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zD2dVQ96EZhv" style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zas7VaUrktys" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2020, Fyber Monetization, an Israeli company in the business
of digital advertising, commenced an action against the Company’s wholly owned subsidiary Advangelists LLC in the Magistrate’s
Court in Tel Aviv, Israel. In its statement of claim, Fyber alleged that Advangelists owes Fyber license fees of $584,945 invoiced in
June through November 3, of 2019 under a February 1, 2017, license agreement for the use of Fyber’s RTB technology and e-commerce
platform with connects digital advertising media buyers and media sellers. In March 2022, this lawsuit was settled with the Company paying
$<span id="xdx_904_eus-gaap--LitigationSettlementExpense_pp0p0_c20220101__20220331__srt--LitigationCaseAxis__custom--FyberMonetizationMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5iMleYi4u37"><ix:nonfraction name="us-gaap:LitigationSettlementExpense" contextref="From2022-01-012022-03-31_custom_FyberMonetizationMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">120,000</ix:nonfraction></span> to Plaintiff.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2020, FunCorp Limited, a Cypriot company which owns and
operates social networking websites and mobile applications, commenced an action against the Company’s wholly owned subsidiary Advangelists
LLC in Superior Court, State of Washington, County of King alleging Advangelists owed FunCorp for unpaid amounts due under an insertion
order for placement of Advangelists’ advertisements on FunCorp’s iFunny website totaling $42,464 plus legal fees. Advangelists
disputed the claim. In September 2021 the action was settled in payment of <span id="xdx_90C_eus-gaap--LitigationSettlementExpense_pp0p0_c20210101__20211231__srt--LitigationCaseAxis__custom--AdvangelistsMember_z6IXH0QcyR6S">$<ix:nonfraction name="us-gaap:LitigationSettlementExpense" contextref="From2021-01-012021-12-31_custom_AdvangelistsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitref="USD">44,000</ix:nonfraction></span> and the exchange of general releases, without Advangelists
admitting any liability. The settlement agreement provides that the terms of the settlement agreement and FunCorp’s allegations
are confidential and may not be disclosed except as required by law, court order or subpoena with certain limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

</ix:nonnumeric><ix:nonnumeric contextref="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zbityn6txzGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOTE 11: <span id="xdx_828_zmoLwIcw4Zx6">SUBSEQUENT EVENTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, Don Walker (“Trey”)
Barrett III accepted the position of Chief Operations and Strategy Officer of Mobiquity Technologies, Inc. The Company entered into an
Employment Agreement with Mr. Barrett, effective as of January 1, 2022, for an initial term of two years, which may be renewed for successive
one-year terms, with an annual salary of $275,000. Mr. Barrett will be entitled to an annual bonus of up to 100% of his annual salary
each year based on the attainment of performance standards, targets or goals which will be mutually agreed upon by the Company and Mr.
Barrett. Mr. Barrett was granted non-statutory options to purchase up to 150,000 shares of common stock, at a price of $4.565 per share
out of the Company’s 2021 Employee Benefit and Consulting Services Compensation Plan. The options will vest in three substantially
equal annual installments of 50,000 shares each on the first, second and third anniversaries of the date of the Employment Agreement provided
Mr. Barrett is employed by the Company on those dates, subject to acceleration if Mr. Barrett is terminated without cause, he resigns
for good reason, or certain change of control events occur. Additionally, Mr. Barrett was granted 25,000 shares of restricted stock as
a signing bonus pursuant to his Employment Agreement, and not out of any other plan, which will vest in full on the six-month anniversary
of the date of his Employment Agreement provided he is employed by the Corporation on that date. Mr. Barrett’s employment Agreement
contains customary provisions permitting the Company to terminate Mr. Barrett’s employment for cause or Mr. Barrett’s disability
and entitling Mr. Barrett to terminate his employment for good reason, before the end of the contractual employment period. Under the
Employment Agreement, Mr. Barrett would be entitled to payment of an amount equivalent to his annual salary for a period of 12 months
after termination if his employment is terminated by the Company without cause or due to his disability, or Mr. Barrett terminates his
employment for good reason. Additionally, if Mr. Barrett’s employment is not renewed at the end of the initial employment period
or any renewal period, Mr. Barrett would be entitled to payment of an amount equivalent to his annual salary for a period of nine months
after termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, the Company entered into a new one-year employment
agreement with Deepankar Katyal. His compensation and benefits under the new contract have not changed from the Agreement summarized in
Note 10 above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 18, 2022, the Company terminated the
Employment Agreement of Don (Trey) W. Barrett III for cause, and it will not incur any material early termination penalties <span style="background-color: white">(due
to the fact the termination was for cause)</span>. His employment Agreement is summarized above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 17, 2022, Anthony Iacovone resigned from
the Company’s board of directors for personal reasons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 18, 2022, Anne S. Provost was elected
to the board of directors to serve as an independent director and as a financial expert. Ms. Provost was also nominated to replace Mr.
Iacovone on all three board committees, which consist of an Audit Committee, Compensation Committee and Nominating and Corporate Governance
Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 18, 2022, the board of directors approved
the payment of $1,000 per month to be paid to each member of the board of directors for serving on the board and any committees thereof.</p>

</ix:nonnumeric><p id="xdx_817_zdLOpBGWDabB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_016"></span>Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_017"></span>Item 9A. Controls and Procedures</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the supervision and with the participation
of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure
controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based on that
evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are
not effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Report of Management on Internal Control over Financial Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management is responsible for establishing
and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process
to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting
principles generally accepted in the United States of America. Internal control over financial reporting includes maintaining records
that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded
as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures of company assets
are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition
of company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because
of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement
of our financial statements would be prevented or detected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management conducted an evaluation
of the effectiveness of our internal control over financial reporting based on the framework in <i>Internal Control – Integrated
Framework (2013) </i>issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management
concluded that the company’s internal control over financial reporting was not effective as of December 31, 2021. There were no
significant changes in our internal control over financial reporting during the year ended December 31, 2021 that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting. Our independent auditors have not audited
and are not required to audit this assessment of our internal control over financial reporting for the fiscal year ended December 31,
2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><i>Internal Controls Remediation
Efforts</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span>&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>We
are working to remediate the deficiencies and material weaknesses in our internal controls. We are taking steps to enhance our internal
control environment establish and maintain effective disclosure and financial controls and procedures, internal control over financial
reporting and changes in corporate governance., In this regard, the Company will be adopting several corporate governance policies and
it has established various committees of the Board of Directors, including an Audit Committee comprised of three independent directors
in accordance with Nasdaq Rule 5605(c)(2), which will take effect at the time that our registration statement of which this prospectus
is a part becomes effective. One of the Audit Committee’s priorities will be to begin the process of segregating tasks and processes
to ensure proper internal controls. In connection with this process, the Company plans to implement the following initiatives under the
oversight of the Audit committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 72px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>Hire additional staff to the Finance department with sufficient GAAP experience. </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Implement ongoing training in U.S. GAAP requirements for our CFO and accounting and other finance personnel. </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Hire a consultant to assist in internal control review, testing of procedures and processes, and analysis as described below.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Initiate a preliminary assessment of management’s internal controls over financial reporting. </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>Improve documentation of existing internal controls and procedures and train personnel to help ensure they are properly followed.
    </td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have hired Refidential
One - SOX Consultants who have set up a time table to review testing procedures and analysis as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt; text-align: justify">Phase 1, which shall be completed on or about
the Company filing its form 10-K for December 31, 2021, will be to identify the gaps and suggested remediations in 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt; text-align: justify">Phase 2, to be completed on or about June 30,2022,
(contingent upon the Company implementing remediation plan) will have all the narratives updated and risk control matrixes (“RCM”)
created and available for testing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Phase 3, to commence
on or about July 15th, 2021 and to be completed for the third quarter ending September 30,2022, will include the testing of all the key
controls identified, implemented in Phases 1 and 2 above</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Phase 4, if necessary,
will be to retest the failures in Phase 3. Phase 4 testing enables MOBI to rectify any fails from Phase 3 testing, thus reducing the
likelihood of significant deficiencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we plan to undertake and complete this
remediation process as quickly as possible, we are unable, at this time to estimate how long it will take; and our efforts may not be
successful in remediating the deficiencies or material weaknesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b><span style="text-decoration: underline"><span id="a_018"></span>Item 9B.&nbsp;Other Information</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_019"></span>PART III</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_020"></span>Item 10. Directors, Executive Officers and
Corporate Governance</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information with respect
to our officers, directors, and significant employees as of the date of this Form 10-K:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 23%"><b>NAME </b></td>
    <td style="width: 5%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 5%"><b>AGE</b></td>
    <td style="width: 5%">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 62%"><b>POSITION</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Dean L. Julia</td>
    <td>&nbsp;</td>
    <td style="text-align: center">54</td>
    <td>&nbsp;</td>
    <td>Chief Executive Officer/President/Treasurer/Director/Co-Founder/Secretary</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Paul Bauersfeld</td>
    <td>&nbsp;</td>
    <td style="text-align: center">58</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Chief Technology Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Sean J. McDonnell, CPA</td>
    <td>&nbsp;</td>
    <td style="text-align: center">61</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Chief Financial Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Sean Trepeta</td>
    <td>&nbsp;</td>
    <td style="text-align: center">54</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">President of Mobiquity Networks /Secretary of the Company</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Dr. Gene Salkind, M.D.</td>
    <td>&nbsp;</td>
    <td style="text-align: center">69</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Chairman of the Board of Directors</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deepanker Katyal</td>
    <td>&nbsp;</td>
    <td style="text-align: center">36</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Chief Executive Officer of Advangelists</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Company is governed by our board. Directors
are elected at the annual meeting of stockholders and hold office until the following annual meeting. The terms of all officers expire
at the annual meeting of directors following the annual stockholders meeting. Officers serve at the pleasure of our board of directors
and may be removed, either with or without cause, by our board of directors, and a successor elected by a majority vote of our board of
directors, at any time. Nevertheless, the foregoing is subject to the employment contracts of our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Independent Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b>Currently we have three independent directors identified
in the table below and all standing committees of our board of directors will be composed either entirely of independent directors, in
each case under NASDAQ’s independence definition applicable to boards of directors, or a majority of independent directors with
a non-independent director as and to the extent permitted under NASDAQ’s listing rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><b>NAME </b></td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>AGE</b></td>
    <td>&nbsp;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>POSITION</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 23%">&nbsp;</td>
    <td style="width: 5%">&nbsp;</td>
    <td style="width: 5%; text-align: center">&nbsp;</td>
    <td style="width: 5%">&nbsp;</td>
    <td style="width: 62%">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Peter L. Zurkow</td>
    <td>&nbsp;</td>
    <td style="text-align: center">68</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Director </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Michael A. Wright</td>
    <td>&nbsp;</td>
    <td style="text-align: center">59</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Director </td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Anne S. Provost</td>
    <td>&nbsp;</td>
    <td style="text-align: center"><span>57</span></td>
    <td>&nbsp;</td>
    <td style="text-align: justify">Director<span style="font-size: 10pt">&nbsp;</span></td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a director to be considered independent, our
board of directors must determine that the director has no relationship which, in the opinion of our board, would interfere with the exercise
of independent judgment in carrying out the responsibilities of a director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Business Experience of our Directors, Officers and Significant
Employees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dean L. Julia</i>. </b>Mr. Julia works at
Mobiquity Technologies, Inc. where he has served as its Chief Executive Officer since December 2000. Mr. Julia co-founded Mobiquity in
1998. Mr. Julia is responsible for establishing our overall strategy and fostering key relationships with technology partners and developers.
Mr. Julia also works at Mobiquity Networks, Inc., Mobiquity’s wholly owned subsidiary, since its formation in 2011. Mr. Julia is
responsible for the integration of the sales and intellectual property departments of Mobiquity. From September 1996 through February
1998, Mr. Julia served as President and Chief Executive Officer of DLJ Consulting, a financial intermediary consultant for public and
private companies. Mr. Julia has served on the board since its inception. Mr. Julia is a graduate of Hofstra University with a Bachelor
of Business Administration in 1990. Except for Mobiquity Technologies, Inc., Mr. Julia does not hold, and has not previously held, any
directorships in any publicly traded reporting companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Paul Bauersfeld</i></b>. Mr. Bauersfeld
works at Mobiquity Technologies, Inc. where he has served as the Chief Technology Officer since June 2013. From 2003 to 2013, he worked
at Varsity Networks, an online media and services company dedicated to serving the local sports market through technology, which he founded
and where he served as its Chief Executive Officer. From 2000 to 2001, he worked at MessageOne, where he served as its Chief Executive
Officer. From 1999 to 2000, he worked at Ziff-Davies where he served as its Vice President of eCommerce. From 1997 to 1999, he worked
at Viacom’s Nickelodeon Online, where he served as its Technology Director. From 1996 to 1997, he worked at GiftOne, where he served
as its President. From 1988 to 1993, he worked at Apple Computer where he served in various engineering positions. From 1986 to 1988 he
worked at Xerox Corporation. Mr. Bauersfeld brings over 20 years of knowledge and experience as an executive, engineer and entrepreneur
in the technology, and software product development industries. His experience in these industries will help the company develop its products
and technologies. Mr. Bauersfeld is a graduate of the Rochester Institute of Technology with a B.S. in Electrical Engineering in 1986.
Mr. Bauersfeld does not hold, and has not previously held, any directorships in any publicly traded reporting companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sean
J. McDonnell, CPA</i></b>. Mr. McDonnell works at Mobiquity Technologies, Inc. where he has served as the Chief Financial Officer since
January 2005. From January 1990 to present, he has owned and operated Sean J. McDonnell CPA, P.C., a private accounting and tax practice.
From 1985 to 1990, he worked at Breiner &amp; Bodian CPAs where he served as a senior staff member. Mr. McDonnell brings knowledge and
experience in the accounting, finance and tax industries. Mr. McDonnell is a graduate of Dowling College with a Bachelor of Business Administration
in 1984. Mr. McDonnell does not hold, and has not previously held, any directorships in any reporting companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sean Trepeta</i></b>. Mr. Trepeta
works at our wholly owned subsidiary, Mobiquity Networks, Inc. where he has served as President since January 2011. He is also the
Secretary of the Company since November 2021. From 2007 to 2011, he worked at Varsity Networks where he served as its President.
From 1998 to 2007, Mr. Trepeta worked at OPEX Communications, Inc., a telecommunication service provider specializing in traditional
long-distance, wireless, and dedicated services, where he served as its President. From 1996 to 1998 he worked at U.S. Buying Group,
Inc., where he served as Vice President of Sales and Marketing and was responsible for developing a small business-buying program,
which included value added services such as overnight shipping, office supplies, and computer software products, as well as a full
line of telecommunications services. Mr. Trepeta also developed and implemented the agent and carrier divisions of U.S. Buying
Group. Mr. Trepeta brings 25 years of knowledge and experience in sales and marketing to our Company to help us grow sales and
develop marketing strategies. Mr. Trepeta is a graduate of the State University of New York at Cortland with a B.S. in Education in
1990. Except for Mobiquity Technologies, Inc., Mr. Trepeta does not hold, and has not previously held, any directorships in any
publicly traded reporting companies. We plan to have a board of directors comprised of five members, including three independent
directors if and when we are approved to have our common stock listed on the NASDAQ Capital Market. Mr. Trepeta is expected to
resign from the board if this occurs, on the listing date of our common stock on the Nasdaq Capital Market to accommodate this board
restructure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gene Salkind,
M.D. </i></b>Dr. Salkind has served as a director of Mobiquity since January 2019 and Chairman of our board of directors since October
2019. Dr. Salkind is a prominent practicing neurosurgeon, and he has been a shareholder and has worked as President of Bruno &amp; Salkind
M.D. P.C. since 1985. He has also worked at Holy Redeemer Hospital where he is the Chief of Neurosurgery, a position he has held since
2001. Dr. Salkind is board certified in neurological surgery by the American Board of Neurological Surgery. He served as Chief of Neurosurgery
of Albert Einstein Medical Center in Philadelphia from 1997 to 2002, and of Jeanes Hospital in Philadelphia from 1990 to 2000. In addition
to Dr. Salkind’s medical career, he is a tech-company investor, with experience guiding small and micro-cap companies in their development
and growth, including up-listings to national securities exchanges. His experience will help the Company with its business growth and
corporate finance strategies. Dr. Salkind is a graduate of Lewis Katz School of Medicine at Temple University with a Doctor of Medicine
in 1979. Dr. Salkind is a graduate of the University of Pennsylvania with a B.A. in Biology, <i>cum laude</i> in 1974. From 2021 to present,
Dr. Salkind has served as a director at Grove Holdings, Inc., which expects to be a publicly traded company in sixty to ninety days. From
2018 to present, Dr. Salkind has served as a director at CURE Pharmaceutical Holding Corp., a publicly traded company. From 2014 to 2020,
Dr. Salkind served as a director at Dermtech Intl., a publicly traded company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Deepanker Katyal.
</i></b>Mr. Katyal works at the Company’s wholly owned subsidiary, Advangelists, LLC where he has served as the Chief Executive
Officer since the 2017 (prior to the Company’s acquisition of an interest in Advangelists by merger in November 2018). From January
2017 to present, he has also served as an advisor providing business and product advice to Q1media, a digital media services company.
Additionally, from 2016 to present, he has served as a strategic advisor to Silicon Valley Stealth Mode Products, a private company. From
May 2016 to April 2017, he served as a strategic advisor to Airupt Inc., a mobile marketing platform for brands. From May 2016 to March
2017, he was head of Partnership and Strategy for Adtile Technologies, a mobile publishing and advertising solution company. From November
2015 to 2016, he served as a strategic advisor to Moonraft Innovation Labs, a company that creates customer experiences to differentiate
the entities’ clients in the market by creating and designing interactive experiences across physical and digital customer touch
points. From April 2014 to May 2016, he also served as a member of the innovation team at Opera Mediaworks, a mobile advertising platform
company. Mr. Katyal brings knowledge and experience in software engineering, leading business development efforts, strategic partnerships,
and product development and strategy. His experience will help the Company grow and develop its technology and product strategies. Mr.
Katyal was a director of our Company from December 2018 following our merger transaction with Advangelists until May 2020, when he stepped
down from that position to attend to family matters and focus his working-time commitment on running the day-to-day operations of Advangelists.
He does not hold any directorships in any publicly traded reporting companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Business Experience of our Independent
Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Peter L. Zurkow</i></b>. Mr. Zurkow serves
as a consultant to Sustainability Industries since 2019. From 2014 to 2019, he worked at Perpetual Recycling Solutions LLC where he served
as the Chief Executive Officer and the head of sales and raw materials procurement. <span style="background-color: white">From 2011 to
2013</span>, <span style="background-color: white">Mr. Zurkow worked at Britton Hill Capital where he served as Managing Director and
Head of Corporate Finance. From 2010 to 2012, Mr. Zurkow worked at Advanced Brain Technologies where he served as Acting EVP and Director
of Finance and Business Development. Prior to that Mr. Zurkow worked in management positions in investment banking, fixed income and asset
management as various securities firms and funds. </span>Mr. Zurkow brings knowledge and experience in corporate finance, financial matters,
and investments, with a background in law. His experience will help the Company with its corporate financing strategies and financial
matters. Mr. Zurkow is a graduate of Harvard College, with an A.B., <i>cum laude</i>, in 1975 and a graduate of Syracuse University College
of Law, with a J.D., <i>magna cum laude</i>, in 1978. From 2012 to 2014, Mr. Zurkow served as a director and member of the audit committee
for National Holdings Corporation, a public company until it was acquired by Fortress Biotech. From 1992 through 2005 Mr. Zurkow served
as director (and Chairman of the Board from 1999 to 2002) of Penn Traffic, a public company until it acquired by Giant Eagle and Tops Markets.
From 1996 to 1998 he served as a Director of Streamline, Inc., a former public company. From 1994 through 1996 Mr. Zurkow served as a
director and representative of majority investor for Kash n’ Karry Supermarkets, then a public company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Michael
A. Wright</i>. </b>Mr. Wright works at Seiden Krieger Associates, where he has served as an Executive Vice President and the head of Human
Resources and Diversity Practice since 2021. From 2009 to 2019, Mr. Wright worked at Covanta Holding Corporation where he served as Chief
Human Resources Officer. From 1984 to 2008, Mr. Wright worked at the Atria family of companies (Kraft and Philip Morris) where he served
in various roles including Vice President of Human Resources and HR Technology. Mr. Wright brings knowledge and experience in human resources,
human resources technology and diversity. </span>Mr. Wright is a graduate of North Carolina State University, with a B.S. in 1984, and
a graduate of Columbia University with an MBA in 1996. <span style="background-color: white">Mr. Wright currently serves as the Chair of
the HR/Legal committee and Vice Chair of the Board of Directors of the YMCA of Greater Monmouth County. He is also a member of the Board
of Trustees and President of the Advisory Council for Lunch Break.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b><i>Anne
S. Provost</i></b></span>&nbsp;has been employed full-time with TNR Technical, Inc. in various capacities since 1996. She has served as
its Chief Financial Officer since 2008 and was recently elected as Acting President. Prior to TNR, she worked as a Business Manager with
the Orlando Business Journal. She graduated from the University of Central Florida in 1991 with a BSBA, Accounting. She completed her
undergraduate degree while working full-time in the accounting departments of various Orlando law firms. In 2008, she obtained an Executive
MBA from the University of Central Florida.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There
are no family relationships among any of our executive officers and directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Attendance at Meetings </b><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors conducts
its business through meetings, both in person and telephonic, and by actions taken by written consent in lieu of meetings. During the
year ended December 31, 2021, our board of directors held meetings and acted through unanimous written consents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors encourages
all directors to attend our future annual meetings of stockholders unless it is not reasonably practicable for a director to do so.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Governance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our
business, property and affairs are managed by, or under the direction of, our Board, in accordance with the New York Business Corporation
Law and our by-laws. Members of the Board are kept informed of our business through discussions with the Chief Executive Officer and other
key members of management, by reviewing materials provided to them by management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to
review our corporate governance policies and practices by comparing our policies and practices with those suggested by various groups
or authorities active in evaluating or setting best practices for corporate governance of public companies. Based on this review, we have
adopted, and will continue to adopt, changes that the Board believes are the appropriate corporate governance policies and practices for
our Company. We have adopted changes and will continue to adopt changes, as appropriate, to comply with the Sarbanes-Oxley Act of 2002
and subsequent rule changes made by the SEC, and the listing rules of the NASDAQ Capital Market and any applicable securities exchange.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Qualifications and Diversity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
board seeks independent directors who represent a diversity of backgrounds and experiences that will enhance the quality of the board’s
deliberations and decisions. Candidates shall have substantial experience with one or more publicly traded companies or shall have achieved
a high level of distinction in their chosen fields. The board is particularly interested in maintaining a mix that includes individuals
who are active or retired executive officers and senior executives, particularly those with experience in the finance and capital market
industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In evaluating nominations
to the board of directors, our board also looks for certain personal attributes, such as integrity, ability and willingness to apply sound
and independent business judgment, comprehensive understanding of a director’s role in corporate governance, availability for meetings
and consultation on Company matters, and the willingness to assume and carry out fiduciary responsibilities. Qualified candidates for
membership on the board will be considered without regard to race, color, religion, sex, ancestry, national origin, or disability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>Oversight
of Risk Management</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risk
is inherent with every business, and how well a business manages risk can ultimately determine its success. We face a number of risks,
including economic risks, financial risks, legal and regulatory risks and others, such as the impact of competition. Management is responsible
for the day-to-day management of the risks that we face, while our board, as a whole and through its committees, has responsibility for
the oversight of risk management. In its risk oversight role, our board of directors is responsible for satisfying itself that the risk
management processes designed and implemented by management are adequate and functioning as designed. Our board of directors assesses
major risks facing our Company and options for their mitigation in order to promote our stockholders’ interests in the long-term
health of our Company and our overall success and financial strength. A fundamental part of risk management is not only understanding
the risks a company faces and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate
for us. The involvement of our full board of directors in the risk oversight process allows our board of directors to assess management’s
appetite for risk and also determine what constitutes an appropriate level of risk for our Company. Our board of directors regularly includes
agenda items at its meetings relating to its risk oversight role and meets with various members of management on a range of topics, including
corporate governance and regulatory obligations, operations and significant transactions, risk management, insurance, pending and threatened
litigation and significant commercial disputes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our board of directors
is ultimately responsible for risk oversight, we plan to establish various committees of our board of directors to oversee risk management
in their respective areas and regularly report on their activities to our entire board of directors. In particular, the Audit Committee
will have the primary responsibility for the oversight of financial risks facing our Company. The Audit Committee’s charter will
provide that it will discuss our major financial risk exposures and the steps we have taken to monitor and control such exposures. Our
board of directors will also delegate primary responsibility for the oversight of all executive compensation and our employee benefit
programs to the Compensation Committee. The Compensation Committee will strive to create incentives that encourage a level of risk-taking
behavior consistent with our business strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the division
of risk management responsibilities described above is an effective approach for addressing the risks facing our Company and that our
board’s leadership structure provides appropriate checks and balances against undue risk taking.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our
board of directors has adopted a code of ethical conduct that applies to our principal executive officer, principal financial officer
and senior financial management. This code of ethical conduct is embodied within our Code of Business Conduct and Ethics, which applies
to all persons associated with our Company, including our directors, officers and employees (including our principal executive officer,
principal financial officer, principal accounting officer and controller). In order to satisfy our disclosure requirements under the Exchange
Act, we will disclose amendments to, or waivers of, certain provisions of our Code of Business Conduct and Ethics relating to our chief
executive officer, chief financial officer, chief accounting officer, controller or persons performing similar functions on our website
promptly following the adoption of any such amendment or waiver. The Code of Business Conduct and Ethics provides that any waivers of,
or changes to, the code that apply to the Company’s executive officers or directors may be made only by the Audit Committee. In
addition, the Code of Business Conduct and Ethics includes updated procedures for non-executive officer employees to seek waivers of the
code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Leadership Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the Company's
by-laws, the Chairman of the Board presides at all meetings of the board. Currently, the Chief Executive Officer is held by a person who
is not the Chairman. The Company has no fixed policy with respect to the separation of these titles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Committees of our board of directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our
board of directors has established and delegated certain responsibilities to its Audit Committee, Compensation Committee and Nominating
and Corporate Governance Committee, effective December 8, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On
December 8, 2021, we have established a separately designated Audit Committee in accordance with Section 3(a)(58)(A) of the Exchange Act.
The Audit Committee’s primary duties and responsibilities include monitoring the integrity of our financial statements, monitoring
the independence and performance of our external auditors, and monitoring our compliance with applicable legal and regulatory requirements.
The functions of the Audit Committee also include reviewing periodically with our independent registered public accounting firm the performance
of the services for which they are engaged, including reviewing the scope of the annual audit and its results, reviewing with management
and the auditors the adequacy of our internal accounting controls, reviewing with management and the auditors the financial results prior
to the filing of quarterly and annual reports, reviewing fees charged by our independent registered public accounting firm and reviewing
any transactions between our Company and related parties. Our independent registered public accounting firm reports directly and is accountable
solely to the Audit Committee. The Audit Committee has the sole authority to hire and fire the independent registered public accounting
firm and is responsible for the oversight of the performance of their duties, including ensuring the independence of the independent registered
public accounting firm. The Audit Committee also approves in advance the retention of, and all fees to be paid to, the independent registered
public accounting firm. The rendering of any auditing services and all non-auditing services by the independent registered public accounting
firm is subject to prior approval of the Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee
will operate under a written charter. The Audit Committee is required to be composed of directors who are independent under the rules
of the SEC and the listing standards of the NASDAQ Stock Market. The SEC’s independence requirement provides that members of the
Audit Committee may not accept directly or indirectly any consulting, advisory or other compensatory fee from us or any of our subsidiaries
other than their directors’ compensation. In addition, under SEC rules, an Audit Committee member who is an affiliate of the issuer
(other than through service as a director) cannot be deemed to be independent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Audit Committee are Peter Zurkow,
the Chairperson of the Audit Committee, Michael Wright and Anne S. Provost These directors have been determined by the board of directors
to be independent under the NASDAQ listing standards and rules adopted by the SEC applicable to audit committee members when they become
directors. The board of directors has determined that Mr. Zurkow qualifies as an “audit committee financial expert” under
the rules adopted by the SEC and the Sarbanes Oxley Act. The term “Financial Expert” is defined under the Sarbanes-Oxley Act
of 2002 as a person who has the following attributes: an understanding of generally accepted accounting principles and financial statements;
has the ability to assess the general application of such principles in connection with the accounting for estimates, accruals and reserves;
experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting
issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the company’s
financial statements, or experience actively supervising one or more persons engaged in such activities; an understanding of internal
controls and procedures for financial reporting; and an understanding of audit committee functions. The Audit Committee held its first
meeting in March 2022 prior to the filing of this Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Compensation Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through the efforts of our Compensation Committee,
the Company has partnered with PricewaterhouseCoopers (PwC), <span style="background-color: white">a multinational professional services
network and one of the Big Four accounting firms,</span> to provide the Company with advice and support for its Executive Compensation
program. PwC will assess Mobiquity’s compensation philosophy as well as its executive compensation programs in an effort to ensure
the competitiveness and strategic alignment of executive pay.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary duties and responsibilities of the Compensation Committee
are to review, modify and approve the overall compensation policies for the Company, including the compensation of the Company’s
Chief Executive Officer and other senior management; establish and assess the adequacy of director compensation; and approve the adoption,
amendment and termination of the Company’s stock option plans, pension and profit-sharing plans, bonus plans and similar programs.
The Compensation Committee may delegate to one or more officers the authority to make grants of options and restricted stock to eligible
individuals other than officers and directors, subject to certain limitations. Additionally, the Compensation Committee will have the
authority to form subcommittees and to delegate authority to any such subcommittee. The Compensation Committee will also have the authority,
in its sole discretion, to select, retain and obtain, at the expense of the Company, advice and assistance from internal or external
legal, accounting or other advisors and consultants. Moreover, the Compensation Committee will have the sole authority to retain and
terminate any compensation consultant to assist in the evaluation of director, Chief Executive Officer or senior executive compensation,
including sole authority to approve such consultant’s reasonable fees and other retention terms, all at the Company’s expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee
will operate under a written charter. All members of the Compensation Committee must satisfy the independence requirements of NASDAQ applicable
to Compensation Committee members. In determining the independence of members of the Compensation Committee, NASDAQ listing standards
require our board of directors to consider certain factors, including, but not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify">&nbsp;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">the source of compensation of the director, including any consulting, advisory or other compensatory fee paid by us to the director; and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">whether the director is affiliated with us, one of our subsidiaries or an affiliate of one of our subsidiaries.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under
our planned Compensation Committee Charter, members of the Compensation Committee also must qualify as “outside directors”
for purposes of Section 162(m) of the Internal Revenue Code of 1986, and as “non-employee directors” for purposes of Rule
16b-3 under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 8, 2021,
the Compensation Committee was established, and it now consists of Michael Wright, Peter Zurkow and Anne S. Provost. Mr. Wright is the
Chairperson of the Compensation Committee. Each of the Compensation Committee members has been determined by the board of directors to
be independent under NASDAQ listing standards applicable to compensation committee members, outside directors under the Internal Revenue
Code, and non-employee directors under Rule 16b-3 under the Exchange Act. The new Compensation Committee is expected to hold its first
meeting after the filing of this Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nominating and Corporate Governance Committee</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On
December 8, 2021, we have established a separately designated Nominating and Corporate Governance Committee. The Nominating and Corporate
Governance Committee identifies, reviews and evaluates candidates to serve on the Board; reviews and assesses the performance of the board
of directors and the committees of the Board; and assesses the independence of our directors. The Nominating and Corporate Governance
Committee is also responsible for reviewing the composition of the Board’s committees and making recommendations to the entire board
of directors regarding the chairpersonship and membership of each committee. In addition, the Nominating and Corporate Governance Committee
is responsible for developing corporate governance principles and periodically reviewing and assessing such principles, as well as periodically
reviewing the Company’s policy statements to determine their adherence to the Company’s Code of Business Conduct and Ethics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating and Corporate
Governance Committee will operate under a written charter that identifies the procedures whereby Board of Director candidates are identified
primarily through suggestions made by directors, management and stockholders of the Company. The Nominating and Corporate Governance Committee
will consider director nominees recommended by stockholders that are submitted in writing to the Company’s Corporate Secretary in
a timely manner and which provide necessary biographical and business experience information regarding the nominee. The Nominating and
Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the criteria considered
by the Nominating Committee, based on whether or not the candidate was recommended by a stockholder. The board of directors does not prescribe
any minimum qualifications for director candidates, and all candidates for director will be evaluated based on their qualifications, diversity,
age, skill and such other factors as deemed appropriate by the Nominating and Corporate Governance Committee given the current needs of
the board of directors, the committees of the board of directors and the Company. Although the Nominating and Corporate Governance Committee
does not have a specific policy on diversity, it considers the criteria noted above in selecting nominees for directors, including members
from diverse backgrounds who combine a broad spectrum of experience and expertise. Absent other factors which may be material to its evaluation
of a candidate, the Nominating and Corporate Governance Committee expects to recommend to the board of directors for selection incumbent
directors who express an interest in continuing to serve on the Board. Following its evaluation of a proposed director’s candidacy,
the Nominating and Corporate Governance Committee will make a recommendation as to whether the board of directors should nominate the
proposed director candidate for election by the stockholders of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No member of the Nominating
and Corporate Governance Committee may be an employee of the Company, and each member must satisfy the independence requirements of NASDAQ
and the SEC, except that the committee may have one member who does not meet the Nasdaq independent standards if that committee member
is not a current executive officer or employee of the Company or a family member of any current executive officer of the Company, and
the Board determines, under exceptional and limited circumstances, that the director’s membership on the Committee is in the best
interests of the Company and its Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 8, 2021,
the Nominating and Corporate Governance Committee was established and consisted of Anthony Iacovone, who was the Chairperson of the committee,
Peter Zurkow and Michael Wright. On March 17, 2022, Mr. Iacovone resigned from the Board and was replaced by Anne S. Provost both as a
Director and Chairperson of the Nominating and Corporate Governance Committee. The aforesaid directors have been determined by the board
of directors to be independent under NASDAQ listing standards. The Nominating and Corporate Governance Committee held its first meeting
on March 18, 2022 prior to the filing of this Form 10-K to recommend Ms. Provost fill the vacancy left by the resignation of Mr. Iacovone.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have implemented no material changes in
the past year to the procedures by which stockholders may recommend nominees for the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 16(a) of the Securities Exchange Act of
1934, as amended, requires our officers and directors, and persons who own more than ten percent of a registered class of our equity securities,
to file reports of ownership and changes in ownership with the Securities and Exchange Commission (the "Commission"). Officers,
directors and greater than ten percent stockholders are required by the Commission's regulations to furnish us with copies of all Section
16(a) forms they file. During fiscal 2021, to the best of the knowledge of the Company’s directors and officers, no form 3’s,
form 4’s or form 5’s were filed late.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="a_021"></span>Item 11. Executive Compensation</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the overall compensation
earned over the fiscal years ended December&nbsp;31, 2021, and 2020 by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>each person who served as the principal executive officer of the company during fiscal year 2021 and 2020;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>the Company’s most highly compensated (up to a maximum of two) executive officers as of December 31, 2021, and 2020 with compensation during fiscal years 2021 and 2020 of $100,000 or more; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>those two individuals, if any, who would have otherwise been in included in bullet point above but for the fact that they were not serving as an executive of the company as of December 31, 2021.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tbody><tr style="vertical-align: bottom"><td style="text-align: center"><b>Name and Principal</b></td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center"><b>Salary</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center"><b>Bonus</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center"><b>Stock</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center"><b>Option Awards</b><span style="font-size: 10pt"></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center"><b>All Other Compensation</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="text-align: center"><b>Total</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Position</b></td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Year</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>($)</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>($)</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>Awards</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>($)(1)</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>($)(2)(3)</b></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><b>($)</b></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td style="width: 31%">Dean L. Julia</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="text-align: center; width: 1%">&nbsp;</td>
    <td style="text-align: center; width: 7%">2020</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="text-align: right; width: 7%">275,539</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="text-align: right; width: 7%">65,318</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="text-align: right; width: 7%">–</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="text-align: right; width: 7%">–</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="text-align: right; width: 7%">61,716</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 1%">$</td>
    <td style="text-align: right; width: 7%">402,573</td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td>CEO of the company</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">2021</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">286,615</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">925,200</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">58,590</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">1,270,405</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td>Deepanker Katyal</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">2020</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">306,154</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">7,622</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">38,119</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">351,895</td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td>CEO of Advangelists</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">2021</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">324,616</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">39,702</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">364,318</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">&nbsp;</td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td>Paul Bauersfeld</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">2020</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">229,616</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">39,970</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">30,533</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">300,119</td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td>Chief Technology Officer</td>
    <td>&nbsp;</td>
    <td style="text-align: center">&nbsp;</td>
    <td style="text-align: center">2021</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">238,846</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">514,000</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">27,365</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>$</td>
    <td style="text-align: right">780,211</td></tr>
  </tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1)&nbsp;&nbsp;&nbsp; The options and restricted stock awards presented
in this table for fiscal years 2021 and 2020 reflect the full grant date fair value, as if the total dollar amount were earned in the
year of grant. The stock awards are valued based on the fair market value of such shares on the date of grant and are charged to compensation
expense over the related vesting period. The options are valued at the date of grant based upon the Black-Scholes method of valuation,
which is expensed over the service period over which the options become vested. As a general rule, for time-in-service-based options,
the company will immediately expense any option or portion thereof which is vested upon grant, while expensing the balance on a pro rata
basis over the remaining vesting term of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2)&nbsp;&nbsp;&nbsp; Includes all other compensation not reported
in the preceding columns, including (i) perquisites and other personal benefits, or property, unless the aggregate amount of such compensation
is less than $10,000; (ii) any “gross-ups” or other amounts reimbursed during the fiscal year for the payment of taxes; (iii)
discounts from market price with respect to securities purchased from the company except to the extent available generally to all security
holders or to all salaried employees; (iv) any amounts paid or accrued in connection with any termination (including without limitation
through retirement, resignation, severance or constructive termination, including change of responsibilities) or change in control; (v)
contributions to vested and unvested defined contribution plans; (vi) any insurance premiums paid by, or on behalf of, the company relating
to life insurance for the benefit of the named executive officer; and (vii) any dividends or other earnings paid on stock or option awards
that are not factored into the grant date fair value required to be reported in a preceding column.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3)&nbsp;&nbsp;&nbsp; Includes compensation for service as a
director described under Director Compensation, below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the material terms of each named executive
officers’ employment agreement, including the terms of the terms of any common share purchase option grants, see that section of
this Form 10-K captioned “Employment Agreements.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No outstanding common share purchase option
or other equity-based award granted to or held by any named executive officer in the past two years were re-priced or otherwise materially
modified, including extension of exercise periods, the change of vesting or forfeiture conditions, the change or elimination of applicable
performance criteria, or the change of the bases upon which returns are determined, nor was there any waiver or modification of any specified
performance target, goal or condition to payout, except as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the material terms of any
contract, agreement, plan or other arrangement that provides for any payment to a named executive officer in connection with his or her
resignation, retirement or other termination, or a change in control of the company see “Employment Agreements” in this Form
10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares of common stock referred to
in this “Executive Compensation” section gives effect to the one-for 400 share reverse stock split that we effectuated on
September 9, 2020, unless the context clearly indicates otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Executive Officer Outstanding Equity Awards
at Fiscal Year-End</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
following table provides certain information concerning any common share purchase options, stock awards or equity incentive plan awards
held by each of our named executive officers that were outstanding as of December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Option
    Awards</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Stock
                                                                                                                          Awards</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Name</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Number
                                            of Securities Underlying Unexercised Options(#) Exercisable</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Number
                                            of Securities Underlying Unexercised Options(#) Unexercisable</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Equity
                                            Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Option
                                            Exercise Price <br> ($)</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Option Expiration Date</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Number
                                            of Shares or Units of Stock That Have Not Vested (#)</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Market</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Value
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Units
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Stock
                                            That</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Vested</b></span></p></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Incentive</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Shares,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Units
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>That</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Have</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Vested</b></span></p></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Incentive
                                            Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Awards:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Market
                                            or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Payout
                                            Value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Unearned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Shares,
                                            Units or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Other
                                            Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>That
                                            Have Not</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt"><b>Vested</b></span></p></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td style="width: 15%; text-align: left"><span style="font-size: 8pt">Dean L.</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-size: 8pt">12,250</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-size: 8pt">–</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-size: 8pt">–</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">20.00</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-size: 8pt">01/24/23</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 7%; text-align: right"><span style="font-size: 8pt">–</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">–</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">–</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="width: 2%"><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right; width: 7%"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td><span style="font-size: 8pt">Julia (1)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">12,500</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">28.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">11/20/23</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">62,500</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">60.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">4/2/29</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">225,000</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right">–</td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right">–</td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">4.565</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">12/08/31</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">–</span></span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">–</span></span></td>
    <td>&nbsp;</td>
    <td>&nbsp;</td><td style="text-align: right"><span style="font-size: 8pt"><span style="font-size: 8pt">–</span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">Deepanker</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">128,517</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">56.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">12/6/28</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">Katyal (1)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">25,000</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">36.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">09/13/24</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">12,500</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">36.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">09/13/25</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td><span style="font-size: 8pt">Paul</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">10,000</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">20.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">01/24/23</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td><span style="font-size: 8pt">Bauersfeld (1)</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">7,500</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">28.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">11/20/23</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td style="text-align: right"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">25,000</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">60.00</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">04/2/29</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right"><span style="font-size: 8pt">–</span></td><td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  <tr style="background-color: rgb(238,238,238); vertical-align: bottom">
    <td style="text-align: right"><span style="font-size: 8pt">&nbsp;</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">125,000</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">4.565</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">12/08/31</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">–</span></td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right">–</td><td><span style="font-size: 8pt">&nbsp;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&nbsp;</span></td><td style="text-align: right">–</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td><td style="text-align: right"><span style="font-size: 8pt">–</span></td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">(1)</td>
    <td style="text-align: justify">All options contain cashless exercise provisions.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In
April of 2020, due to the COVID-19 pandemic all employees’ salaries were reduced by 40% and we terminated one employee. In October
of 2020 the employees pay reduction was reduced to a 20% reduction where it stands through December 17, 2021, employees’ salaries
were returned to full pay.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Dean Julia</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dean
Julia is employed as the Company’s Chief Executive Officer under an employment agreement with an initial term of three years which
commenced on April 2, 2019. In January 2022, his employment agreement automatically was renewed for a period of an additional two years.
Mr. Julia’s annual base salary is $360,000. In addition to his base salary, Mr. Julia is entitled to a quarterly bonus of at least
1% of gross revenue for each completed fiscal quarter, so long as the Company’s gross revenue meets or exceeds 75% of management’s
stated goal. The quarterly bonus may be paid either in cash, common stock or stock options, at Mr. Julia’s election. Should his
employment agreement be terminated prior to the end of any fiscal year for any reason, other than for cause by the Company, a pro rata
portion of the quarterly bonus shall be paid within 30 days of termination. The Company's board of directors will determine a revenue
target each year for the purpose of calculating the quarterly bonus in that year. Mr. Julia also received a signing bonus of vested 10-year
options to purchase 62,500 shares, exercisable at $60 per share. Additionally, he is also entitled to 10-year options to purchase an additional
12,500 shares of common stock, exercisable at $60 per share, annually on April 1<sup>st</sup> of each year which commenced on April 1,
2020. Additionally, if the Company is acquired through a board of directors-approved change in control of at least 50% of the Company’s
outstanding voting stock, or the sale of all or substantially all of the Company’s assets, Mr. Julia shall be entitled to receive
a payment in-kind equal to 3% of the consideration paid in connection with that transaction. He is also entitled to paid disability insurance
and term life insurance at an annual cost of not more than $15,000. Additionally, he is also entitled to receive health, dental and 401(k)
benefits as is made available by the Company for its other senior officers, as well as indemnification by the Company to the fullest extent
permitted by law, and the Company’s certificate of incorporation and bylaws. Mr. Julia also has the use of a Company-leased or -owned
automobile. Mr. Julia’s employment agreement contains customary non-competition and non-solicitation of Company customers or employees
provisions during the term of the agreement. The Company may terminate Mr. Julia’s employment for cause, and Mr. Julia may terminate
his employment at any time on three-months’ notice. Also, the Company may terminate Mr. Julia’s employment agreement on Mr.
Julia’s death or disability – disability being unable to perform his essential functions for four consecutive months due to
physical, mental of emotional incapacity resulting from sickness, disease, or injury. In each of these termination cases, the Company
is obligated only to pay Mr. Julia amounts that were due or accrued prior to termination, plus, other than in a for-cause-termination,
any pro-rata quarterly bonus described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Don Walker “Trey” Barrett, III</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, Don Walker
(“Trey”) W. Barrett III accepted the position of Chief Operations and Strategy Officer of Mobiquity Technologies, Inc. The
Company entered into an Employment Agreement with Mr. Barrett, effective as of January 1, 2022, for an initial term of two years, which
may be renewed for successive one-year terms, with an annual salary of $275,000. Mr. Barrett will be entitled to an annual bonus of up
to 100% of his annual salary each year based on the attainment of performance standards, targets or goals which will be mutually agreed
upon by the Company and Mr. Barrett. Mr. Barrett was granted non-statutory options to purchase up to 150,000 shares of common stock, at
a price of $4.565 per share out of the Company’s 2021 Employee Benefit and Consulting Services Compensation Plan. The options will
vest in three substantially equal annual installments of 50,000 shares each on the first, second and third anniversaries of the date of
the Employment Agreement provided Mr. Barrett is employed by the Company on those dates, subject to acceleration if Mr. Barrett is terminated
without cause, he resigns for good reason, or certain change of control events occur. Additionally, Mr. Barrett was granted 25,000 shares
of restricted stock as a signing bonus pursuant to his Employment Agreement, and not out of any other plan, which will vest in full on
the six-month anniversary of the date of his Employment Agreement provided he is employed by the Corporation on that date. Mr. Barrett’s
employment Agreement contains customary provisions permitting the Company to terminate Mr. Barrett’s employment for cause or Mr.
Barrett’s disability, and entitling Mr. Barrett to terminate his employment for good reason, before the end of the contractual employment
period. Under the Employment Agreement, Mr. Barrett would be entitled to payment of an amount equivalent to his annual salary for a period
of 12 months after termination if his employment is terminated by the Company without cause or due to his disability, or Mr. Barrett terminates
his employment for good reason. Additionally, if Mr. Barrett’s employment is not renewed at the end of the initial employment period
or any renewal period, Mr. Barrett would be entitled to payment of an amount equivalent to his annual salary for a period of nine months
after termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 18, 2022, the Company
terminated the Employment Agreement of Don (Trey) W. Barrett III for cause and it will not incur any material early termination penalties
<span style="background-color: white">(due to the fact the termination was for cause)</span>. Mr. Barrett served as Chief Operations and
Strategy Officer since January 4, 2022. As a result of his termination, Mr. Barrett forfeited his right to retain 25,000 shares of restricted
common stock and options to purchase 150,000 shares which had not vested<span style="background-color: white">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Paul Bauersfeld</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paul
Bauersfeld is employed as the Company’s Chief Technology Officer under an at-will employment agreement which commenced on April
2, 2019. Mr. Bauersfeld’s monthly salary is $25,000. Mr. Bauersfeld is entitled to a quarterly bonus of at least 1% of gross revenue
for each completed fiscal quarter, so long as the Company’s gross revenue meets or exceeds management’s stated goal. The quarterly
bonus may be paid either in cash, common stock or stock options, at Mr. Bauersfeld’s election. Should his employment agreement be
terminated prior to the end of any fiscal year for any reason, other than for cause by the Company, a pro rata portion of the quarterly
bonus shall be paid within 30 days of termination. The Company's board of directors will determine a revenue target each year for the
purpose of calculating the quarterly bonus in that year. Mr. Bauersfeld also received a signing bonus of 10-year options to purchase 25,000
shares, exercisable at $60 per share; 35% of which vested immediately, 35% of which vested on April 2, 2020 and 30% of which vested on
April 2, 2021. Mr. Bauersfeld is entitled to participate in the Company’s health plans as well as indemnification by the Company
to the fullest extent permitted by law, and the Company’s certificate of incorporation and bylaws. Mr. Bauersfeld’s employment
agreement contains customary non-competition and non-solicitation of Company customers or employees’ provisions during the term
of the agreement. Although Mr. Bauersfeld’s employment agreement is at-will, the Company may terminate Mr. Bauersfeld’s employment
for cause. In the event Mr. Bauersfeld’s employment agreement is terminated other than for cause by the Company, the Company will
pay Mr. Bauersfeld severance pay equal to three months of his salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Sean Trepeta</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sean
Trepeta is employed as President of our wholly owned subsidiary, Mobiquity Networks, Inc. under an at-will employment agreement which
commenced on April 2, 2019. Mr. Trepeta’s monthly salary is $20,000. Mr. Trepeta is entitled to a quarterly bonus of at least 1%
of gross revenue for each completed fiscal quarter, so long as the Company’s gross revenue meets or exceeds management’s stated
goal. The quarterly bonus may be paid either in cash, common stock or stock options, at Mr. Trepeta’s election. Should his employment
agreement be terminated prior to the end of any fiscal year for any reason, other than for cause by the Company, a pro rata portion of
the quarterly bonus shall be paid within 30 days of termination. The Company's board of directors will determine a revenue target each
year for the purpose of calculating the quarterly bonus in that year. Mr. Trepeta also received a signing bonus of 10-year options to
purchase 25,000 shares, exercisable at $60 per share; 35% of which vested immediately, 35% of which vested on April 2, 2020, and 30% of
which vested on April 2, 2021. Mr. Trepeta is entitled to participate in the Company’s health plans as well as indemnification by
the Company to the fullest extent permitted by law, and the Company’s certificate of incorporation and bylaws. Mr. Trepeta’s
employment agreement contains customary non-competition and non-solicitation of Company customers or employees’ provisions during
the term of the agreement. Although Mr. Trepeta’s employment agreement is at-will, the Company may terminate Mr. Trepeta’s
employment for cause. In the event Mr. Trepeta’s employment agreement is terminated other than for cause by the Company, the Company
will pay Mr. Trepeta severance pay equal to three months of his salary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Deepanker Katyal</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deepanker
Katyal is employed as Chief Executive Officer of our wholly owned subsidiary, Advangelists, LLC under employment agreement with Advangelists
with a term of three years which commenced on December 7, 2018. The agreement was amended on September 13, 2019. Mr. Katyal’s annual
base salary is $400,000. Mr. Katyal’s employment agreement, as amended, also provides the following compensation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">a bonus, payable in cash or common stock of the Company, equal to 1% of the Company’s gross revenue for each month during the 2019 fiscal year, subject to certain revenue thresholds as set forth in the agreement. Those revenue thresholds were not attained, and this bonus was not earned;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">commissions equal to 10% of the net revenues derived from all New Katyal Managed Accounts (as defined in the agreement – being accounts directly introduced by Mr. Katyal or assigned to Employee in writing by the Manager of the Company);</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">options to purchase 37,500 shares of the Company’s common stock at an exercise price of $36.00 per share, of which 25,000 vested on September 13, 2019, the date Mr. Katyal’s employment agreement was amended, and 12,500 vested on September 13, 2020; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">one share of Company Series B Preferred Stock which was issued to Mr. Katyal. The Series B Preferred Stock, as a class, provided cash dividend rights, payable in cash, to the holders thereof in an aggregate amount equivalent to 10% of the annual gross revenue of Advangelists or the Company, whichever is higher, up to a maximum aggregate annual amount of $1,200,000, for each of its 2019 and 2020 fiscal years. As a holder of 50% of the Series B Preferred Stock, the maximum amount of annual dividends that Mr. Katyal would be entitled to $600,000. The Series B Preferred Stock rights, privileges, preferences, and restrictions was to terminate by its terms as of December 31, 2020; and, immediately upon declaration and payment of the dividend in respect of Mobiquity's 2020 fiscal year, Mobiquity was to withdraw such class from its authorized capital. The Series B Preferred Stock was subject to cancellation if Mr. Katyal terminated his employment without good reason or the Company terminated his employment for cause. Mr. Katyal did not receive any Series B Preferred Stock dividends and the Series B Preferred Stock was redeemed by the Company from Mr. Katyal in consideration for entering into the amendment of his employment agreement on September 13, 2019, and for no other consideration.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During
the term of the employment agreement, Mr. Katyal is entitled to a monthly allowance of up to $550 per month to cover lease or purchase
finance costs of an automobile. Mr. Katyal’s employment agreement provides for indemnification by the Company to the fullest extent
permitted by the Company’s certificate of incorporation and bylaws, as well as participation in all benefit plans, programs and
perquisites as are generally provided by Advangelists to its employees, including medical, dental, life insurance, disability and 401(k)
participation. Mr. Katyal’s employment agreement contains customary non-solicitation of Company customers or employees provisions
during the term of the agreement and for one year after termination. The agreement provides for termination by Advangelists for cause
upon 30 days’ prior written notice; and without cause after 60 days’ prior written notice. The employment agreement terminates
automatically upon Mr. Katyal’s death, and it may also be terminated by Advangelists if Mr. Katyal is disabled for more than six
consecutive months in any 12-month period—disability being the inability to substantially perform Mr. Katyal's duties and responsibilities
by reason of mental or physical illness or injury. Mr. Katyal is entitled to terminate the agreement for “good reason”. If
Mr. Katyal is terminated by Advangelists for cause, Advangelists is obligated only to pay Mr. Katyal amounts of base salary and expense
reimbursements that were due or accrued prior to the termination date. If Mr. Katyal is terminated by Advangelists without cause, and
provided Mr. Katyal is not in breach under the agreement, Advangelists is obligated to pay Mr. Katyal his compensation and expense reimbursements
that would payable to Mr. Katyal for the remainder of the contractual employment term had Mr. Katyal remained an employee. If Mr. Katyal’s
employment is terminated as a result of his death, Advangelists is obligated to pay Mr. Katyal his salary though the date of termination,
and his other compensation for the remainder of the contractual employment term had Mr. Katyal remained an employee. If Mr. Katyal’s
employment is terminated as a result of his disability, provided Mr. Katyal provides a general release, Advangelists is obligated to pay
Mr. Katyal his salary though the date of termination, and his other compensation for the remainder of the contractual employment term
had Mr. Katyal remained an employee. If Mr. Katyal terminates his employment for good reason, and provided Mr. Katyal provides a general
release, Advangelists is obligated to pay Mr. Katyal his compensation and expense reimbursements that would payable to Mr. Katyal for
the remainder of the contractual employment term had Mr. Katyal remained an employee. Mr. Kaytal’s employment agreement provides
for assignment of ownership rights regarding intellectual property created by Mr. Katyal relating to the Company’s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, the Company entered into a new one-year employment
agreement with Deepankar Katyal. His compensation and benefits under the new contract have not changed from the Agreement summarized above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Sean McDonnell</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&nbsp;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sean
McDonnell is employed as the Company’s Chief Executive Officer on a non-full-time basis as an employee at-will with no employment
agreement. He has a monthly base salary of $11,000 and he is eligible to receive options and other bonuses at the discretion of the board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>DIRECTOR COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, one director of the Company is an
executive officer of the Company. He receives compensation as an officer as described above under the heading “Executive
Compensation” and as a Director. All Board members received Options under our 2021 Compensation Plan as described elsewhere in
this Form 10-K. On March 18, 2022, the board of directors approved the payment of $1,000 per month to be paid to each member of the
board of directors for serving on the board and any committees thereof. Future compensation of board members/committee members are
at the discretion of the board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employee Benefit and Consulting Services
Compensation Plans</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On
January 3, 2005, our company established the 2005 Employee Benefit and Consulting Services Compensation Plan covering 5,000 shares, which
2005 Plan was ratified by our shareholders in February 2005. On August 12, 2005, the company’s stockholders approved a 5,000-share
increase in the 2005 Plan to 10,000 shares. On August 28, 2009, the Board adopted the 2009 Employee Benefit and Consulting Services Compensation
Plan identical to the 2005 Plan covering 10,000 shares. In September 2013, the Company’s stockholders ratified a board amendment
to increase the number of shares covered by the 2009 Plan to 25,000 shares. As the 2005 and 2009 Plans are identical other than the number
of shares covered by each Plan, it is the Company’s intention to first utilize the shares issuable (available) under the 2005 Plan
prior to issuing shares under the 2009 Plan. In February 2015, the Board approved an increase in the number of shares covered by the 2009
Plan from 25,000 shares to 50,000 shares, subject to shareholder approval within one year. However, shareholder approval was not obtained
within the requisite time period, and the Board established the 2016 Employee Benefit and Consulting Services Compensation Plan covering
25,000 shares which is otherwise identical to the 2005 and 2009 Plans. All options granted under the 2009 Plan, which exceed the Plan
limits, have been moved to the 2016 Plan. In December 2018, the Company approved the 2018 Employee Benefit and Consulting Services Compensation
Plan identical to the other Plans described above, except for the number of shares covered by the Plan is 75,000. The 2018 Plan was ratified
by shareholders in February 2019. On April 2, 2019, the Board approved the 2019 Employee Benefit and Consulting Services Compensation
Plan identical to the other Plans described above, except for the number of shares covered by the Plan is 150,000. Approval of the 2019
Plan was not approved by the shareholders within one year in order to grant incentive stock options under said Plan, and it remains unratified
by our shareholders. On October 13, 2021, the Board approved the Employee Benefit and Consulting Services Compensation Plan identical
to the 2019 Plan except that the number of shares underlying the Plan is 1,100,000. The 2021 Plan must be approved by the shareholders
within one year in order to grant incentive stock options under said Plan. We refer to the 2005, 2009, 2016, 2018, 2019 and 2021 Plans
as the “Plans”.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Administration</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our
board of directors administers the Plans, has the authority to determine and designate officers, employees, directors and consultants
to whom awards shall be made; and the terms, conditions and restrictions applicable to each award (including, among other things, the
option price, any restriction or limitation, any vesting schedule or acceleration of vesting, and any forfeiture restrictions).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Types of Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
Plans are designed to enable us to offer certain officers, employees, directors and consultants of us and our subsidiaries equity interests
in us and other incentive awards in order to attract, retain and reward such individuals and to strengthen the mutuality of interests
between such individuals and our stockholders. In furtherance of this purpose, the Plans contain provisions for granting non-statutory
stock options and incentive stock options and common stock awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stock Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A “stock option”
is a contractual right to purchase a number of shares of common stock at a price determined on the date the option is granted. An incentive
stock option is an option granted under the Internal Revenue Code of 1986 to our employees with certain tax advantages to the grantee
over non-statutory stock options. The option price per share of common stock purchasable upon exercise of a stock option and the time
or times at which such options shall be exercisable shall be determined by the Board at the time of grant. Such option price in the case
of incentive stock options shall not be less than 100% of the fair market value of the common stock on the date of grant and may be granted
below fair market value in the case of non-statutory stock options. Incentive stock options granted to owners of 10% or more of our common
stock must be granted at an exercise price of at least 110% of the fair market value of our common stock and may not have a term greater
than five years. Also, the value of incentive options vesting to any employee cannot exceed $100,000 in any calendar year. The option
price of our options must be paid in cash, money order, check or common stock of the company. The non-statutory stock options may also
contain at the time of grant, at the discretion of the board, certain other cashless exercise provisions. These cashless exercise provisions
are included in the currently outstanding non-statutory stock options granted by the board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Options shall be exercisable
at the times and subject to the conditions determined by the Board at the date of grant, but no option may be exercisable more than ten
years after the date it is granted. If the optionee ceases to be an employee of our company for any reason other than death, any incentive
stock option exercisable on the date of the termination of employment may be exercised for a period of thirty days or until the expiration
of the stated term of the option, whichever period is shorter. In the event of the optionee’s death, any incentive stock option
exercisable at the date of death may be exercised by the legal heirs of the optionee from the date of death until the expiration of the
stated term of the option or six months from the date of death, whichever event first occurs. In the event of disability of the optionee,
any incentive stock options shall expire on the stated date that the Option would otherwise have expired or 12 months from the date of
disability, whichever event first occurs. The termination and other provisions of a non-statutory stock option shall be fixed by the board
of directors at the date of grant of each respective option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Common Stock Award</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Common
stock awards are shares of common stock that will be issued to a recipient at the end of a restriction period, if any, specified by the
board if he or she continues to be an employee, director or consultant of us. If the recipient remains an employee, director or consultant
at the end of the restriction period, the applicable restrictions will lapse and we will issue a stock certificate representing such shares
of common stock to the participant. If the recipient ceases to be an employee, director or consultant of us for any reason (including
death, disability or retirement) before the end of the restriction period unless otherwise determined by the board, the restricted stock
award will be terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the
Company has granted a total of 1,109,159 options under the Plans and a total of<span style="font-size: 10pt">&nbsp;</span> 26,750 options
outside the Plans, or a total of options to purchase 1,135,909 shares of the Company’s Common Stock with a weighted average exercise
price of $16.69 per share. The board has granted options with varying terms<b>. </b>The Company has also granted to various officers,
directors and employees of Advangelists, warrants to purchase an aggregate of 166,017 shares at varying terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is not possible to predict the individuals who
will receive future awards under the Plans or outside the Plans or the number of shares of Common Stock covered by any future award because
such awards are wholly within the discretion of the Board. The table below contains information as of December 31, 2021, on the known
benefits provided to certain persons and group of persons who own options under or outside the Plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="text-align: center">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of Shares</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Subject to Options/Warrants</b></p></td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average Exercise</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Price ($) per Share</b></p></td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Value of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Unexercised</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Options/</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants at</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Dec. 31, 2021 (1)</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: left">Dean L. Julia</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right">337,250</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right">20.38</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">–</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sean McDonnell</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">28,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">6.58</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Don Walker “Trey” Barrett, III</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sean Trepeta</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">166,750</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">14.79</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Paul Bauersfeld</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">167,500</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">14.81</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deepanker Katyal</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">166,017</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">51.48</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Executive Officers as a group</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">865,517</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">23.74</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gene Salkind <br></td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">425,625</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">44.43</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Three Independent Directors as a group</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">78,125</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">6.30</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">$</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1)&nbsp;&nbsp;&nbsp; Value is normally calculated by multiplying
(a) the difference between the market value per share at period end (i.e. $2.13 based upon a last sale on (or the last trade date before)
December&nbsp;31, 2021) and the option exercise price by (b) the number of shares of Common Stock underlying the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the past, the Company has granted certain employees
and consultants, stock awards for services for the prior year with vesting to occur after the passage of 12 months from grant. These awards
totaled the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">112 shares for 2008, subject to continued
services with the Company through December 31, 2009.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">127 shares for 2009 subject to continued
services with the Company through December 31, 2010.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">262 shares for 2010 subject to continued
services with the Company through December 31, 2011.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">112 shares for 2011, subject to continued
services with the Company through December 31, 2012.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A total of 509 shares were issued under the 2005
Plan pursuant to the stock award program described above (net of cancellations). No stock awards were granted in fiscal 2012 through fiscal
2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Eligibility</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our
officers, employees, directors and consultants of Mobiquity and our subsidiaries are eligible to be granted stock options, and common
stock awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Termination or Amendment of the Plans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
board may at any time amend, discontinue, or terminate all or any part of the Plans, provided, however, that unless otherwise required
by law, the rights of a participant may not be impaired without his or her consent, and provided that we will seek the approval of our
stockholders for any amendment if such approval is necessary to comply with any applicable federal or state securities laws or rules or
regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 96 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Options granted under the 2021 Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the 2021 Plan, the Board approved
effective December 8, 2021 the granting of 10 year options to purchase an aggregate of 810,000 shares to various Board members and
executive officers, employees with the options exercisable commencing February 7, 2022 at an exercise price equal $4.565 per share.
The following table reflects the number of options granted to each officer and/or director:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Amount</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 85%; text-align: left; padding-bottom: 1pt">Dean L. Julia</td><td style="width: 2%; padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; width: 11%; text-align: right">225,000</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Paul Bauersferld</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">125,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Sean J. McDonnell, CPA</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Sean Trepeta</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">125,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Dr. Gene Salkind, M.D.</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">35,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Peter L. Zurkow</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Michael A. Wright</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Anthony Iacovone</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, Mr. Barrett was granted options
to purchase up to 150,000 shares of common stock at an exercise price of $4.465 per share to vest in three equal annual installments
of 50,000 shares on the first, second and third anniversaries of the date of the employment agreement provided Mr. Barrett is employed
by the Company on those dates, subject to acceleration if Mr. Barrett is terminated without cause, he resigned for good reason or certain
changes in control event On March 18, 2022, the Company terminated the Employment Agreement of Don (Trey) W. Barrett III for cause and
Mr. Barrett forfeited his right to retain options to purchase 150,000 shares which had not vested<span style="background-color: white">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">&nbsp;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Item 12. <span style="text-decoration: underline"><span id="a_022"></span>Security Ownership of Certain
Beneficial Owners and Management and Related Stockholder Matters</span>.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information
regarding beneficial ownership of our voting stock as of March 25, 2022 based upon 6,560,751. common shares outstanding and by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">each person or group of affiliated persons known by us to be the beneficial owner of more than 5% of any class of our voting stock;</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>each “named executive officer” of the Company;</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>each of our directors; and</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>all executive officers and directors as a group.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise noted below, the address of each
person listed on the table is c/o Mobiquity Technologies, Inc. at the address set forth herein. To our knowledge, each person listed below
has sole voting and investment power over the shares shown as beneficially owned except to the extent jointly owned with spouses or otherwise
noted below. Beneficial ownership is determined in accordance with the rules of the SEC. The information does not necessarily indicate
ownership for any other purpose. Under these rules, shares of stock which a person has the right to acquire (i.e., by the exercise of
any option or the conversion of such person’s outstanding Preferred Stock) within 60 days after March 25, 2022 are deemed to be
beneficially owned and outstanding for purposes of calculating the number of shares and the percentage beneficially owned by that person.
However, these shares are not deemed to be beneficially owned and outstanding for purposes of computing the percentage beneficially owned
by any other person. The percentage of shares owned as of March 25, 2022 is based upon 6,560,751 shares of Common Stock outstanding on
that date. The number of shares in this “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters” section gives effect to the one-for 400 share reverse stock split that we effectuated on September 9, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Address of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares of<br> Common<br> Stock</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br> Shares<br> Underlying<br> Convertible<br> Preferred<br> Stock, Notes<br> Options and<br> Warrants</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br> Shares<br> Beneficially<br> Owned</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Percentage<br> of<br> Shares<br> Beneficially<br> Owned (%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left">Directors and Executive Officers</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Paul Bauersfeld</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right">250</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right">167,500</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right">167,750</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 11%; text-align: right">2.5</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Dean L. Julia</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">4,884</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">337,500</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">342,384</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">5.0</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sean Trepeta</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">2,525</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">166,750</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">169,275</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">2.5</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Sean McDonnell</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">417</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">28,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">28,417</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">*</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deepanker Katyal</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">0</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">166,017</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">166,017</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">2.5</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Michael Wright</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">0</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">25,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">25,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">*</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gene Salkind</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">1,116,021</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">1,066,250</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">2,182,271</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">28.6</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Anne S. Provost</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">0</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">25,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">25,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">*</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Peter Zurkow</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">0</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">25,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">25,000</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">*</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">All Officers and directors as a group (nine persons)</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">1,124,097</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">2,007,017</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">3,131,114</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">36.5</td><td style="text-align: left">&nbsp;</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Less than one percent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="a_023"></span>Item 13. Certain Relationships and Related Transactions and Director
Independence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We describe below all transactions and series of
similar transactions, other than compensation arrangements, during our last three fiscal years, to which we were a party or will be a
party in which:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>the amounts exceeded or will exceed $120,000; and</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td>any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of the foregoing persons, had or will have a direct or indirect material interest.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Compensation arrangements for our directors and named executive
officers are described under “Item 12.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements and Executive Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into various employment agreements
as described under the heading “Executive Compensation”. These agreements also provide for us to indemnify such officers and/or
directors to the maximum extent permitted by law. We also carry directors’ and officers’ liability insurance which protects
each of our officers and directors up to the policy maximum of <span>$1.5</span> million, subject to
a $1.5 million deductible for securities claims and $75,000 for other claims. For more information regarding our employment agreements
and indemnification provisions, see “Item 12.”</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Related Party Debt Financing </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 13, 2019, Dr. Gene Salkind, who is
a director of the Company, and an affiliate of Dr. Salkind subscribed for 15% Senior Secured Convertible Promissory Notes and loaned the
Company an aggregate of $2,300,000. These notes were amended and restated on December 31, 2019, by Amended and Restated 15% Senior Secured
Convertible Promissory Notes which deferred interest payments from the date of the original notes to December 31, 2020, and added an aggregate
interim payment of $250,000 payable on December 31, 2020, that covered the deferred interest payments. These notes were again amended
and restated on April 1, 2021, by the Second Amended and Restated 15% Senior Secured Convertible Promissory Notes which reflected an additional
principal amount of $150,000 loaned by Dr. Salkind, and also amended the interim payment date to December 31, 2021, and the conversion
price from $32 to $4 per share. The notes are secured by the assets of the Company and its subsidiaries. The total amount loaned under
the notes, as amended and restated, including the principal amount and the interim payment amount is $2,700,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The notes, as amended and restated, bear annual
interest at 15% which is payable monthly in cash or, at the Salkind lenders’ option, in shares of the Company’s common stock.
The principal amount under the Notes is due on September 30, 2029, and the interim payment is payable on December 31, 2021, unless, in
either case, earlier converted into shares of our common stock under the terms of the notes, as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The outstanding principal plus any accrued
and unpaid interest, and the interim payment under the notes, are convertible into shares of Company common stock at a conversion price
of $4 per share at any time, until the notes are fully converted, on the following terms:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 24px">&nbsp;</td>
    <td style="width: 24px"><span style="font-family: Symbol">·</span></td>
    <td>The Salkind lenders may convert the notes at any time.</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td><span style="font-family: Symbol">·</span></td>
    <td style="text-align: justify">The Company may convert the notes at any time that the trailing thirty (30) day volume weighted average price per share (as more particularly described in the Notes) of the Company’s common stock is above $400 per share.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
notes contain customary events of default, which, if uncured, entitle the holders to accelerate payment of the principal and all accrued
and unpaid interest under their notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the subscription of the notes
and upon conversion thereof (if at all), the Company will issue to each Salkind lender a warrant to purchase one share of the Company’s
common stock for every two shares of common stock issuable upon conversion of the Notes, at an exercise price of $48 per share. The warrant
exercise price was amended to $4 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the second quarter of 2020, we halted required
interest payments under the September 2019 and June 30, 2021, Notes to Dr. Salkind and his affiliate due to economic hardships stemming
from a downturn in our business and the related decline of our revenue resulting from the COVID 19 pandemic. See “Risk Factors –
Impacts of COVID-19 to business and the general economy.” Dr. Salkind and his affiliate have not declared a default under the Notes
due to the non-payment of interest. They have the right to declare the Notes in default at any time if we do not cure the non-payment.
On December 17, 2021, the Company paid Dr. Salkind and his affiliate an aggregate of $400,000 in accrued interest and the Company paid
down principal of $137,500 to reduce the outstanding principal to $2,562,500 and unpaid interest to $256,850. Since January 2022, the
Company is making timely payments of $31,875 per month toward accrued interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b></b></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to the Financial Statements and Other
Disclosures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The
disclosures contained in this Form 10-K, in particular in the notes to our consolidated financial statements as well under “Item
12,” describe various other transactions between the Company’s and its officers, directors and principal shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All related party transactions described
elsewhere in this Form 10-K are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="a_024"></span>Item 14. Principal Accountant Fees and Services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 16, 2018, the Company engaged BF Borgers
CPA PC as our registered independent public accountants. Their fees are described in the table below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year&nbsp;Ended&nbsp;December&nbsp;31,</td></tr>
  <tr style="vertical-align: bottom">
    <td>&nbsp;</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: justify">Audit fees</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">48,600</td><td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">48,600</td><td style="width: 1%; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Audit- related fees</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">32,400</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">32,400</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Tax fees</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">–</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">All other fees</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&nbsp;</td><td style="border-bottom: Black 1pt solid; text-align: right">37,800</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total fees</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">81,000</td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td><td style="padding-bottom: 2.5pt">&nbsp;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">118,800</td><td style="padding-bottom: 2.5pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policy on Board Pre-Approval of Services of
Independent Registered Public Accounting Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has responsibility for appointing, setting
compensation and overseeing the work of the independent registered public accounting firm. In recognition of this responsibility, the
Board has established a policy to pre-approve all audit and permissible non-audit services provided by the independent registered public
accounting firm. Prior to engagement of the independent registered public accounting firm for the following year’s audit, management
will submit to the Board for approval a description of services expected to be rendered during that year for each of following categories
of services:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit services</i> include audit work performed
in the preparation and audit of the annual financial statements, review of quarterly financial statements, reading of annual, quarterly
and current reports, as well as work that generally only the independent auditor can reasonably be expected to provide, such as the provision
of consents and comfort letters in connection with the filing of registration statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&nbsp;</i>&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit-related services</i> are for assurance
and related services that are traditionally performed by the independent auditor, including due diligence related to mergers and acquisitions
and special procedures required to meet certain regulatory requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tax services</i> consist principally of assistance
with tax compliance and reporting, as well as certain tax planning consultations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other services </i>are those associated with
services not captured in the other categories. We generally do not request such services from our independent auditor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the engagement, the Board pre-approves
these services by category of service. The fees are budgeted, and the Board requires the independent registered public accounting firm
and management to report actual fees versus the budget periodically throughout the year by category of service. During the year, circumstances
may arise when it may become necessary to engage the independent registered public accounting firm for additional services not contemplated
in the original pre-approval. In those instances, the Board requires specific pre-approval before engaging the independent registered
public accounting firm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board may delegate pre-approval authority
to one or more of its members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval
decisions to the audit Board at its next scheduled meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the services described above provided
by our auditors were approved by the Board pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_025"></span>PART IV </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="a_026"></span>Item&nbsp;15. Exhibits, Financial Statement Schedules</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">(a)&nbsp; FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following documents are filed under ITEM 8
FINANCIAL STATEMENTS as the financial statements of the Company for the years ended December 31, 2021, and 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reports of Independent Registered
Public Accounting Firms</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consolidated Balance Sheets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consolidated Statements of
Operations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consolidated Statement of
Stockholders' Equity</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notes to Consolidated Financial
Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">(b)&nbsp; EXHIBITS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 8%"><b>Exhibit</b></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 91%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td><b>Number</b></td>
    <td>&nbsp;</td>
    <td><b>Exhibit&nbsp;Title</b></td></tr>
  <tr style="vertical-align: top">
    <td>2.1</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316818003665/mobiquity_8k-ex0201.htm">Agreement and Plan of Merger dated November 20, 2018 between Mobiquity Technologies, Inc., Glen Eagles Acquisition LP, Avng Acquisition Sub, LLC, Advangelists, LLC, and Deepankar Katyal as Member Representative (the “Advangelists Merger Agreement”) (Incorporated by reference to Form 8-K dated December 11, 2018.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.2</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316818003665/mobiquity_8k-ex0202.htm">First Amendment to the Advangelists Merger Agreement dated December 6, 2018 (Incorporated by reference to Form 8-K dated December 11, 2018.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.3</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001377/mobiquity_8k-ex0101.htm">Membership Interest Purchase Agreement dated as of April 30, 2019 between Mobiquity Technologies, Inc. and Glen Eagles Acquisition LP (Incorporated by reference to Form 8-K dated April 30, 2019.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.4</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001592/mobiquity_8k-ex1001.htm">Membership Interest Purchase Agreement, effective as of May 8, 2019 between Mobiquity Technologies, Inc. and Gopher Protocol, Inc. (<span style="background-color: white">Incorporated by reference to Form 8-K dated May 10, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.5</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001592/mobiquity_8k-ex1003.htm">Assignment and Assumption Agreement effective as of May 8, 2019 between Mobiquity Technologies, Inc. and Gopher Protocol, Inc. (<span style="background-color: white">Incorporated by reference to Form 8-K dated May 10, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.6</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819002981/mobiquity_ex1001.htm">Stock Purchase Agreement, effective as of September 13, 2019, by and between Mobiquity Technologies, Inc. and GBT Technologies, Inc. (<span style="background-color: white">Incorporated by reference to Form 8-K dated September 13, 2019.</span></a>)</td></tr>
  <tr style="vertical-align: top">
    <td>2.7</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819003458/mobiquity_ex1006.htm">Subscription Agreement, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Dr. Gene Salkind (Incorporated by reference to Form 8-K/A dated September 13, 2019.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.8</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819003458/mobiquity_ex1008.htm">Subscription Agreement, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Marital Trust GST Subject U/W/O Leopold Salkind (Incorporated by reference to Form 8-K/A dated September 13, 2019.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>2.9</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004466/mobiquity_ex1007.htm">Securities Purchase Agreement dated September 20, 2021 by and between Mobiquity Technologies, Inc. and Talos Victory Fund, LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)</a></td></tr>

<tr style="vertical-align: top">
    <td>2.10</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004466/mobiquity_ex1002.htm">Securities Purchase Agreement dated September 20, 2021 by and between Mobiquity Technologies, Inc. and Blue Lake Partners LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.1</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968705000350/ace_ex3-1.txt">Certificate of Incorporation filed March 26, 1998 (Incorporated by reference to Registrant's Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.2</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968705000350/ace_ex3-2.txt">Amendment to Certificate of Incorporation filed June 10, 1999 (Incorporated by reference to Registrant's Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.3</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968705000350/ace_ex3-3.txt">Amendment to Certificate of Incorporation approved by stockholders in 2005(Incorporated by reference to Registrant's Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.4</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968713000856/ace_10k-ex304.htm">Amendment to Certificate of Incorporation dated September 11, 2008 (<span style="background-color: white">Incorporated by reference to the Registrant's Form 10-K for its fiscal year ended December 31, 2012.</span></a>)</td></tr>
  <tr style="vertical-align: top">
    <td>3.5</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968713000856/ace_10k-ex305.htm">Amendment to Certificate of Incorporation dated October 7, 2009 (<span style="background-color: white">Incorporated by reference to the Registrant's Form 10-K for its fiscal year ended December 31, 2012.</span>)</a></td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td style="width: 8%">3.6</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 91%"><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968713000856/ace_10k-ex306.htm">Amendment to Certificate of Incorporation dated May 18, 2012 (<span style="background-color: white">Incorporated by reference to the Registra</span>nt's Form 10-K for its fiscal year ended <span style="background-color: white">December 31, 2012.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.7</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968713003537/ace_ex0301.htm">Amendment to Certificate of Incorporation dated September 10, 2013 (Incorporated by reference to Registrant’s Form 8-K filed on September 11, 2013.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.8</td>
    <td>&nbsp;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1084267/000101968716005670/mobiquity_10k-ex0310.htm">Amendment to Certificate of Incorporation filed December 22, 2015 (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2015.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.9</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968716005562/mobiquity_ex0301.htm">Amendment to Certificate of Incorporation dated March 23, 2016 (<span style="background-color: white">Incorporated by reference to Form 8-K dated March 24, 2016.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.10</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316817000468/mobiquity_8k-ex0301.htm">Amendment to Certificate of Incorporation (Incorporated by reference to Form 8-K dated March 1, 2017.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.11</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819000902/mobiquity_10k-ex0313.htm">Amendment to Certificate of Incorporation – September 2018 (<span style="background-color: white">Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.12</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819000902/mobiquity_10k-ex0314.htm">Amendment to Certificate of Incorporation – February 2019 (<span style="background-color: white">Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.13</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819000902/mobiquity_10k-ex0315.htm">Amendment to Certificate of Incorporation – December 17, 2018 (<span style="background-color: white">Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.14</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819000902/mobiquity_10k-ex0316.htm">Amendment to Certificate of Incorporation – December 4, 2018 (<span style="background-color: white">Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.15</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819002258/mobiquity_ex0301.htm">Restated Certificate of Incorporation (<span style="background-color: white">Incorporated by reference to Form 8-K dated July 15, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.16</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex0316.htm">Certificate of Amendment to Certificate of Incorporation-Series E preferred Stock</a>**</td></tr>
  <tr style="vertical-align: top">
    <td>3.17</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968705000350/ace_ex3-4.txt">Amended By-Laws (Incorporated by reference to Registrant's Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.18</td>
    <td>&nbsp;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1084267/000101968714004818/mobiquity_8k-0301.htm">2014 Amendment to By-Laws (<span style="background-color: white">Incorporated by reference to Form 8-K filed with the SEC on December 24, 2014.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>3.19</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821005448/mobiquity_ex0319.htm">November 2021 Amendment to By-Laws</a>**</td></tr>
  <tr style="vertical-align: top">
    <td>4.1</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001592/mobiquity_8k-ex1002.htm">Amended and Restated $7,512,500 Promissory Note dated as of May 10, 2019 from Mobiquity Technologies, Inc. to Deepanker Katyal, as representative of the former members of Advangelists, LLC (<span style="background-color: white">Incorporated by reference to Form 8-K dated May 10, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.2</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819002981/mobiquity_ex1011.htm">Second Amended and Restated Promissory Note, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Deepankar Katyal, as representative of the former owners of Advangelists, LLC (<span style="background-color: white">Incorporated by reference to Form 8-K dated September 13, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.3</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819002981/mobiquity_ex1012.htm">Form of Common Stock Purchase Warrant (<span style="background-color: white">Incorporated by reference to Form 8-K dated September 13, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.4</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819003458/mobiquity_ex1007.htm">Convertible Promissory Note in favor of Dr. Gene Salkind, dated as of September 13, 2019 (Incorporated by reference to Form 8-K/A dated September 13, 2019.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.5</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex0405.htm">Amended and Restated Convertible Promissory Note in favor of Dr. Gene Salkind, dated as of December 31, 2019**</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.6</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex0406.htm">Second Amended and Restated Convertible Promissory Note in favor of Dr. Gene Salkind, dated as of April 1, 2019**</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.7</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819003458/mobiquity_ex1009.htm">Convertible Promissory Note in favor of Marital Trust GST Subject U/W/O Leopold Salkind, dated as of September 13, 2019 (Incorporated by reference to Form 8-K/A dated September 13, 2019.)</a></td></tr>

<tr style="vertical-align: top">
    <td style="width: 8%">4.8</td>
    <td>&nbsp;</td>
    <td style="width: 91%"><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex0408.htm">Amended and Restated Convertible Promissory Note in favor of Marital Trust GST Subject U/W/O Leopold Salkind, dated as of December 31, 2019</a>**</td></tr>
  <tr style="vertical-align: top">
    <td>4.9</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex0409.htm">Second Amended and Restated Convertible Promissory Note in favor of Marital Trust GST Subject U/W/O Leopold Salkind, dated as of April 1, 2019</a>**</td></tr>
  <tr style="vertical-align: top">
    <td>4.10</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819003458/mobiquity_ex1010.htm">Form of Lender Warrant (Incorporated by reference to Form 8-K/A dated September 13, 2019.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.11</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004466/mobiquity_ex1006.htm">Promissory Note in favor of Talos Victory Fund, LLC dated September 20, 2021 (Incorporated by reference to Form 8-K dated September 20, 2021.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.12</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004466/mobiquity_ex1001.htm">Promissory Note in favor of Blue Lake Partners LLC dated September 20, 2021 (Incorporated by reference to Form 8-K dated September 20, 2021.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.13</td>
    <td>&nbsp;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1084267/000168316821004466/mobiquity_ex1008.htm">Common Stock Purchase Warrant dated September 20, 2021 issued to Talos Victory Fund, LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.14</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004466/mobiquity_ex1003.htm">Common Stock Purchase Warrant dated September 20, 2021 issued to Blue Lake Partners LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>4.15</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821005448/mobiquity_ex0415.htm">Form of Representative’s Warrant</a>**</td></tr>
</tbody></table>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0">&nbsp;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt">&nbsp;</div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td>4.16</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821005845/mobiquity_ex0416.htm">Form of Warrant Agent Agreement by and between the Company and Continental Stock Transfer &amp; Trust Company</a>**</td></tr>
  <tr style="vertical-align: top">
    <td>4.17</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821005845/mobiquity_ex0416.htm">Form of Warrant</a> (Annex C to the Form of Warrant Agent Agreement attached as Exhibit 4.16)**</td></tr>
  <tr style="vertical-align: top">
    <td>10.1</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001213/mobiquity_10k-ex1015.htm">Employment Agreement dated April 2, 2019 – Dean L. Julia (<span style="background-color: white">Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.2</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001213/mobiquity_10k-ex1016.htm">Employment Agreement dated April 2, 2019 – Sean Trepeta (<span style="background-color: white">Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.3</td>
    <td>&nbsp;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1084267/000168316819001213/mobiquity_10k-ex1017.htm">Employment Agreement dated April 2, 2019 – Paul Bauersfeld (<span style="background-color: white">Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.4</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819001213/mobiquity_10k-ex1018.htm">Employment Agreement dated December 7, 2018 – Deepanker Katyal (<span style="background-color: white">Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.5</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819002981/mobiquity_ex1002.htm">Amendment No. 1 to Employment Agreement, dated as of September 13, 2019, by and between Advangelists, LLC and Deepankar Katyal (<span style="background-color: white">Incorporated by reference to Form 8-K dated September 13, 2019.</span></a>)</td></tr>
  <tr style="vertical-align: top">
    <td>10.6</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819002981/mobiquity_ex1003.htm">Class B Preferred Stock Redemption Agreement, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Deepankar Katyal (<span style="background-color: white">Incorporated by reference to Form 8-K dated September 13, 2019.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.7</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex1007.htm">Merchant Agreement dated April 29, 2021, 2021 by and between Mobiquity Technologies, Inc. and Business Capital Providers, Inc.**</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.8</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex1008.htm">Merchant Agreement dated July 28, 2021 by and between Mobiquity Technologies, Inc. and Business Capital Providers, Inc.**</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.9</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex1009.htm">Form of Investor Convertible Debt Subscription Agreement (5% Original Issue Discount)**</a></td></tr>
  <tr style="vertical-align: top">
    <td>10.10</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex1010.htm">Form of Investor Convertible Debt Subscription Agreement (10% Original Issue Discount)**</a></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10.11</p></td>
    <td>&nbsp;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex1011.htm">Form
    of Investor Convertible Debt Subscription Agreement (10% Annual Interest)**</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td></tr>
  <tr style="vertical-align: top">
    <td>10.12</td>
    <td>&nbsp;</td>
    <td><a href="mobiquity_ex1012.htm">Employment Agreement dated January 4, 2022 – Deepanker Katyal</a>
    *</td></tr>
  <tr style="vertical-align: top">
    <td>10.13</td>
    <td>&nbsp;</td>
    <td>Employment Agreement dated January 4, 2022 – Don Walker (“Trey”)
    Barrett, III (incorporated by reference to Form 8-K filed with the SEC on January 6, 2022).</td></tr>
  <tr style="vertical-align: top">
    <td>21.1</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819000902/mobiquity_10k-ex2101.htm">Subsidiaries of the Issuer (<span style="background-color: white">Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.</span></a>)</td></tr>

<tr style="vertical-align: top">
    <td style="width: 8%"><span style="font-size: 10pt">31.1</span></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="text-align: justify; width: 91%"><span style="font-size: 10pt"><a href="mobiquity_ex3101.htm">Rule 13a-14(a) Certification in accordance with Section 302 of the Sarbanes-Oxley Act of 2002</a></span> <span style="font-size: 10pt">(*)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 10pt">31.2</span></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="mobiquity_ex3102.htm">Rule 13a-14(a) Certification in accordance with Section 302 of the Sarbanes-Oxley Act of 2002</a>(*)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 10pt">32.1</span></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="mobiquity_ex3201.htm">Certification pursuant to 18. U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a>(*)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-size: 10pt">32.2</span></td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="mobiquity_ex3202.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a>(*)</span></td></tr>

<tr style="vertical-align: top">
    <td style="width: 8%">99.1</td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 91%"><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968705000751/ace_10sbaex99-1.txt">2005 Employee Benefit and Consulting Services Compensation Plan (<span style="background-color: white">Incorporated by reference to Registrant’s Registration Statement on Form 10-SB/A filed with the Commission March 21, 2005.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>99.2</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968705002245/ace_10qsb-ex9904.txt">Amendment to 2005 Plan (<span style="background-color: white">Incorporated by reference to the Registrant's Form 10-QSB/A filed with the Commission on August 15, 2005.</span>)</a></td></tr>
  <tr style="vertical-align: top">
    <td>99.3</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000101968710001181/ace_10k-ex9907.txt">2009 Employee Benefit and Consulting Services Compensation Plan (Incorporated by reference to Form 10-K filed for the fiscal year ended December 31, 2009.)</a></td></tr>
  <tr style="vertical-align: top">
    <td>99.4</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316819000077/mobiquity_def14a.htm">2018 Employee Benefit and Consulting Services Compensation Plan. (Incorporated by reference to Definitive Proxy Statement filed with the SEC on January 11, 2019.)</a></td></tr>
<tr style="vertical-align: top">
    <td>99.5</td>
    <td>&nbsp;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1084267/000168316821004928/mobiquity_ex9905.htm" style="-sec-extract: exhibit">2021 Employee Benefit and Consulting Compensation Plan</a>**</td></tr>

<tr style="vertical-align: middle">
    <td>101.INS</td>
    <td>&nbsp;</td>
    <td>Inline XBRL Instance Document *</td></tr>
  <tr style="vertical-align: middle">
    <td>101.SCH</td>
    <td>&nbsp;</td>
    <td>Inline Document, XBRL Taxonomy Extension *</td></tr>
  <tr style="vertical-align: middle">
    <td>101.CAL</td>
    <td>&nbsp;</td>
    <td>Inline Calculation Linkbase, XBRL Taxonomy Extension Definition *</td></tr>
  <tr style="vertical-align: middle">
    <td>101.DEF</td>
    <td>&nbsp;</td>
    <td>Inline Linkbase, XBRL Taxonomy Extension Labels *</td></tr>
  <tr style="vertical-align: middle">
    <td>101.LAB</td>
    <td>&nbsp;</td>
    <td>Inline Linkbase, XBRL Taxonomy Extension *</td></tr>
  <tr style="vertical-align: middle">
    <td>101.PRE</td>
    <td>&nbsp;</td>
    <td>Inline Presentation Linkbase *</td></tr>
  </tbody></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;_______________</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tbody><tr style="vertical-align: top">
    <td style="width: 0px">&nbsp;</td>
    <td style="width: 27px">*</td>
    <td style="text-align: justify">Filed herewith</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tbody><tr style="vertical-align: top">
    <td style="width: 0px">&nbsp;</td>
    <td style="width: 27px">**</td>
    <td style="text-align: justify">Previously filed under Form S-1 Registration Statement, File No. 333-260364.</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">(c)&nbsp; FINANCIAL STATEMENT SCHEDULES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not filing any financial statement schedules
as part of this Form 10-K because such schedules are either not applicable or the required information is included in the financial statements
or notes thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned,
thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tbody><tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2">MOBIQUITY TECHNOLOGIES, INC.</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 5%">&nbsp;</td>
    <td style="width: 45%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>By:</td>
    <td style="border-bottom: black 1pt solid">/s/&nbsp;Dean L. Julia</td></tr>
  <tr>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: top">&nbsp;</td>
    <td style="vertical-align: bottom">Dean L. Julia, </td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>Principal Executive Officer</td></tr>
  </tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: Shoreham, New York</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">March 29, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in
the capacities and on the dates indicated:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
  <tbody><tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%; font-weight: bold">Name</td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 32%; font-weight: bold">Title</td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; width: 1%; font-weight: bold; text-align: center">&nbsp;</td><td style="border-bottom: Black 1pt solid; width: 30%; font-weight: bold; text-align: center">Date</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left; padding-bottom: 1pt">/s/ Dean L. Julia</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">Principal Executive Officer and Director</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">March 29, 2022</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Dean L. Julia</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left; padding-bottom: 1pt">/s/Anne S. Provost</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt">Director</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">March 29, 2022</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Anne S. Provost</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left; padding-bottom: 1pt">/s/Peter Zurkow</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt">Director</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">March 29, 2022</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Peter Zurkow</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left; padding-bottom: 1pt">/s/Sean J. McDonnell, CPA</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">Principal Financial Officer</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">March 29, 2022</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Sean J. McDonnell</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left; padding-bottom: 1pt">/s/Michael Wright</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt">Director</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">March 29, 2022</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Michael Wright</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-decoration: underline; text-align: left; padding-bottom: 1pt">/s/Gene Salkind</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">Chairman of the Board</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">March 29, 2022</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">Gene Salkind</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="text-align: left; padding-bottom: 1pt">&nbsp;</td><td style="padding-bottom: 1pt">&nbsp;</td>
    <td style="padding-bottom: 1pt; text-align: left">&nbsp;</td><td style="padding-bottom: 1pt; text-align: center">&nbsp;</td><td style="padding-bottom: 1pt; text-align: left">&nbsp;</td></tr>
  </tbody></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dean L. Julia, Anne S. Provost, Peter Zurkow,
Michael Wright and Dr. Gene Salkind represent all the current members of the Board of Directors.&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<!-- Field: Page; Sequence: 104; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&nbsp;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&nbsp;</td></tr></tbody></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>





























































































































<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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
     10cfP/luu8IqLSz9tu1PBpp/i51/w10iMb26anCZrN/9e3Wbgm5sKOuXaJq9mRQ+QBDdSrE9XcnI+ZvWpt24qRj7b7+8tZ4= -->

</body>
</html>